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Silent aspiration is associated with pneumonia and mortality, and is poorly identified by 
traditional clinical swallowing evaluation (CSE). Currently, there is no reliable test for 
detecting silent aspiration during CSE. There is, however, increasing evidence for the 
validity of cough reflex testing (CRT) for identifying silent aspiration. This test has the 
potential to significantly improve clinical assessment of dysphagia. The aim of this research 
programme was to further investigate the validity, reliability and clinical utility of CRT for 
identifying patients at risk of silently aspirating.  
 
Several aspects of CRT were explored during this research programme. Two correlational 
studies were conducted to validate CRT for identifying silent aspiration against 
videofluoroscopic swallowing study (VFSS) and flexible endoscopic evaluation of 
swallowing (FEES). Cough reflex threshold testing was completed on 181 patients using 
inhaled, nebulised citric acid. Within one hour, 80 patients underwent VFSS and 101 
patients underwent FEES. All tests were recorded and analysed by two researchers blind to 
the result of the alternate test. Significant associations between CRT result and cough 
response to aspiration on VFSS (p = .003) and FEES (p < .001) were identified. Sensitivity 
and specificity were optimised at 0.6mol/L in patients undergoing VFSS (71%, 60% 
respectively) and at 0.4mol/L in patients undergoing FEES (69%, 71% respectively). A 
concentration of 0.8mol/L had the highest odds ratio (OR) for detecting silent aspiration (8 
based on VFSS, 7 based on FEES). Coughing on lower concentrations of citric acid 
(0.4mol/L compared with 1.2mol/L) was a better predictive measure of silent aspiration. 
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Diminished cough strength has also been associated with aspiration and increased risk of 
pneumonia. Reflexive cough is our primary defensive mechanism against aspiration and a 
measure of reflexive cough strength therefore holds greater relevance than one of voluntary 
cough strength. Despite common use and clinical applicability, the reliability of subjective 
cough judgements has received little attention. The inter- and intra-rater reliability of 
subjective judgements of cough in patients following inhalation of citric acid was assessed. 
Forty-five speech-language therapists (SLTs) were recruited to the first study. Of these, 11 
SLTs were currently using CRT in their clinical practice (experienced raters) and 34 SLTs 
reported no experience with CRT (inexperienced raters). Participants provided a rating of 
strong, weak or absent to ten video segments of cough responses elicited by inhalation of 
nebulised citric acid. The same video segments presented in a different sequence were re-
evaluated by the same clinicians following a 15-minute break. Inter-rater reliability for 
experienced raters was calculated with a Fleiss’ generalised kappa of .49; intra-rater 
reliability was higher with a kappa of .70. Inexperienced raters showed similar reliability 
with kappa values for inter-rater and intra-rater reliability of .36 and .62, respectively. SLTs 
demonstrated only fair to moderate reliability in subjectively judging a patient’s cough 
response to citric acid. Experience in making cough judgements did not improve reliability 
significantly.  
 
In a second study, specific training in cough physiology and cough judgement was provided 
to 58 trained SLTs. Inter-rater reliability of subjective judgements of cough in patients 
following inhalation of citric acid was assessed. Participants provided a rating of present or 
absent, and if present then a rating of strong or weak, to ten video segments of cough 
responses. Inter-rater reliability for cough presence was calculated with a Fleiss’ generalised 
kappa of .71 and cough strength was calculated at .61. Years of clinical experience did not 
COUGH REFLEX TESTING IN DYSPHAGIA 
 
viii 
improve inter-rater reliability significantly. Experience in using CRT did improve inter-rater 
reliability. Further validity and reliability research would be beneficial for guiding clinical 
guidelines and training programmes. 
 
By identifying patients at risk of silent aspiration, more informed management decisions 
can be made that consequently lead to a reduction in preventable secondary complications 
such as pneumonia. The clinical utility of CRT for reducing pneumonia in acute stroke 
patients was assessed through a randomised, controlled trial. Three hundred and eleven 
patients referred for swallowing evaluation were assigned to either 1) a control group 
receiving standard evaluation or 2) an experimental group receiving standard evaluation 
with CRT. Participants in the experimental group were administered nebulised citric acid 
with test results contributing to clinical decisions. Outcomes for both groups were measured 
by pneumonia rates at three months post stroke and other clinical indices of swallowing 
management. Analysis of the data identified no significant differences between groups in 
pneumonia rate (p = .38) or mortality (p = .15). Results of CRT were shown to influence 
diet recommendations (p < .0001) and referrals for instrumental assessment (p < 
.0001). Despite differences in clinical management between groups, the end goal of 
reducing pneumonia in post stroke dysphagia was not achieved.  
 
Through this research, the characteristics and outcomes associated with dysphagia secondary 
to stroke in New Zealand were identified. Baseline characteristics of 311 patients with 
dysphagia following acute stroke were collected during their hospital stay and outcomes 
were measured at three months post stroke. Mortality rates were 16% and pneumonia rates 
27%. Mean length of stay was 24 days and only 45% of patients were in their own home at 
three months post stroke. Pneumonia was significantly associated with mortality and 
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increased length of stay. Only 13% of patients received referral for instrumental assessment 
of swallowing. These data are discussed in reference to the National Acute Stroke Services 
Audit 2009 and internationally published data. The outcomes for stroke patients with 
dysphagia in New Zealand are poor with a high risk of pneumonia and long hospital stays 
when compared internationally.  
 
In summary, this research programme has contributed to our understanding of the use of CRT 
in patients with dysphagia. The addition of a measure of reflexive cough strength may add to 
clinical assessment but specific training is required to reach adequate reliability. CRT results 
are significantly associated with aspiration response on instrumental assessment and lower 
concentrations of citric acid provide a better predictive measure of silent aspiration. CRT can 
be standardised and therefore is not as susceptible to interpretative variance that plagues much 
of CSE. Sensitivity and specificity values using this CRT methodology are adequate for CRT 
to be incorporated into clinical protocols. Inclusion of CRT alone was not shown to be 
sufficient to change clinical outcomes however integration of CRT into clinical pathways may 
prove more successful. Further research evaluating the addition of CRT to a comprehensive 
CSE would add greatly to the field of dysphagia assessment.  
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Dysphagia is associated with pneumonia, mortality and longer hospital stays. Aspiration, 
particularly silent aspiration, is associated with increased pneumonia and mortality. 
Unfortunately, traditional clinical swallowing evaluation is not able to effectively identify 
patients who silently aspirate. There is, however, increasing evidence of the validity of CRT 
for identifying silent aspiration. Methodological limitations in previous studies prevent CRT 
from being easily translated into clinical protocols. Researchers have used sub-optimal 
methods for the neurologically impaired patient and have not justified dosage of tussive 
agent utilised. This research programme addressed the validity, reliability and clinical utility 
of CRT for identifying patients at risk of silently aspirating.  
 
Part A provides a literature review beginning with an introduction to swallowing physiology 
and airway protection as a clinical foundation for this thesis. Dysphagia and its 
consequences are reviewed with a particular focus on stroke and current literature on 
dysphagia assessment and its limitations are explained. An overview of cough physiology is 
provided to support the methodology of the research studies. Dystussia (impaired cough) 
has a significant impact on airway protection in those with dysphagia. Both impaired cough 
sensitivity and impaired cough strength are described in relation to dysphagia. Finally, 
cough testing methodology and existing literature on cough testing in dysphagia are 
presented. This will build the methodological basis for study designs and protocols in this 
thesis. Again, testing of both cough sensitivity and cough strength is discussed. 
 
Part B, C and D include five methodological studies looking at three aspects of CRT as part 
of dysphagia assessment: validity, reliability and clinical utility. This research improved 
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upon the methodologies used previously in CRT for dysphagia assessment and used a 
controlled CRT protocol appropriate for a neurological population. In Part B, Studies I and 
II investigated the validity of CRT against two previously validated instrumental measures 
of aspiration (videofluoroscopy and videoendoscopy). The diagnostic accuracies of a range 
of concentrations of citric acid for identifying patients at risk of silent aspiration are 
reported. Cough strength has been associated with increased aspiration and pneumonia risk 
and thus a subjective judgement of cough strength was included to the CRT protocol in the 
experimental studies. In Part C, Study III investigated the inter- and intra-reliability of 
subjective judgements of cough following citric acid inhalation in SLTs without any 
specific training. Study IV investigated if the inter-rater reliability of SLTs improved when 
specific training was provided. In Part D, Study V investigated the clinical utility of CRT 
for reducing pneumonia in patients with dysphagia after stroke. This randomised control 
trial compared functional outcomes for patients with and without CRT as a component of 
acute swallowing assessment. A discussion of the results of the research programme is 
provided in Part E. Introduction of a new tool comes with the challenge of changing clinical 
practice. Literature on changing clinical practice and the complexity of clinical decision-
making are reviewed while discussing the possible barriers to implementation of CRT by 
the clinicians in the studies.  
 
Study V uncovered valuable national data regarding clinical outcomes and clinical practices 
for patients with dysphagia after stroke in New Zealand. As a subordinate project, in Part F, 
Study VI defined these clinical outcomes and compared them to international standards. 
These outcomes have not been previously reported.  
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Finally, the clinical applicability of the results of this research programme and directions for 
future research are discussed. Adequate swallowing assessment remains a problem in 
dysphagia management with sub-optimal identification of silent aspiration by CSE, low 
instrumental assessment rates, and at a national level, high pneumonia rates when compared 
with published international data. Cough reflex testing with cough strength judgement is a 
valid and reliable tool for identifying silent aspiration in patients with dysphagia. CRT 
methodology described in this thesis is appropriate for the neurological patient and can be 
incorporated into clinical protocols. 
  

















Swallowing is a rapid, complex neuromuscular process involving 34 pairs of 
muscles, five cranial nerves, two cervical nerves and coordination between the brainstem 
and swallowing control regions in the cortex (Daniels & Huckabee, 2008; Lowell et al., 
2008). In studying the impact of neurological disease on swallowing and cough, a clear 
understanding of the physiology of swallowing is essential. To conceptualise this complex 
process, swallowing can be discussed in terms of phases: pre-oral, oral, pharyngeal and 
oesophageal (Daniels & Huckabee, 2008).  
 
2.1 Pre-Oral Phase 
 Before the bolus enters the mouth, a number of sensory inputs may already be 
activated through smell (olfactory nerve CN I) and sight (occipital nerve CN II). The 
primary visual and olfactory cortices receive these inputs and information is processed in 
preparation for the arrival of the bolus into the oral cavity (Daniels & Huckabee, 2008). 
Depending on the information received, motor efferents may initiate salivary production 
(facial nerve CN VII and glossopharyngeal nerve CN IX) and/or anticipatory airway closure 
(vagus nerve CN X) (Daniels & Huckabee, 2008).  
 
2.2 Oral Phase 
The motor aspects of the oral phase of swallowing are under voluntary control 
(Perlman & Schilze-Delrieu, 2003). The muscles of the lips (CN VII), cheeks (CN VII), jaw 
(trigeminal nerve CN V, hypoglossal nerve XII, cervical nerves C1 and C2) and intrinsic 
and extrinsic tongue (CN XII) hold the bolus within the oral cavity. They control and 
prepare the bolus for swallowing (Perlman & Schilze-Delrieu, 2003). The bilateral 
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palatoglossus muscles (CN IX) contract to ensure the tongue base and soft palate maintain 
contact throughout bolus preparation, preventing the bolus from entering the pharynx 
prematurely (Daniels & Huckabee, 2008). Contraction of styloglossus muscles (CN XII), 
stylohyoids and posterior belly of digastrics (CN VII) also support this closed port (Daniels 
& Huckabee, 2008). Inadequacy of this seal may lead to aspiration of the bolus before 
airway closure is completed (Daniels & Huckabee, 2008). 
Meanwhile, stimulation of taste receptors across the tongue (CN VII, CN IX) and 
abundant pressure receptors across the tongue and palate (CN V, CN VII, CN IX) synapse 
either directly or indirectly in the NTS, allowing the motor response to be modulated for 
each specific bolus (Daniels & Huckabee, 2008; Perlman & Schilze-Delrieu, 2003). Once 
the bolus is prepared, the tongue base is pulled downwards, the tongue squeezes against the 
palate in a backwards motion, pushing the bolus into the pharynx (CN XII) (Perlman & 
Schilze-Delrieu, 2003).  
 
2.3 Pharyngeal Phase 
The pharyngeal phase of swallowing is rapid and involves a complex sequence of 
movements. Pharyngeal swallowing is initiated by a combination of sensory inputs from 
CN V, CN VII, CN IX during the oral phase of swallowing and can be cortically modulated 
for bolus type and size (Perlman & Schilze-Delrieu, 2003). It is thought that deep tongue 
receptors during the downwards motion of the tongue may also play a part in initiating 
swallowing (Daniels & Huckabee, 2008). Without timely triggering of swallowing, the 
bolus again risks entering the airway before airway protection has been fully completed 
(Daniels & Huckabee, 2008). 
Superior and anterior hyoid movement (CN V, CN VII, CN XII, C1, C2) often 
begins early in the pharyngeal swallowing sequence (Leonard & Kendall, 2008). At its 
COUGH REFLEX TESTING IN DYSPHAGIA 
 
8 
maximum point, this leads to full deflection of the epiglottis and opening of the upper 
oesophageal sphincter (UES). The palate rises (CN IX, CN X) to close off the nasal 
passages and allows the bolus to leave the oral cavity (Perlman & Schilze-Delrieu, 2003). 
Sensory information in the pharynx (CN V, CN IX, CN X) not only leads to elicitation of 
pharyngeal swallowing but also modulation of airway closure, pharyngeal constriction and 
clearance swallows (Daniels & Huckabee, 2008). 
The transit of the bolus through the pharynx is a closely coordinated sequence of 
events. The base of tongue pushes against the posterior pharyngeal wall providing the 
positive pressure and the driving force for the bolus through the pharynx. At the same time 
the pharyngeal muscles contract to achieve pharyngeal shortening (Ekberg, 2012). This 
provides a compliant tube for the bolus to travel through and brings the UES towards to 
base of tongue to meet the bolus (Ekberg, 2012).The superior, middle and inferior 
constrictors then sequentially constrict to clear the bolus through the pharynx and through 
the compliant, open UES (Kahrilas, 1993). Inadequacies in any of these motor and sensory 
functions may lead to reduced airway protection, residue remaining in the pharynx post 
swallowing and aspiration risk (Daniels & Huckabee, 2008). 
 
2.4 Oesophageal Phase 
The final stage of swallowing is the oesophageal phase. This involves an involuntary 
peristaltic wave of muscle contraction taking the bolus from the UES to the stomach 
(Logemann, 1998). The oesophagus begins as striated muscle in the cervical oesophagus but 
transitions to smooth muscle in the thoracic oesophagus (Goyal & Chaudhury, 2008). The 
oesophagus is innervated predominately by vagal efferents projecting from the nucleus 
ambiguous (NA) (Goyal & Chaudhury, 2008). Redirection of food, fluids or acidic stomach 
contents back into the pharynx leads to aspiration risk (Logemann, 1998). 




2.5 Neural Control 
In studying swallowing after neurological injury, an understanding of 
neurophysiology is critical. The basic motor plan for swallowing is controlled by a central 
pattern generator in the medulla of the brainstem (Daniels & Huckabee, 2008). As a result, 
injury to the brainstem results in impairments of swallowing as well as cough and 
respiration (Cichero & Murdoch, 2006). Neurones involved in swallowing have been found 
in the bilateral nuclei of tractus solitarius (NTS) and NA (Perlman & Schilze-Delrieu, 
2003). The NTS receive all afferent signals from the pharynx and larynx and is the primary 
sensory nucleus for CN VII, CN IX and CN X (Daniels & Huckabee, 2008). NTS receive 
secondary input from trigeminal sensory nuclei in the pons. The NA are the primary motor 
nuclei for CN IX, CN X and CN XI. The NA has extensive interconnections with the NTS 
for CN V, CN VII and CN XII. The primary sensory nuclei for the superior laryngeal nerve 
(SLN) of CN X are in the NTS but these nerves also connect directly to the NA for 
initiation of reflexive cough (Daniels & Huckabee, 2008). 
The role of the cortex in swallowing is not easily understood. Swallowing involves 
complex motor and sensory processing, motor planning and initiation, motor control and 
coordination. Timely coordinated swallowing requires efficient feed-forward/ feedback 
loops between the brainstem and cortex through the cortico-bulbar tract as well as between 
distinct areas in the cortex (Malandraki, Johnson, & Robbins, 2011). Damage to the cortex 
may also result in swallowing impairments (Lowell et al., 2008). Using functional magnetic 
resonance imaging (fMRI) and positron emission tomography (PET), a number of areas of 
bilateral activation have been consistently found during swallowing: pre-motor cortex, 
primary motor cortex, primary sensory cortex, operculum, supplementary motor area, 
cingulate cortex, parietal-occipital regions, insula cortex, thalamus and cerebellum during 
COUGH REFLEX TESTING IN DYSPHAGIA 
 
10 
volitional swallowing (Hamdy et al., 1999; Kern, Jaradeh, Arndorfer, & Shaker, 2001; 
Lowell et al., 2008; Malandraki, Sutton, Perlman, Karampinos, & Conway, 2009; Sawcruk 
& Mosier, 2001).  
Imaging studies are especially difficult in swallowing. Limitations in temporal 
sensitivity make separating components of the rapid swallowing process difficult and add 
complexity to analysis and interpretation (Huckabee, Deecke, Cannito, Gould, & Mayr, 
2003). Subjects are required to lie supine and the effect of this abnormal swallowing 
position on neural activity is unknown. Subjects are often required to follow visual or 
auditory cues during procedures and the effect of these cues on parietal-occipital activation 
is also unknown (Malandraki et al., 2009). Finally, imaging of truly reflexive swallowing 
events has proven difficult in this controlled environment and most studies report activation 
during voluntary swallowing tasks only (Kern et al., 2001).  
The primary sensorimotor areas were traditionally thought to be activated during the 
volitionally controlled oral phase of swallowing while pharyngeal, reflexive swallowing 
relies primarily on brainstem control (Kern et al., 2001). However there is now strong 
evidence to the contrary. Hamdy and colleagues have contributed greatly to this field of 
study. They have used transcranial magnetic stimulation (TMS) and electromyography to 
map the organisation of the primary motor cortex projections for oral, pharyngeal and 
oesophageal swallowing muscles (Hamdy, Rothwell, Aziz, & Thompson, 2000; Hamdy et 
al., 1999). Malandraki and colleagues have also contributed to our enhanced understanding 
of the neural control of different components of the swallowing process (Malandraki et al., 
2009). Recently, they compared 3ml water swallowing with three oro-pharyngeal tasks: i) 
“prepare to swallow” task to represent pre-oral phase ii) a tongue tap task to represent the 
oral phase and iii) a throat clear task to represent the pharyngeal phase. The study involved 
ten healthy young adults and a detailed justification of imaging techniques were provided 
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(Malandraki et al., 2009). Primary sensorimotor areas were consistently activated during 
water swallowing as well as all three oro-pharyngeal tasks. Tongue tapping led to more 
activation in this area than other tasks and the authors speculate increase voluntary motor 
control requirements for this oral task. The pre-motor cortices are known to contribute to 
motor planning and execution and again were activated in all tasks. The insular cortices, 
known for their sensory-motor integration role, while activated in all tasks, were activated 
more during throat clear suggesting an increased role in laryngeal control. Finally, 
cerebellum, known for its role in coordination of sensori-motor output was activated during 
water swallowing but not in the experimental tasks. The authors hypothesise that the 
cerebellum may be more involved in coordination of the complex sensori-motor tasks of the 
pharynx rather than simple oral tasks (Malandraki et al., 2009).  
Similar findings have been reported in studies using non-imaging methodologies 
(Huckabee et al., 2003). Using electroencephalography (EEG), Huckabee and colleagues 
studied pre-motor activation on 20 healthy subjects. They also found consistent 
supplementary motor cortex activation and concluded that the supplementary motor cortex 
has a significant role in pre-motor planning and temporal sequencing of volitional 
swallowing (Huckabee et al., 2003).  
Despite bilateral cortical activation, hemispheric dominance for swallowing has 
been shown and varies from subject to subject irrespective of handedness (Hamdy et al., 
2000; Hamdy et al., 1999; Humbert et al., 2009). This may be of interest in dysphagia after 
cortical stroke. With a significant portion of stroke events in cortical regions rather than the 
brainstem, the impact of primary sensorimotor damage to all phases of swallowing is of 
importance.  
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2.6 Respiration and Airway Protection 
A basic understanding of respiration is useful for understanding neurological 
impairment of swallowing and cough as the systems share common neurophysiological 
pathways and functions are biomechanically integrated (Martin-Harris, 2008). Respiration 
is controlled by the inspiratory and expiratory respiratory centres in the dorsomedial 
medulla, which are associated with the NTS and NA. It is regulated by the pneumotaxic 
area in the pons (Sawcruk & Mosier, 2001). The sensory receptors involved in respiration 
are discussed in Chapter Four. Receptors respond to changes in carbon dioxide in the blood 
as well as other lung changes (Canning, 2006). Sensory information is transmitted through 
CN X to the NTS and the respiratory centres where respiratory activity is modified 
(inspiration, expiration, rate and depth of response) through motor pathways to the 
diaphragm, intercostal muscles, abdominal muscles as well as the larynx (Canning, 2002). 
During inspiration, the cricothyroid muscles lengthen and tense the vocal cords while the 
posterior cricoarytenoid muscles increase the diameter of the glottis (Sasaki & Buckwalter, 
1984). During expiration, the cricothyroid muscles appear to have a crucial and complex 
role in airflow control through the glottis (Sasaki & Buckwalter, 1984). As with 
swallowing, respiratory acts can be consciously altered suggesting a capacity for cortical 
modulation (Davenport & Reep, 1995). Functional MRI studies report activation in primary 
motor and supplementary cortices, premotor cortex, insular cortex, basal ganglia, 
hypothalamus and cerebellum during passive respiration (Davenport & Reep, 1995). 
 
2.6.1 Airway protection. 
During swallowing, the airway is protected by closure of the true and false vocal 
cords, medial movement of the arytenoids towards each other and the downward tilting of 
the epiglottis (Flaherty, Seltzer, Campbell, Weisskoff, & Gilbert, 1995; Jafari, Prince, Kim, 
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& Paydarfar, 2003). The larynx moves upward and forward, contributing to pharyngeal 
shortening, opening of the hypopharynx, inverting of the epiglottis, closure of the airway 
and opening of the UES (Flaherty et al., 1995; Jafari et al., 2003). Activation of the bilateral 
thyroarytenoid and cricothyroid muscles as well as the lateral cricoarytenoid muscles and 
vocalis muscles close the vocal cords (Sasaki & Buckwalter, 1984). The false cords come 
together when the thyroarytenoid muscles are activated. Extrinsic laryngeal muscles 
(sternothyroid and thyrohyoid muscles) move the arytenoid cartilages anteriorly and elevate 
the larynx (Sasaki & Buckwalter, 1984). Impairment to any of these multiple laryngeal 
muscles groups can lead to aspiration (Cichero & Murdoch, 2006).  
It has long been established that the recurrent laryngeal nerve (RLN) provides 
sensory innervation to the subglottis while the superior laryngeal nerve (SLN) innervates 
the supraglottis and larynx (Jafari et al., 2003; Sant’Ambrogio, 1996). Numerous studies 
using internal SLN anaesthesia have established the importance of the sensory function of 
the internal SLN in swallowing and airway protection (Jafari et al., 2003). Jafari and 
colleagues conducted a carefully designed study on the effect of internal SLN anaesthesia 
on swallowing and respiration in humans. Saline control procedures were completed in six 
subjects and endoscopy confirmed anaesthesia in all subjects. VFSS, airflow measures, 
respiratory inductance plethysmography and manometry were completed (Jafari et al., 
2003). Healthy subjects were able to voluntarily close the airway during internal SLN 
anaesthesia but regularly penetrated and aspirated despite no abnormal findings in timing or 
biomechanics in the oro-pharynx on VFSS and manometry (Jafari et al., 2003). In all cases 
of aspiration, coughing did not occur until the aspirated material reached the trachea again 
confirming the lack of sensation to the vocal cords (Jafari et al., 2003). They conclude that 
intact supraglottic sensation is necessary to modulate adequate airway closure during 
swallowing. 




2.6.2 Coordination of swallowing and respiration. 
Although efficient, timely transit of the bolus through the oropharynx and adequate 
airway closure are vitally important, the respiratory system is also crucial to safe 
swallowing (Cichero & Murdoch, 2006). In normal subjects, there is a consistent 
respiratory-swallowing pattern emphasising the inter-connections between systems. 
Swallowing usually occurs after a small inspiration followed by a small exhalation. During 
the swallow there is a period of apnoea and then after the conclusion of the swallow, there is 
an immediate exhalation (Preiksaitis & Mills, 1996; Shaker et al., 1992). The period of 
apnoea occurs during swallowing and facilitates protection of the airway (Hiss, Strauss, 
Treole, Stuart, & Boutilier, 2003). It usually occurs before the palate is fully raised and 
precedes laryngeal closure (Hiss et al., 2003). Swallowing apnoea is a protective 
mechanism and increases in duration with bolus size and with age (Hiss, Treole, & Stuart, 
2001; Perlman, Ettema, & Barkmeier, 2000). Respiratory-swallowing coordination is 
disturbed in neurological disease, with evidence of increased inspiration before and/ or 
following a swallow (Martin-Harris, 2008). This altered respiratory-swallowing pattern has 
implications for airway safety. Patients following head and neck cancer treatment, also, 
have shown the same a tendency to inhale before and/ or after swallowing and this pattern 
correlates with aspiration and dysphagia severity (Brodsky et al., 2010).  
Neural control of the respiratory-swallowing pattern is not well defined. It is thought 
that there is a close neural relationship between respiratory and swallowing systems in the 
NTS in the brainstem (McFarland & Tremblay, 2006; Shiba, 2009) and that swallowing 
neural elements re-task respiratory neural elements to reconfigure the respiratory neural 
network i.e. reset the respiratory rhythm (Davenport, Bolser, & Morris, 2011). The 
influence of the cortex on respiratory-swallowing coordination is unclear.  





In summary, swallowing physiology and airway protection are complex and, 
although highly reliant on brainstem control, are also dependent on multiple areas of the 
cortex and subcortex for planning and execution. Respiration is also a cortically modulated 
act and is intrinsically linked with swallowing and airway protection. Without a clear 
understanding of respiration and swallowing physiology, assessment and management of 
patients with swallowing impairment will be sub-optimal.    














 Dysphagia is defined as difficulty with swallowing. Dysphagia is a symptom of a vast 
number of developmental or acquired disorders and diseases and can occur at any phase of the 
swallowing process (Cichero & Murdoch, 2006). Dysphagia is common in neurological 
conditions such as stroke (Daniels & Huckabee, 2008; Mann, Hankey, & Cameron, 2000), 
progressive neurological diseases such as Parkinson’s disease (Johnston, Li, & Castell, 1995) 
and neurological trauma (E. Ward & Morgan, 2009). Advanced dementia is associated with 
dysphagia rates as high as 86% (Mitchell et al., 2009). It is a common symptom of structural 
abnormalities such as head and neck cancer and its treatments, trauma and burns, surgery, 
tracheostomy as well as medication effects, respiratory disease, infectious disease, 
autoimmune diseases, gastro-oesophageal conditions and many others (Cichero & Murdoch, 
2006). As a symptom of an underlying disease, dysphagia is often described by its clinical 
signs (coughing, food sticking in the throat, dehydration) and the primary focus of the 
problem (oral, pharyngeal, oesophageal) (Groher & Crary, 2010). More detailed descriptions 
of the symptoms (residue in the vallecula, premature spillage to the pyriform fossa) and 
physiological causes (impaired hyoid movement, reduced base of tongue strength) are 
commonly used. 
 Dysphagia after stroke is well documented. Up to 64% of stroke patients are likely to 
have dysphagia in the acute stages with one study reporting a prevalence of 54% in bilateral 
hemispheric strokes and 50% prevalence in brainstem strokes (Daniels & Foundas, 1999; 
Mann et al., 2000). Dysphagia has been associated with increased stroke severity, multiple 
strokes, reduced level of consciousness, cognitive impairment, aphasia and dysarthria (Baroni, 
Fabio, & Dantas, 2012; Falsetti et al., 2009; Okubo, Fabio, Domenis, & Takayanagui, 2012). 
A score of 12 or less on the National Institutes of Health Stroke Scale (NIHSS), an 
COUGH REFLEX TESTING IN DYSPHAGIA 
 
18 
internationally recognised subjective stroke severity measure, was found to predict dysphagia, 
as classified by another subjective assessment, the CSE, with 88% sensitivity and 85% 
specificity (Okubo et al., 2012). In a retrospective study of 378 patients referred for VFSS, 
those with multiple stroke, brainstem stroke and subcortical stroke had a higher incidence of 
aspiration than those with cortical stroke (Ding & Logemann, 2000). The most frequent 
dysphagic impairments on VFSS documented after stroke are delayed swallowing, poor 
tongue control, weak pharyngeal stripping and poor hyo-laryngeal excursion (Logemann, 
1998), with delayed swallowing and decreased hyo-laryngeal elevation the most commonly 
judged causes of aspiration (Lundy et al., 1999).  
 
3.1 Assessment of Dysphagia 
3.1.1 Swallowing assessment. 
 Dysphagia has been associated with pneumonia and mortality (Barber, Curran, 
Fishwick, Niimi, & Mishima, 2003; Baroni et al., 2012; WF Westendorp, Nederkoorn, 
Vermeij, Dijkgraaf, & vandeBeek, 2011), poor functional outcomes (Finlayson et al., 2011; 
Lakshminarayan et al., 2010), increased length of hospital stay (Altman, Yu, & Schaefer, 
2010), dehydration (Crary et al., 2013) and malnutrition (Doggett et al., 2001). These 
consequences of dysphagia will be discussed in detail later in the chapter. Given the 
significantly poorer outcomes associated with dysphagia, it is critical that clinicians identify 
high-risk patients early in their hospitalisation (Perry & Love, 2001). Disappointingly, the 
New Zealand National Acute Stroke Audit 2009 found only 57% of stroke patients received a 
swallowing screening prior to commencing oral intake and the report strongly advised that 
DHBs addressed this with urgency (Stroke Foundation of New Zealand, 2010). Swallowing 
screening and assessment can take many forms: a checklist of risk factors (Daniels, Lindsay, 
Ballo, Mahoney, & Foundas, 2000), a water test (DePippo, Holas, & Reding, 1994; Leder, 
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Suiter, & Green, 2010) or a standardised swallowing assessment including both checklists and 
oral trials (Ellul & Barar, 1996; McCullough, Rosenbek, Wertz, & McCoy, 2005; Smithard et 
al., 1998; Trapl et al., 2007). Although the focus of this thesis is on aspiration detection, 
swallowing assessments clearly have much greater scope in the identification of physiological 
impairments as well as mealtime competence. 
Silent aspiration is difficult to assess at bedside. Asking a patient to cough does not 
provide information about cough sensitivity only voluntary cough. Absence of cough while 
drinking or eating also does not reliably indicate absence of aspiration, because the 
aspiration may be occurring with no response, silently. Validity of the water test has received 
substantial attention. Its appeal is likely that it is quick and easy to perform. Table 3.1 
summarises the results of water swallow tests in predicting aspiration.  
Validity varies considerably across studies with the 3oz water test reaching 97% 
sensitivity in one mixed cohort but only achieving 48% sensitivity in a cohort of stroke 
patients (McCullough et al., 2005; Suiter & Leder, 2007). Results are difficult to compare. In 
addition to patient population differences, there are differences in bedside assessment 
protocols as well as differences in instrumental assessment protocols and definitions of 
aspiration. Many studies do not disclose whether assessors were blinded to the result of the 
other test and in the case of the Suiter and Leder study, the same clinician completed the 
second test immediately after the first adding significant potential for bias (Suiter & Leder, 
2007). Studies with time delays between administration of CSE and instrumental assessments 
in acute, rapidly changing stroke patients should be interpreted with caution. Most 
importantly, water tests identify patients who cough on aspiration but are limited in their 
ability to predict silent aspiration. The water test is unlikely to be a reliable tool for 
identifying patients at risk of silent aspiration. 
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The reliability of identifying aspiration in a comprehensive CSE is also poor with 
most studies indicating that the CSE underestimates aspiration, again due to the presence of 
silent aspiration (Ramsey, Smithard, & Kalra, 2003; Smithard et al., 1998; Splaingard, 
Hutchins, Sulton, & Chaudhuri, 1988). By 2012, there were 35 published swallowing 
assessments according to a recent systematic review (Schepp, Tirschwell, Miller, & 
Longstreth, 2012). Only four met the authors’ basic but unspecified quality criteria for 
reliability, validity and ease-of-use: the Barnes Jewish Hospital Stroke Dysphagia Screen, 
the Modified Mann Assessment of Swallowing Ability, Emergency Physician Swallowing 
Screening and the Toronto Bedside Swallowing Screening Test. A systematic review in 
2003 found a wide range of values for sensitivity (42%-92%) and specificity (59%-91%) for 
identifying aspiration through bedside tests of swallowing (Ramsey et al., 2003). Inter-rater 
reliability was also variable (ț = 0 to 1.0) (Ramsey et al., 2003).  
Terre and Mearin compared CSE findings with VFSS findings in 64 patients with 
clinically suspected dysphagia after stroke. They found no statistically significant 
correlation between CSE results and aspiration on VFSS (Terre & Mearin, 2006). The CSE 
used was far from comprehensive, consisting of an assessment of palatal and gag reflexes, 
followed by a judgement of coughing and voice quality changes during thickened fluid 
intake. The experience and training of the assessors was not described nor was the timing 
of CSE compared to VFSS. Similarly, Splaingard and colleagues compared CSE findings of 
107 mixed aetiology inpatients with VFSS findings performed within 72 hours of CSE. 
Standardised protocols were used for both assessments and clinicians who completed the 
VFSSs were blinded to the results of the CSE. They found that 40% of their subjects 
aspirated (20% silently) with the CSE only identifying 42% of the aspirating patients. 
Seventy percent of patients with profound aspiration on VFSS were not identified as 
aspirating during their CSE (Splaingard et al., 1988). The 72-hour time period between 




studies leads to concern in an acute population where patients’ clinical manifestations can 
change rapidly. However, the VFSS always occurred after the CSE and thus if swallowing 
had improved during the time lag, the CSE should have over-predicted aspiration rather than 
under-predicted it. 
Daniels and colleagues have contributed significantly to our understanding of the 
clinical predictors for aspiration. They completed a number of studies looking at the clinical 
characteristics and outcomes for patients with dysphagia after stroke (Daniels et al., 1998; 
Daniels et al., 2000). Swallowing was assessed by CSE and VFSS and they found six 
predictors of aspiration risk that can be identified at bedside: dysphonia, dysarthria, abnormal 
gag, abnormal volitional cough, coughing after drinking, voice changes after drinking 
(Daniels et al., 1998). Although sensitivity and specificity of coughing on water was not 
substantial (sensitivity 57%, specificity 85%), they demonstrate that combining clinical 
features provides stronger predictive values. Combining abnormal volitional cough with 
coughing when swallowing provided 69.9% sensitivity and 84.4% specificity for predicting 
aspiration (Daniels et al., 2000). The literature to date suggests that no one clinical sign in 
isolation will provide both high sensitivity and specificity values and that the clinician needs 
to synthesise a large number of factors in clinical decision-making. However, the significant 
flaw in even the most comprehensive clinical swallowing assessments is still the absence of a 
test of airway responsiveness. If a patient does not cough, there is no distinction between 
those who aspirate silently and those who do not aspirated.  
 
3.1.2 Instrumental assessments. 
 Considering the poor identification of silent aspiration on clinical assessment, Ding 
and Logemann strongly criticise the lack of instrumental assessment use in dysphagia 
following stroke (Ding & Logemann, 2000). Until a reliable, valid bedside assessment of 




aspiration is established, instrumental assessments of swallowing such as VFSS or FEES are 
the only reliable way to identify silent aspiration. VFSS and FEES are both established 
instrumental tools for identifying normal and abnormal swallowing physiology and 
identifying presence and absence of aspiration (Langmore, Schatz, & Olson, 1991; Leder, 
Sasaki, & Burrell, 1998; Logemann, 1998; Wu, Hsiao, Chen, Chang, & Lee, 1996).  
 VFSS is a multidisciplinary dynamic radiographic study performed in a radiology 
suite. Patients ingest food and fluids containing radio-opaque barium and the procedure is 
usually recorded and played back for analysis (Carrau & Murry, 1999). VFSS has the 
advantage of allowing lateral and anterior-posterior views of the oral, pharyngeal and 
oesophageal phases of swallowing as well as the airway (Logemann, 1998). FEES, in 
comparison, is a procedure where a flexible endoscope with a camera and light source is 
passed through the nose into the pharynx allowing a view of the pharynx and airway while a 
patient is instructed to eat and drink (Logemann, 1998). The procedure is regarded as safe 
and is easy to perform at a patient’s bedside but like VFSS requires specialist equipment and 
staff (Warnecke et al., 2009). Again the procedure is usually recorded for later analysis. It has 
the advantage of avoiding radiation and provides a direct view and access to the vocal cords, 
airway and the accumulation of secretions (Murray, Langmore, Ginsberg, & Dostie, 1996). 
However the camera view is obliterated mid-swallow as the scope is covered and FEES 
provides less information about the oral phase of swallowing, hyoid movement, the UES and 
oesophagus when compared with VFSS (Aviv, 2000; Logemann, Rademaker, Pauloski, 











                  
              a)                                                                    b) 
Figure 3.1 Comparison of views seen on a) VFSS vs. b) FEES 
 
Although both assessments are established tools in dysphagia management, they have 
been criticised for their subjectivity and insufficient reliability (McCullough et al., 2001; 
Scott, Perry, & Bench, 1998). Fortunately, there is a growing interest in the development of 
more objective protocols (Leonard & Kendall, 2008; Martin-Harris et al., 2008; Murray et al., 
1996). Rosenbek and colleagues have developed strong reliability evidence (Ƹ .96) within 
their research laboratory for their 8-point scale: the Penetration-Aspiration Scale (PAS) 
(Figure 3.2) (Rosenbek et al., 1996). It can be used in both VFSS and FEES procedures for 
defining airway invasion and response and encourages more standardised reports of 
penetration and aspiration (Colodny, 2002; Rosenbek et al., 1996). This scale is widely used 
in clinical practice and research but has some limitations. It has been published as a scale 
with progressing severity marked by increasing scores, but this classification is arguable. It 
relies on depth of aspiration as the primary marker of severity so although a score of five may 
well be one step more severe than a score of four, the same degree of difference is not as 
clear for a score of three compared with a score of four where the aspirated material is still 




present and risks entering deeper in the airway after the assessment concludes. In fact even an 
ordinal scale could be argued, as it does not consider silent aspiration (depicted by scores 5 
and 8) as more severe than aspiration events where the aspirated material is ejected (depicted 
by scores 4 and 6). Consequentially, parametric statistical methods have often been used in 
research using this scale. Yet non-parametric analysis for nominal data may be more 
appropriate. In research identifying silent aspiration, this internationally recognised scale may 
not be ideal. 
 
 
8-Point Penetration-Aspiration Scale 
Score. Description of events.  
1.        Material does not enter airway 
2.        Material enters the airway, remains above the vocal folds, and is ejected from the airway. 
3.        Material enters the airway, remains above the vocal folds, and is not ejected from the airway. 
4         Material enters the airway, contacts the vocal folds, and is ejected from the airway. 
5.        Material enters the airway, contacts the vocal folds, Ϯ  and is not ejected from the airway. 
6.        Material enters the airway, passes below the vocal folds, and is ejected into the larynx or out 
of the airway. 
7.        Material enters the airway, passes below the vocal folds, and is not ejected from the trachea 
despite effort. 
8.        Material enters the airway, passes below the vocal folds, Ϯand no effort is made to eject 
Figure 3.2 Penetration-Aspiration Scale scores (Adapted from Rosenbek et al., 1996, p. 94) 
 
 FEES is thought to identify small amounts of penetration and aspiration that are not 
visible on VFSS. Although whether this penetration is clinically significant is questionable as 
trace penetration and aspiration is relatively common in healthy individuals of all ages (Allen, 




White, Leonard, & Belafsky, 2010; Butler, Stuart, Markley, & Rees, 2009). Kelly and 
colleagues found significantly higher penetration-aspiration scale scores using FEES 
compared with VFSS in a study using simultaneous FEES and VFSS in 15 dysphagic 
patients (Kelly, Drinnan, & Leslie, 2007). However, this study has limitations that make 
strong conclusions from these findings difficult. The 15 SLT raters only reached moderate 
inter-rater reliability (FEES ț  .64, VFSS ț = .67) and rater experience also had a significant 
impact on penetration-aspiration scores with higher scores rated by more experienced SLTs. 
Most importantly, the mean difference in scale scores between assessment type was 1.15 
which may not be clinically significant, especially as the majority of scores were within the 
penetration section of the scale (scores between 1-3) (Kelly et al., 2007). 
It is important to acknowledge that neither VFSS nor FEES directly assesses airway 
sensitivity. Instead, a clinician must wait for an aspiration event to occur, and then observe 
the airway response. An adjunct to FEES is fibreoptic endoscopic evaluation of swallowing 
with sensory testing (FEESST) (Aviv, Kim, Sacco, & Kaplan, 1998; Flaksman et al., 2006; 
C. Rees, 2006). This direct test of laryngeal sensation uses an air-pulse stimulator to ‘puff’ air 
on the mucosa of the vocal cords stimulating an expiratory reflex (ER)/ laryngeal adductor 
reflex (LAR) (Aviv et al., 1998). The air pulse pressures can be controlled and normative data 
has been collected allowing objective interpretation (Aviv et al., 1998). The ER can be 
visualised and a patient can also be asked to “lift your hand when you feel something”. The 
air puff is accompanied by a marked ‘clicking noise’ and the travelling air (through the 
sheath on the scope) is felt through the nose as well as on the vocal cords. It is unknown how 
these factors impact on test reliability. Placebos involving the subject receiving intermittent 
zero intensity trials have been used to ensure subjects are responding to sensation rather than 
the noise of the equipment (Aviv, Sacco, Thomson, & Tandon, 1997). Other reported 
techniques for assessing laryngo-pharyngeal sensation are described by Nishino and 




colleagues and include touching the vocal folds with the endoscope tip or injecting a small 
amount of distilled water into the larynx and watching for an LAR response (Nishino, 
Tagaito, & Isono, 1996). These latter techniques are simple, binary measures of sensitivity in 
comparison to the pressure thresholds obtained during FEESST and are thought to hold a 
higher risk of laryngospasm (Kidder, Langmore, & Martin, 1994).  
 
3.2 Consequences of Dysphagia 
 According to the National Acute Stroke Services Audit 2009 (Stroke Foundation of 
New Zealand, 2010), there were approximately 6,000 first ever and 2,000 recurrent strokes 
in New Zealand in 2009. Stroke is New Zealand’s third highest cause of death and the 
greatest cause of long-term adult disability (Stroke Foundation of New Zealand, 2010). A 
large recent international review of stroke services found one third of early stroke-related 
fatalities were caused by modifiable factors such as pneumonia and the authors state that it 
is the responsibility of stroke units to reduce these statistics (Koennecke et al., 2011). 
Dysphagia has been associated with poor outcomes (Altman et al., 2010; Barber et al., 
2003; Baroni et al., 2012; Crary et al., 2013; Doggett et al., 2001; Finlayson et al., 2011; 
Lakshminarayan et al., 2010; WF Westendorp et al., 2011). A recent UK study of 2983 
patients found longer hospitalisation and higher mortality for patients with dysphagia with 
the odds ratio for death of 12.5 if dysphagia was present (Guyomard et al., 2009). Most 
large-scale stroke studies diagnose dysphagia by subjective CSE rather than instrumental 
assessment for feasibility reasons and this study is no exception. The dysphagia researcher 
needs to be cautious in the interpretation of these studies and compare them against the 
smaller, more objective studies for a fuller picture of the consequences of dysphagia. 
Prevention of the modifiable consequences of dysphagia and stroke needs careful attention. 
 




3.2.1 Aspiration pneumonia. 
 Aspiration pneumonia is an infectious process caused by the inhalation of oro-
pharyngeal secretions that are colonized by pathogenic bacteria (Marik, 2001). There is a 
high rate of pneumonia in patients with neuropathologies (Marik & Kaplan, 2003; Yamaya, 
Yanai, Ohrui, Arai, & Sasaki, 2001). Aspiration pneumonia is the leading cause of sickness 
and death in patients in residential care (Pace & McCullough, 2010) and is common in 
patients who are tube-fed as well as those on oral diets (Langdon, Lee, & Binns, 2009). A 
chart review of 441 consecutive patients transferred to a rehabilitation ward found higher 
risks of aspiration pneumonia for patients with brainstem strokes (10%) compared with 
cortical strokes (3%) (Teasell, McRae, Marchuk, & Finestone, 1996). Increasing evidence 
suggests a critical period of central nervous system induced immunosuppression after stroke 
when patients are at heightened risk of infection (Emsley & Hopkins, 2010; Langdon et al., 
2009; Meisel, Schwab, Prass, Meisel, & Dirnagl, 2005). Langmore and colleagues studied 
189 inpatients and outpatients at their medical centre using a strict pneumonia diagnosis 
criteria and instrumental assessment of swallowing. The authors list the following predictors 
for aspiration pneumonia: dependency for feeding, dependency for oral care, poor dentition, 
tube feeding, multiple medical diagnosis and medications and smoking. They hypothesise 
that dysphagia alone may not be sufficient to cause pneumonia (Langmore et al., 1998). 
This hallmark research has led to a number of studies and reviews on prevention of 
pneumonia (Echevarria & Schwoebel, 2012; Eisenstadt, 2010; El-Solh, 2011) with some 
promising results on reducing pneumonia by increasing oral cares (Maarel-Wierink, 
Vanobbergen, Bronkhorst, Schols, & Baat, 2013; Ozcaka et al., 2012; Watando et al., 
2004). Hoffmann and colleagues have conducted one of the larger studies (N:15,335) on 
risk factors for development of pneumonia after stroke (Hoffmann et al., 2012). The 
strongest predictors for pneumonia were older age, atrial fibrillation, dysphagia, male 




gender and stroke severity (Hoffmann et al., 2012). Again, dysphagia was classified by a 
more subjective, standardised swallowing screening tool rather than instrumental 
assessment perhaps weakening the strength of the results. 
 
3.2.2 Aspiration pneumonia and aspiration. 
 Although the development of pneumonia is multi factorial (Langmore et al., 1998), 
there is a significant relationship between dysphagia, developing pneumonia and mortality 
after stroke (Finlayson et al., 2011; Katzan, Cebul, Husak, Dawson, & Baker, 2003; Lundy 
et al., 1999; Prass, Braun, Dirnagl, Meisel, & Meisel, 2006; Schmidt, Holas, Halvorson, & 
Reding, 1994). A prospective study of 166 patients receiving VFSS reported incidence of 
aspiration and correlated aspiration with demographic factors. Five institutions participated 
in the study but protocols were strictly controlled and data collection sheets were detailed 
and comprehensive. They found 51% of patients aspirated (53% of these silently) and 
aspiration was significantly associated with a history of aspiration pneumonia (Lundy et al., 
1999). Schmidt and colleagues completed a small retrospective review of the clinical files 
of 26 patients with aspiration and 33 randomly selected, case-matched, non-aspirating 
dysphagic controls. They found that the odds ratio of developing pneumonia was 7.6 times 
greater for those who aspirated during a VFSS and that the odds ratio for death was 9.2 times 
greater for those who aspirated thickened fluids or solids (Schmidt et al., 1994). In a larger 
study, Teasell and colleagues found a 20-fold increase in pneumonia rates in 441 
rehabilitation patients who aspirated during their VFSS versus those who did not (Teasell et 
al., 1996). However, this study was also retrospective and only 106 patients received a VFSS; 
patients who did not receive a VFSS were judged as non-aspirators based on their CSE alone. 
This could have led to inaccurate results in view of the inadequate reliability of CSE for 
detecting aspiration (Ramsey et al., 2003). 




 The normal protective response to aspiration is the cough. A physiological 
impairment called silent aspiration can occur. It is defined as “the occurrence of aspiration 
before, during or after swallowing in the absence of cough” (Smith-Hammond et al., 2001, p. 
504). In a two-year retrospective study of response to aspiration, 1101 patients of mixed 
aetiology received a VFSS: 469 aspirated (43%) and 276 of these patients aspirated silently 
(59%) (C. Smith, Logemann, Colangelo, Rademaker, & Pauloski, 1999). In comparison, 
Lundy and colleagues detected a 51.2% rate of aspiration in their mixed aetiology cohort of 
166, of whom 47% silently aspirated (Lundy et al., 1999) and Garon and colleagues viewed 
1,000 patients with neuropathologies and noted aspiration in 57%, with 53% of these silently 
aspirating (Garon, Engle, & Armiston, 1996). When looking exclusively at patients after 
stroke, Daniels and colleagues identified 38% of their cohort of 55 aspirated, of whom 67% 
did not produce a cough response (Daniels et al., 1998).  
Silent aspiration has been linked with increased prevalence of pneumonia and 
mortality (Nakagawa et al., 1997; Pikus et al., 2003). Pikus and colleagues retrospectively 
reviewed 381 VFSS studies from patients of mixed aetiology. VFSS protocols and data 
collection methods were carefully described. They reported that patients with penetration of 
the larynx during swallowing as seen on VFSS had a fourfold increased risk of pneumonia. 
Those with profound aspiration had a tenfold increased risk and those with silent aspiration 
had a thirteen fold increased risk of pneumonia (Pikus et al., 2003). Interestingly, depth of 
aspiration into the airway (tracheal vs. bronchial) was not significantly correlated with 
pneumonia and they concluded that response to aspiration is more critical than depth of 
aspiration (Pikus et al., 2003). Reducing aspiration and particularly silent aspiration through 
improved dysphagia assessment and management should therefore have the potential to 
reduce pneumonia rates.  




 Given the severity of consequences of pneumonia post stroke, strict international 
protocols for pneumonia prevention and treatment would be expected. Surprisingly, current 
international guidelines do not make strong recommendations regarding early medical 
intervention to prevent infection (Ionita et al., 2011). Nursing shift changes have been 
associated with increased pneumonia (Jones, Albright, Fossati-Bellani, Siegler, & Martin-
Child, 2011). The authors hypothesised that poorer monitoring of early signs of infection and 
poorer adherence to swallowing protocols during staff handover contributed to the 
development of pneumonia. In 1999, Alberts and Brass advocated for careful monitoring of 
signs of infection and early aggressive antibiotic and antipyretic use (Alberts & Brass, 1999). 
Yet, the impact of prophylactic antibiotics has still not been investigated thoroughly (Ionita et 
al., 2011). A recent Cochrane review found five, small, randomised control trials (506 
patients) reporting the impact of preventive antibiotics on functional outcomes. There was a 
reduction in infections but not mortality across trials and the authors urge for larger 
randomised trials (WK Westendorp et al., 2012).  
 
3.3 Relevance of Sensation 
Sensory impairment has been associated with aspiration, pneumonia and disease 
severity and is relevant to the identification of silent aspiration. Kidd and colleagues tested 
pharyngeal sensation by touching the pharyngeal wall with the tip of an orange stick and 
found a correlation between reduced pharyngeal sensation and aspiration identified on 
VFSS with 80% of patients without pharyngeal sensation aspirating (Kidd, Lawson, 
Nesbitt, and MacMahon, 1993). In people with Parkinson’s disease, impaired laryngeal 
sensation (using FEESST) has been linked with increased dysphagia severity and disease 
severity (Hammer, 2009; Hammer, Murphy, & Abrams, 2010).  




Aviv and colleagues have extensively studied the relationship of aspiration to 
laryngeal sensation using FEESST (Aviv, 2000; Aviv et al., 1998; Aviv, Martin, Sacco, & 
Zagar, 1996; Aviv, Martin, Thomson, & Kim, 1999; Aviv et al., 1997; Aviv, Spitzer, & 
Cohen, 2002). Their FEESST protocol has been published in detail and assessors were 
blinded to the results of the instrumental swallowing assessments and to the threshold being 
stimulated to avoid bias. In a study of 122 patients referred for swallowing assessment, they 
found that patients with dysphagia and an absent LAR aspirated on thin liquids 94% of the 
time in comparison with those with an intact LAR who only aspirated 17% of the time 
(Aviv et al., 2002). There was also a significant association between impaired LAR and 
pharyngeal weakness as tested by FEESST and a pharyngeal squeeze manoeuvre which 
involves asking a patient to make a forced “eee” sound and watching for degree of 
pharyngeal movement (Aviv et al., 2002). Patients with both pharyngeal motor 
impairments and laryngeal sensory impairments had significantly greater risks of aspiration 
than those patients with impaired pharyngeal contraction but normal LAR (Aviv et al., 
2002). Parallel findings were found by Setzen and colleagues in a similarly designed study 
of 204 consecutive patients referred for FEESST. Aspiration occurred in 100% of patients 
with both laryngeal sensory and pharyngeal motor impairments while an absence of solely 
laryngopharyngeal sensory impairment led to only 15% chance of aspiration (Setzen et al., 
2003).  
Aviv and colleagues report increased pneumonia rates in patients post stroke with 
bilateral laryngopharyngeal sensory impairments (Aviv et al., 1997). In a two-year follow-
up study of 20 patients with acute stroke and dysphagia, six developed pneumonia. Ten 
patients aspirated on VFSS and nine of these patients had bilateral laryngeal sensory 
deficits on FEESST; only two developed pneumonia. Of the ten patients who did not 
aspirate on VFSS, five had bilateral sensory deficits on FEESST; four developed 




pneumonia. The authors speculate that patients with bilateral sensory deficits who aspirated 
on VFSS were placed nil-by-mouth while patients with bilateral sensory deficits who did 
not aspirate were placed on oral diets. The authors concluded that an assessment of sensory 
integrity (FEESST) provides a better prediction of pneumonia risk than VFSS alone and 
that bilateral sensory deficits are associated with pneumonia even in the absence of 
aspiration documented by VFSS. Again FEESST assessors were blinded to threshold being 
tested throughout the procedure and blinded to the results of the VFSS and 20 matched 
controls were assessed as a comparison. However the sample size was small and actual 
management of patients was not carefully recorded or controlled. Strong conclusions 
regarding the relationship between sensory deficits, aspiration and pneumonia rates and 
patient management were speculative.  
 
3.4 Prognosis 
The prognosis for dysphagia after stroke is thought to be optimistic with the majority 
of patients managing oral diets safely within the first week (Barer, 1989; Finestone, 
Woodbury, Foley, Teasell, & Greene-Finestone, 2002). Mann and colleagues followed 128 
patients referred to speech-language therapy after stroke. All 128 patients received a CSE and 
VFSS within seven days of their stroke and 82 (64%) were diagnosed with dysphagia on 
VFSS. At six months post stroke, 97 of 112 survivors (87%) had returned to their pre-stroke 
diet. Interestingly, despite these positive functional outcomes, of the 67 patients who received 
a follow-up VFSS at three months post stroke, 54 of them showed some persistent 
swallowing impairments despite being back on their pre-stroke diets (Mann, Hankey, & 
Cameron, 1999). Sensory deficits of delayed swallowing and delayed oral transit were the 
highest predictors for pneumonia and failure to return to a normal diet (Mann et al., 1999). 
Ickenstein and colleagues found that aspiration on instrumental assessment within 72 hours 




of stroke was associated with poorer prognosis. Out of 114 acute stroke patients, those who 
aspirated on FEES were 12 times less likely to be orally fed by 90 days (Ickenstein et al., 
2012). Whether these functional outcomes are related to cautious management in patients 
who aspirated on FEES versus true poor recovery cannot to determined.  
 
3.5 Summary 
Dysphagia, especially when accompanied by sensory deficits and silent aspiration, is 
associated with pneumonia and death (WF Westendorp et al., 2011). After stroke, dysphagia 
is often a transient problem yet it carries an odds ratio of 12.5 for mortality (Guyomard et al., 
2009). Knowledge of risk factors and implications of dysphagia and pneumonia are needed to 
drive thorough assessment and management of dysphagia. Currently CSEs are not reliable at 
identifying aspiration, primarily because absence of cough does not reliably indicate absence 
of aspiration, as aspiration may occur silently (Splaingard et al., 1988). Instrumental 
assessments can reliably identify silent aspiration but, despite their clinical benefits, referral 
rates are low (Ding & Logemann, 2000). One possible reason for this may be that they hold 
disadvantages for the acute stroke patient either in radiation exposure, difficulties accessing 
the equipment for acutely ill patients, expense, availability of equipment and/or lack of 
expertise. A reliable tool for identifying silent aspiration, or cough responsiveness, in 
neurological disease would allow early identification of these high-risk patients. 
  
















There are a number of different airway responses to irritation. Cough reflexes and 
expiratory reflexes (ERs) both occur in response to acute airway invasion. The cough reflex 
is a three-phase process: an inspiration, followed by a forceful expiratory effort against a 
closed glottis, and finally the re-opening of the glottis and fast expiratory airflow (Morice et 
al., 2007). Unlike the cough reflex, ER, sometimes referred to as laryngeal adductor reflex 
(LAR), consists of a strong, brisk expiration without an initial inspiration (Korpas & Jakus, 
2000; J Widdicombe & Fontana, 2006). ER is often overlooked in cough studies (G Fontana, 
2008; J Widdicombe & Fontana, 2006) (Aviv et al., 1999). The absence of an initial 
inspiration prior to expiration suggests a different afferent pathway to that of a cough reflex 
(Korpas & Jakus, 2000). The most likely function of ER is the prevention of aspirated 
material entering the lungs rather than the clearance of mucus and materials from the lungs 
and bronchus (G Fontana, 2008). This makes it an important consideration in dysphagia 
research. The ER has been consistently triggered in studies through mechanical stimulation of 
the medial margin of the vocal folds, injection of distilled water onto the vocal folds (Korpas 
& Jakus, 2000; Nishino et al., 1996), through electrical stimulation of the superior laryngeal 
nerve (Ludlow, Schulz, Yamashita, & Deleyianni, 1995) and through acid cough challenges 
(R. Addington, Stephens, Widdicombe, Anderson, & Rekab, 2003). It should be noted that 
although ER was visualised in the mechanical and electrical stimulation studies, the acid 
cough challenge study only implied ER stimulation through measurements of external 
abdominal oblique latencies (W. Addington et al., 2003). Although its protective function 
suggests that the ER would be triggered solely in the larynx, Tatar and colleagues (2008) also 
demonstrated triggering of the ER through mechanical stimulation of the tracheobronchial 




tree (Tatar, Hanacek, & Widdicombe, 2008). Addington and colleagues report that the 
latencies for ER responses are too short to involve C-fibres and that the cough receptor is the 
likely afferent route (R. Addington et al., 2003). The ER is not depressed by sleep, anesthetic 
or codeine like the cough reflex (J Widdicombe & Fontana, 2006). In studying the validity of 
CRT in neurological disease, the difference between attempting to trigger a cough reflex and 
triggering an ER may therefore be important if the neural pathways are indeed distinct. 
However in reality, an ER is often followed by a series of coughs and the distinction may not 
be clinically relevant (W. Addington et al., 2003; Korpas & Jakus, 2000). Addington and 
colleagues believe ER to be the vital, initial component of cough reflex in response to 
aspiration in humans rather than a reflex that should be considered in isolation but this has 
not been proven empirically (W. Addington et al., 2003). 
Cough is our primary defense mechanism for airway protection. In humans, not only 
can a cough be triggered reflexively, it can be suppressed or initiated voluntarily, implying 
cortical involvement (GA Fontana & Lavorini, 2006). Neurological damage at the level of the 
brainstem or cortex therefore has the potential to lead to impairments in cough. In order to 
assess and treat cough in neurological disease, an understanding of its neurophysiology and 
biomechanics are necessary. 
 
4.1 Airway Sensory Receptors 
The cough reflex is triggered by mechanical or chemical irritants which provide 
sensory information primarily to receptors in the larynx, tracheobronchial tree and proximal 
gastrointestinal tract (Canning, 2006). Our understanding of the anatomy and physiology of 
airway receptors comes primarily from animal studies and, although researched over 
decades, many uncertainties remain. The differences between species and the effects of the 




anaesthesia used in some study protocols have led to many conflicting results across studies 
(Mazzone, 2005). Human cough involves significantly more supramedullary influences 
than seen in other species and results from animal studies should be translated to human 
cough with caution (J Widdicombe et al., 2006). In mammals, there are several types of 
sensory receptors found in the airway. The receptors can be broadly classified as 
mechanically sensitive receptors [low threshold mechanoreceptors such as slowly adapting 
receptors (SAR) and rapidly adapting receptors (RAR)] or chemically sensitive receptors 
(chemoreceptors/ nocioceptors such as C-fibres) (Figure 4.1) (Canning, 2006; Ho, Gu, Lin, 
& Lee, 2001; Mazzone, 2005; Mokry & Nosalova, 2007). In order to develop an 
appropriate CRT, an understanding of sensory receptors and their function is beneficial. 
 









Mechanoreceptors, in contrast to chemoreceptors, are activated by mechanical 
stimuli such as lung inflation and light touch (Mazzone, 2005). The cell bodies are found in 
the nodose ganglia and project to the airways via RLNs (Canning et al., 2004). Both SARs 
and RARs are myelinated neurones that appear to have primarily respiratory regulation 
functions. These receptors have relatively fast conduction velocities compared with other 
airway receptors (10-20m/sec in guinea pigs). SARs are found primarily in the alveoli and 
bronchioles and are thought to be responsible for initiation and inhibition of respiration 
throughout the respiratory cycle, leading to reductions in smooth muscle tone in the airway 
and reduced phrenic nerve activity. SARs do not respond to chemical stimuli (Canning, 
Mori, & Mazzone, 2006). As respiratory regulators, it is likely that although SARs may 
regulate cough pattern, they do not have a primary role in the cough reflex (Canning et al., 
2006).  
RARs terminate in the epithelium of the intrapulmonary and extrapulmonary 
airway. These receptors are active throughout normal respiration and respond rapidly to 
changes in respiratory rate and lung inflation (Canning, 2006; Canning et al., 2006). RARs 
do not respond to chemical stimuli but do respond to irritants that evoke bronchospasm and 
obstruction (such as mucus or oedema), e.g., histamine, capsaicin and substance P. 
Substance P is a sensory neuropeptide found in the epithelium of the airways and when 
released has an inflammatory effect. It has been linked with submucosal gland secretion, 
airway smooth muscle contraction and cough production (Sekizawa et al., 1996). Increased 
substance P has been linked to increased cough sensitivity in patients on angiotensin-
converting enzyme (ACE) inhibitors. Substance P levels are lower in patients with 
advanced Parkinson’s disease which is a disease associated with diminished cough (S. 
Ebihara et al., 2003; Sekizawa et al., 1996). Despite this link to bronchospasm and 




substance P, many stimuli activate RARs without resulting in cough. The constant activity 
of the RARs throughout respiration makes it an unlikely primary receptor for cough and it 
is thought that RAR activation regulates cough rather than produces it (Canning et al., 
2006). There may be situations in which RARs produce cough and these will be discussed 
in relation to C-fibres in Section 4.2.2. 
The extrapulmonary, low threshold mechanosensor, often called the ‘cough 
receptor’, appears to serve a different function to other mechanoreceptors (Canning, 2006). 
Again, cell bodies are found in the nodose ganglia and project to the airways via RLNs and 
SLNs (Canning et al., 2004). Unlike intrapulmonary RARs, the cough receptor is found 
primarily within the mucosa of the larynx and trachea as well as, to a lesser degree, the 
mainstem bronchi (Mazzone, 2005). Although similar to myelinated RARs in many ways, 
researchers believe this receptor to be unique and the primary receptor responsible for the 
ER and ‘pure’ cough reflex, i.e. in response to aspiration or significant irritation (Canning, 
2006). It responds to mechanical touch or changes in pH like RARs and is insensitive to 
capsaicin and hypertonic saline solution (Canning, 2006; Canning et al., 2006; Mazzone, 
2005; Stockwell et al., 1993). This receptor does not appear to have a primary respiratory 
role as it does not respond to smooth muscle contraction or other stimuli known to 
stimulate RARs and it produces a conduction velocity slower than other mechanoreceptors 
(up to 5 m/s in guinea pigs) (Canning, 2006). Microinjections of receptor antagonists into a 
specific point in the NTS (rostal and lateral to obex and commissural subnucleus) abolishes 
cough but not respiration and RAR or C-fibre activity suggesting a specific site in the NTS 
for cough alone (Canning, 2008).  
 





Chemoreceptors are generally activated by chemical stimulation. Seventy-five 
percent of all airway sensory receptors have been classified as the chemoreceptor, C-fibre, 
and many researchers have previously hypothesised that C-fibres must play an important 
role in cough reflex response (Canning, 2006). C-fibres are non-myelinated with a 
conduction velocity of < 2 m/s in guinea pigs (Canning et al., 2006). These receptors 
remain inactive during the respiratory cycle and are activated at higher thresholds than 
RARs and SARs (Ho et al., 2001). C-fibres are thought to have a role in regulating 
defensive reflexes such as apnoea, bradycardia, and hypotension (Ho et al., 2001). In 
animals, there appear to be subtypes of C-fibres within the airway (Kollarik, Ru, & Undem, 
2007). The majority of C-fibre sensitive neurones innervating the trachea, larynx and lungs 
have their cell bodies in the jugular ganglia and project to the airways via the SLNs 
(Canning et al., 2004). These nerves express the neuropeptide, substance P (Canning et al., 
2004). Other C-fibres with cell bodies in the nodose ganglia terminate in the lungs only, 
rarely express substance P and are unlikely to be involved in cough (Canning et al., 2006). 
In conscious humans, C-fibre activation through chemo-irritants such as capsaicin, 
bradykinin and citric acid leads to coughing (Canning et al., 2004). However anaesthesia in 
animals results in immediate cessation of C-fibre-mediated cough while mechanoreceptor 
cough remains (Canning, 2002; Canning et al., 2004). The need for consciousness perhaps 
suggests a cortically modulated cough after chemical stimulation rather than a true cough 
reflex (Mazzone, 2005). Further evidence against C-fibre involvement in cough is that 
vagal cooling (blocking of the vagal nerve through cooling to 8-10° C) stops coughing but 
C-fibres remain active (Canning et al., 2004; JG Widdicombe, 1996). Canning describes 
these findings as evidence that C-fibres are not the primary receptor for cough and 




hypothesises that although cough occurs when C-fibres are activated, they are likely 
dependent on on-going activity from the mechanoreceptor cough (Canning, 2002, 2006). In 
fact, it has been hypothesised that C-fibre stimulation leads to the release of tachykinins 
such as substance P that cause airway obstruction or oedema. This oedema results in RAR 
and cough receptor stimulation and cough (JG Widdicombe, 1996). Evidence for this 
central interaction between C-fibres and RARs comes again from animal studies. In 
anaesthetised guinea pigs, capsaicin and bradykinin (chemo-irritants) do not evoke cough 
but lower the threshold for cough production by electrical stimulation (mechanical 
stimulation). Microinjections of substance P into the NTS have exactly the same effect on 
cough induced by electrical (mechanical) stimulation (Mazzone, Mori, & Canning, 2005).  
 
4.2.3  Summary 
In summary, the cough receptor is likely primarily responsible for eliciting ER and 
cough reflex with other receptor types having a modulating role. This cough receptor is 
found primarily in the larynx and trachea and responds rapidly to touch and pH changes. 
Cough receptor activation is not hindered by general anaesthetic. Cough receptors can be 
blocked independently of RAR and C-fibre activity in the NTS resulting in abolished cough 
but not abolished respiration. Central interactions in the NTS or perhaps cortex may lead to 
cough induced by chemo-irritants through more indirect routes and account for the role of 
C-fibres and substance P in cough production. However, the cough receptor is the most 
likely receptor to respond to aspiration and therefore of great interest to the dysphagia 
researcher. An understanding of its location and behaviour to different irritants is useful in 
designing a cough reflex test for dysphagia assessment. 




4.2 Sensory Input 
Both SLN and RLN carry axons of vagal neurones to the nodose and the jugular 
ganglia but bilateral severing of the RLN abolishes cough while cough continues despite 
severing of SLN (Canning et al., 2004). Cough is bilaterally innervated and unilateral 
severing of the vagus nerve does not affect respiration or coughing (Canning et al., 2004). 
The cough reflex is threshold-activated with low levels of stimulation triggering receptors 
but not resulting in a cough (Canning, 2007). At threshold, vagal sensory afferent nerves 
are activated, sending an excitatory signal through neurones to the nodose and the jugular 
ganglia and then into the NTS and trigeminal/ paratrigeminal nuclei (Canning et al., 2004; 
GA Fontana & Lavorini, 2006; Mazzone & Geraghty, 2000; Mazzone et al., 2013). 
Neurotransmitters are released and act on relay neurones in the brainstem respiratory 
networks of the ventrolateral medulla [Botzinger and ventral respiratory group (Bot- VRG)] 
as well as the NTS, midline raphe nuclei, lateral tegmental field, pontine respiratory group 
(PRG) and cerebellum (Pantaleo, Bongianni, & Mutolo, 2002; Shannon et al., 2004). Motor 
responses of respiratory reflexes such as ER, apnoeic reflex and cough reflex are produced 
(GA Fontana & Lavorini, 2006; Vianna, Gilbey, Barnes, Guy, & Gray, 1988).  
 
4.3 Motor Output 
To generate an effective cough, muscles of both inspiration and expiration are 
recruited (GA Fontana & Lavorini, 2006; Gauld, 2009). The respiratory muscles are 
innervated by a complex combination of thoracic (T1-T12), cervical (Phrenic nerve, C2-
C8) and cranial nerves (CN X) (GA Fontana & Lavorini, 2006). Inspiration has a great 
influence on the intensity of the cough response, i.e. the volume of air inspired relates to the 
force of the expiration (GA Fontana & Widdicombe, 2007). Inspiration is influenced by 
contraction of the diaphragm, the intercostal muscles, the accessory muscles 




(sternocleidomastoid and  scalene muscles) and lengthening of the expiratory muscles 
(Brooks, 2011; Gauld, 2009; McCool, 2006). The primary expiratory muscles are internal 
intercostals, oblique muscles, tranversus abdominis and rectus abdominis (GA Fontana & 
Widdicombe, 2007). The more air that is inhaled, the more lengthening occurs and the 
higher the intrathoracic pressure (McCool, 2006). During a strong reflexive cough, 
inhalation can be as much as 50% of vital capacity (between 3-5 litres in an adult), however 
a cough can be produced by inhaling as little as 50% of tidal volume (approximately 
500ml) (McCool, 2006). The closure of the glottis supports the contraction of the 
expiratory muscles and further builds intrathoracic pressures (McCool, 2006). When the 
glottis opens, high intrathoracic pressure causes high expiratory flow (McCool, 2006). 
Power and control is required to ensure the small airways remain patent during the sudden 
intrathoracic pressure changes (Brooks, 2011; Lasserson et al., 2006).  
Laryngeal closure plays an important role in cough efficiency, however a closed 
glottis is not essential for cough as seen in patients with tracheostomies and laryngectomies 
(GA Fontana & Widdicombe, 2007). During the inspiratory phase of cough, the laryngeal 
abductors (posterior cricoarytenoids and cricothyroids) activate and subglottic pressure is low 
(GA Fontana & Lavorini, 2006; Sant'Ambrogio, Kuna, Vanoye, & Sant-Ambrogio, 1997). 
During the forceful expiratory phase, the laryngeal adductors (thyroarytenoids and 
arytenoideus) move rapidly to close the glottis and the abductors relax (GA Fontana & 
Lavorini, 2006; Sant'Ambrogio et al., 1997) before the posterior cricoarytenoids are finally 
recruited and adductors inhibited to complete the expiratory forceful movement (GA Fontana 
& Lavorini, 2006). Experiments have shown the thyroarytenoid muscles to be the fastest to 
respond to direct recurrent laryngeal nerve stimulation and likely crucial in the ER (Sasaki & 
Buckwalter, 1984). Impairment to any of these muscle groups or their neural pathways is 
likely to result in weakened cough and poor airway protection.   




4.4 Modulation of Cough  
There is evidence of initation of cough or modulation of cough outside of the 
airway (Widdecombe et al., 2011). Mechanical pharyngeal stimulation results in cough in 
humans (Nishino, 2000) as does mechanical (distention) and chemical (acid) stimulation of 
the stomach and oesophagus (Canning & Mazzone, 2003). Researchers hypothesise that 
oral and nasal sensory receptors also have the potential to influence cough modulation 
(Widdecombe et al., 2011; Wise, Breslin, & Dalton, 2012). Inflammation and irritation of 
the nose increases coughing while cold water in the nose and menthol vapours reduce 
coughing stimulated in the airway (Laude, Morice, & Grattan, 1994; Widdecombe et al., 
2011). Likewise, stringent oral cares and capsaicin troche supplements in elderly patients in 
residental care have both led to increased cough sensitivity (T. Ebihara et al., 2005; 
Watando et al., 2004). With the closely related sensory and motor pathways of the nose, 
mouth, pharynx, larynx and oesophagus in swallowing and cough, these influences may 
well be affected in stroke also. In a patient with neurogenic oropharyngeal dysphagia, can 
the subtle modulation of cough from the mouth and pharynx be impaired and if so, what 
impact does this have on swallowing safety? 
Although the reflexive cough arc controlled by neurons in the medulla is well 
established, more recently, evidence has grown in the involvement of cortical pathways in 
cough. This is crucial to our understanding of cough impairment in cortical stroke. 
Widdicombe and colleagues propose a model of supramedullary influence on cough (Figure 
4.2) (J Widdicombe et al., 2006). This is supported by humans’ ability to cough voluntarily 
and suppress cough as well as the reduction of cough in subjects in coma (Pecova, Javorkova, 
Kudlicka, & Tatar, 2007; J Widdicombe et al., 2006). It has been postulated that coughing, 
like swallowing, requires higher brain control of the motor act in response to the sensory 




message (Mazzone et al., 2011). In addition to cortical descending pathways modulating the 
motor response of coughing, higher level sensory pathways also generate the cognitive 
perception of irritation (Mazzone et al., 2013). 
 
Figure 4.2 Supra-medullary influence on cough (J Widdicombe et al., 2006, p. 323). 
Reprinted with permission. 
 




Mazzone and colleagues have contributed significantly to the study of neural 
control of cough. They found cough induced by tussive agent inhalation leads to activation 
of many cortical and subcortical areas involved in sensory perception, affective processing, 
motor control and planning. These include the primary motor and somatosensory cortices, 
supplementary motor cortex, anterior and posterior mid-cingulate cortex, insula, orbitofrontal 
cortex, thalamus and cerebellum in addition to the brainstem. (Mazzone et al., 2011). 
Functional MRI studies in cough are plagued with the same methodological complications 
as those of swallowing. Separating cough related blood oxygen level-dependant (BOLD) 
responses from other head movements and on-going respiratory and homeostatic acts is 
problematic (Mazzone et al., 2011). Mazzone and colleagues are explicit in these 
limitations and describe in detail the filtering approach taken to reduce ‘noise.’ In a recent 
study comparing neural activity in evoked cough, suppressed cough and voluntary cough, 
they found that despite many shared areas of cortical activation, there were unique areas of 
activation associated with each condition (Figure 4.3). Subjects were provided with visual 
cues (‘go’, ‘cough’, ‘no cough’) and it is possible that some cortical activation relates to 
cognitive-language processing. However, unique activations in posterior insula and 
posterior cingulate cortex were found for evoked cough in comparison to voluntary cough 
and suppressed cough. Mazzone and colleagues suggest these represent the enhanced motor 
control of accessory muscles and laryngeal muscles needed in evoked cough tests 
compared with voluntary cough (Mazzone et al., 2011).  





Figure 4.3 Functional MRI comparing brain activation during reflexive cough, suppressed 
cough and voluntary cough (Mazzone et al., 2011, p. 2952). Reprinted with permission. 
 
The term urge-to-cough has been used to describe the sensation that precedes a 
sensory-stimulated cough. Mazzone and colleagues describe this as higher level sensory and 
cognitive processing of airway irritation (Mazzone et al., 2013). Davenport further describes 
this as a supramedullary brain component of the cough “motivation-to-action system” 
(Davenport, 2008, p. S107). In certain circumstances, urge-to-cough precedes a motor cough 
and is triggered at a lower threshold of tussive agent than a cough response. Like a reflexive 




cough, the urge-to-cough has a defined threshold and increases as the stimulus increases 
(Davenport, 2008). A modified Borg scale (1-10; 1= no sensation, 10= maximum urge-to-
cough) is the most frequently used measure (Dicpinigatis, Tibb, & Hull, 2011). Interestingly, 
fMRI has shown capsaicin inhalation evoked urge-to-cough (without coughing) associated 
with similar motor activations to that of reflexive cough. Additional regions of activation 
included sensory and cognitive regions such as the primary sensory cortex, supplementary 
motor area and orbitofrontal cortex (Mazzone, McGovern, Koo, & Farrell, 2009; Mazzone, 
McLennan, McGovern, Egan, & Farrell, 2007).  
 Davenport describes the stages for motivation-to-action as: i) the stimulus (ii) the 
urge to respond (iii) the desire to respond to the urge (iv) the action (v) feedback to the neural 
system on the action and (vi) the reward, the urge has been satisfied (Davenport, 2008). This 
model aids our understanding of the human ability to suppress reflexive cough by 
consciously terminating the process at stage III: Desire for Action (Figure 4.4).  
 
 
Figure 4.4 Stages of motivation to action of cough (Davenport, 2008, p. S108). Reprinted 
with permission. 




Dicpinigaitis and colleagues have completed the largest evaluation of urge-to-cough 
to date with 100 participants. They found no gender differences in urge-to-cough, despite 
gender differences in capsaicin cough reflex test thresholds (Dicpinigatis et al., 2011). Of 
interest, 21% of subjects did not have a measurable urge-to-cough threshold prior to the 
cough response, their cough was not perceived as being preceded by an urge. It seems clear 
that if the stimulus is strong enough, the cough will occur regardless of the desire to suppress 
it (Dicpinigatis et al., 2011). A study comparing smokers to non-smokers found both 
decreased cough reflex sensitivity and decreased urge-to-cough in smokers (Kaneszaki et al., 
2010). Expanding on this work, another study found immediate increases in number of 
coughs and urge-to-cough thresholds when nicotine was withdrawn for 12 hours (Davenport, 
Vovk, Duke, Bolser, & Robertson, 2009). Ebihara and colleagues, using a similar 
methodology but with citric acid, found that although elderly subjects do not differ in cough 
reflex threshold in comparison to young subjects, their urge-to-cough was significantly 
reduced (S. Ebihara et al., 2011). Interestingly, people with congenital central hypoventilation 
syndrome show the same pattern (Lavorini et al., 2007) and as Ebihara and colleagues 
ruminate, both population groups are prone to aspiration pneumonia (S. Ebihara et al., 2011). 
Similar down-regulatory results were found in a study comparing elderly patients with and 
without aspiration pneumonia. Both heightened cough reflex thresholds and urge-to-cough 
thresholds were found in those with aspiration pneumonia suggesting a supramedullary 
dysfunction (Yamanda et al., 2008). Results from urge-to-cough studies are proving 
reproducible across research groups but the subjectivity of urge-to-cough judgement needs 
interpretive caution especially in cognitively impaired population groups. This increasing 
understanding of urge-to-cough may significantly aid our understanding of dystussia and 
aspiration pneumonia in neurological disease outside of the brainstem. The theory that 
afferents activate high order cognitive and sensory processes prior to completing the cough 




reflex arc holds significant interest for assessment of cough reflex sensitivity in neurological 
populations. Urge-to-cough measures in cough assessment have potential. In healthy people, 
low threshold stimuli such as pooling saliva and small amounts of aspiration may often lead 
to a cortically modulated cough response that begins with an urge. In cortical stroke, this may 
not be the case. Patients with supramedullary impairment, who perhaps trigger reflexive 
coughs to large quantities of aspirate or significant irritation may not initiate cortically-
modulated coughs to lesser stimuli. If urge-to-cough is impaired, is a higher threshold of 
irritant required before an ER or cough reflex can be triggered? 
 
4.5 Voluntary Cough 
Voluntary cough is also worthy of discussion. Voluntary cough originates in the 
cerebral cortex and is the purposeful, conscious production of a cough (GA Fontana & 
Lavorini, 2006; J Widdicombe, Addington, Fontana, & Stephens, 2011). In most cases, 
except when asked to cough to command, a voluntary cough is still often in response to a 
sensation of irritation, e.g., during an acute upper respiratory tract infection (Lee, Cotterill-
Jones, & Eccles, 2002). Yet, Mazzone and colleagues demonstrate that cortically 
modulated evoked cough is not simply an urge-to-cough followed by a voluntary cough.  
Imaging studies of voluntary cough report activation across large parts of cortex and 
subcortex much like that of reflexive cough (Mazzone et al., 2009; Simonyan, Saad, 
Loucks, Poletto, & Ludlow, 2007). In contrast, voluntary cough lacks the activation of the 
posterior insula and posterior cingulate seen in evoked cough tasks and there is a significant 
scarcity of activation in the lower brainstem (Mazzone et al., 2011). Mazzone and 
colleagues hypothesised an increased role for the cortex in voluntary cough and suggest 




possible cortico-spinal pathway involvement rather than brainstem respiratory circuitry 
(Mazzone et al., 2013). 
Little is known about the pathways between the cortex and brainstem in voluntary 
cough (GA Fontana & Lavorini, 2006) and separating respiratory activity from cough 
activity is difficult in fMRI studies. Simonyan and colleagues asked 15 healthy subjects to 
cough, sniff and breath voluntarily during fMRI (Simonyan et al., 2007). Auditory cues 
were used with an eight second delayed response to avoid confounding auditory processing 
activation. Subjects were asked to fixate on a cross in mid-line to reduce extraneous 
movement. They found similar areas of activation to Mazzone and colleagues. Voluntary 
cough produced significantly more primary motor cortex, primary somatosensory cortex, 
and parieto-opercular cortex activation than voluntary breathing. They concluded that 
voluntary breathing, voluntary cough and sniff all activate similar sensorimotor regions of 
the brain to different degrees depending on the motor control demands and respiratory-
modulation demands of the task. Additional activation was found at the junction of the 
midbrain and pons during voluntary coughing and the authors postulate a role for this 
junction in linking the cortex and the cough centres of the brainstem (Simonyan et al., 
2007). Functional MRI studies of voluntary cough involve asking a subject to cough to 
command and results may not translate precisely to voluntary coughing to mild irritation 
seen in people with a common cold where more sensory interaction may be present. 
 
4.6 Suppressed Cough 
With this evidence of complex cortical activation during reflexive as well as 
voluntary cough, it has been suggested that the addition of a suppressed cough test may 
represent a more true sensory response in that cortical inhibition can no longer over-ride 
brainstem responses (Hegland et al., 2012; Monroe, Huckabee, & Robb, 2010). As discussed, 




a degree of supramedullary modulation appears to occur during an evoked cough, whilst 
during a true reflex arc, cortical modulation should not be possible (Hegland et al., 2012). 
Suppressed CRT thresholds are greater than natural cough thresholds perhaps providing 
evidence of the supramedullary influence in evoked coughs challenges (Mazzone et al., 2009; 
Monroe et al., 2010). However, on fMRI suppressed cough appears to activate many of the 
same regions of the brain as an evoked cough (Mazzone et al., 2011). The only unique 
activations in the suppressed cough task compared with the evoked cough task were in 
anterior insula, anterior mid-cingulate cortex, and right inferior frontal gyrus (areas known to 
be activated during pain stimuli and respiratory suppression) (Mazzone et al., 2011). Hegland 
and colleagues investigated cough modulation in healthy adults using high concentrations of 
capsaicin where suppression was not longer possible (Hegland et al., 2012). They asked 20 
healthy, young subjects to i) cough smaller/ softer ii) cough longer or iii) not cough. Methods 
are detailed and carefully controlled and all participants coughed on baseline measures at the 
supra-threshold capsaicin. They found significant reductions in many components of cough 
intensity (airflow and sEMG measures) but not in number of coughs produced. Interestingly, 
a wide range of non-cough respiratory behaviours were noted in participants in the 
suppressed cough test including breath holding, swallowing, throat clearing and expiratory 
efforts. They hypothesise that although in the anesthetised patient, a pure brainstem cough 
may be relevant, in a conscious person even a reflexive cough is likely to involve some 
cortical modulation (Figure 4.6, revised model of reflexive cough) (Hegland et al., 2012). 
The impact of age or neurological impairment on this hypothesised model is still unknown. 
The suggestion is that a suppressed cough task may not, in fact, represent a true cough 
reflex without supra-medullary influence as previously proposed but instead represents 
another cough type that is also capable of cortical modulation. 
 





Figure 4.6 Revised model of cortical interaction with reflexive cough (Hegland et al., 2012, 
p. 45). Reprinted with permission. 
 
4.7 Cough Response to Aspiration 
With this substantial history of research in cough physiology and cortical influences, 
there is surprisingly little research describing either the peripheral or central levels of activity 
during an aspiration event. Early work by Sant’Ambrogio and colleagues studied laryngeal 
receptor response to water, dextrose and sodium gluconate in isolated larynges of 
anaesthetized dogs (Saint'Ambrogio, Anderson, Sant'Ambrigio, & Mathew, 1991). They 
found randomly active, superficial receptors that responded rapidly to all stimuli and were 
inactivated by topical lidocaine (Saint'Ambrogio et al., 1991). These receptors fit the 




description of ‘cough receptors’ and these results suggest that cough receptors are likely 
stimulated by aspiration of both water and salty/ sugar solutions.  
Thresholds for producing cough in response to aspiration have also not been 
described. Summation, defined as the increase in sensitivity as the size or duration of 
stimulation increases, is well documented in skin experiments but little is known about its 
transference to visceral mechanoreceptors (Gescheider, Guclu, Sexton, Karalunas, & 
Fontana, 2005; Leder et al., 2010). On the skin, the size of the surface stimulated, the 
pressure and the duration of exposure all affect the threshold level (Gescheider et al., 2005; 
B. Green & Craig, 1974; Verrillo, 1966). Hypothetically, larger heavier volumes of aspirated 
material should lead to greater summation of irritation (by increased surface area and 
pressure) resulting in a cough response, while smaller quantities might not reach threshold. 
Sticky, viscous aspirated materials may remain on the vocal cords for longer, again leading to 
a cough response, while fast moving substances may exit quickly and not reach threshold. 
This corresponds with evidence that trace penetration and aspiration without a cough 
response is relatively common in humans (Allen et al., 2010; Butler et al., 2009). As 
previously discussed, Leder and colleagues studied the diagnostic sensitivity of a large 
volume water test on cough responsiveness in 4102 patients who received FEES (Leder et al., 
2010). Their primary hypothesis was that increased amounts of aspiration would lead to a 
cough response in patients who may silently aspirate smaller amounts. In their false negative 
group of patients who passed the large volume water test but were found to silently aspirate 
on FEES (24/346), one quarter to one third of these patients were classified trace aspirators 
(Leder et al., 2010). Forty-eight percent (12/25) of patients who silently aspirated on the 10cc 
of water and 65.5% (21/32) of patients who silently aspirated on puree, audibly aspirated on 
the larger volume (90cc). This may give strength to the theory that a threshold of stimulation 




is required to produce a cough response to aspiration in both healthy and dysphagic 
individuals, conceivably including those at risk of silent aspiration.   
Cough receptors are phasic receptors that are inactive until stimulated and rapidly 
adapt. These receptors should be vulnerable to adaptation, the phenomenon in which sensory 
receptors change their sensitivity to a stimulus after prolonged stimulation (Sternberg, 2009). 
Little has been written about sensory receptor adaptation after prolonged aspiration. Patients 
with severe dysphagia may aspirate food and drink multiple times per day and may 
continually have secretions pooled in the upper airways. It is believed that adaptation to 
mechanical stimuli does not occur until the mechanical stimulus becomes static (Canning, 
2011). Although aspiration of food and drink may often be transient as it is either expelled 
through cough or gradually dispersed lower in the airways, static accumulation of secretions 
is common in severe dysphagia. Do these patients have neurological sensory impairments 
preventing them from attempting to clear their airway or, have their sensory receptors 
adapted to the static stimuli and reduced their sensitivity below the threshold for producing 
cough? This rapid adaptation of cough receptors has been shown in anaesthetised guinea pigs 
where a 20-fold increase in acid stimulation had no effect on the number of coughs produced 
(Canning et al., 2006). However in conscious guinea pigs, C-fibres continued to produce 
coughs as long as the stimulus was sustained. This suggests that although cough produced via 
cough receptors adapts rapidly and coughing may halt, chemically irritated C-fibres may 
continue to fire as long as the irritation continues. This may account for the chronic coughing 
described in patients with gastro-oesophageal reflux where acid, pepsin and bile may remain 
in the airway for prolonged periods of time (Canning, 2011). Tachyphylaxis of different 
tussive agents will be discussed in further detail in Chapter 5. 





Swallowing and coughing are complex inter-related neural activities. In 
neurological disease, whether involving the brainstem, sub-cortex or cortex, swallowing 
impairment is likely to be accompanied by impairments of cough and respiration. Sensory 
integrity is essential to the entire swallowing process with modulation of motor output in all 
phases (Steele & Miller, 2010). Afferent information from sensory receptors in the mouth, 
pharynx, oesophagus and airway modulate multiple components of motor response: 
mastication, bolus preparation and propulsion, swallowing initiation, airway closure and 
protection (Steele & Miller, 2010).  
Intact sensory pathways are vital for emergency respiratory reflexes during 
aspiration: ER and cough reflex and therefore impairments in these reflexes carry an 
increased risk for developing pneumonia (Steele & Miller, 2010). During an aspiration 
event, aspirated material irritates cough receptors in the larynx and then in the trachea 
(should the aspirated material descend further). This irritation may lead to high level 
sensory and cognitive processing. If the irritation is sufficient, an excitatory signal is send 
through the SLNs (above the vocal cords) and RLNs (below the vocal cords) to the NTS 
where a motor response is initiated. A rapid ER is initially produced followed, most likely, 
by a series of cough reflexes. The cortically modulated motor response (number and force 
of coughs) will depend on the type and quantity of aspirated material.  
In designing a cough reflex test for identifying those at risk of silent aspiration, 
choosing the right ‘cough’ and the right ‘sensory receptor’ to stimulate may be critical. It is 
important that the researcher understands whether the cough test is assessing cortically 
modulated cough versus a pure brainstem act as well as triggering cough receptors versus 
C-fibres. A good understanding of swallowing and cough physiology is vital for 
comprehensive dysphagia assessment and a well-designed CRT.  














COUGH TESTING IN DYSPHAGIA 
________________________________________________________________ 
5.1 Cough Reflex Testing Methodology  
CRT has been studied in respiratory medicine for more than 50 years. Most 
frequently it has been used to evaluate the effect of pharmaceuticals on cough sensitivity or in 
epidemiological surveys (PV Dicpinigaitis, 2007). CRT challenges the sensory integrity of 
the aerodigestive tract by introducing a tussive agent and observing for a cough response. It 
therefore has potential as a test of airway sensitivity in dysphagia management. From early in 
its history, Bickerman stated that in order for CRT to be clinically reliable, the following 
must be in place: i) there must be a uniform and consistent response in subjects to the same 
threshold, ii) there must be reproducibility for the same individual, and iii) the method must 
be non-toxic and simple to administer (Bickerman, Barach, Itkin, & Drimmer, 1954). A 
clinical guideline on the assessment of cough was produced in 2007 by the ERS Task Force 
(Morice et al., 2007). It highlighted the continuing lack of standardisation of cough testing 
despite its longevity. CRT use in dysphagia management requires the same level of 
reliability, reproducibility, safety and simplicity. Respiratory medicine methodology and 
experimental findings can serve as useful guidelines for the development of evidence for 
CRT in dysphagia diagnosis. 
Tussive agents most commonly used in CRT include tartaric acid (W. Addington, 
Stephens, & Gilliland, 1999), capsaicin (Sams, Truncale, & Brooks, 2005; J Smith, Owen, 
Earis, & Woodcock, 2006), ultrasonic distilled water (GA Fontana, Lavorini, & Pistoles, 
2002) and citric acid (Leow, Beckert, Anderson, & Huckabee, 2012; Monroe et al., 2010; 
Wakasugi et al., 2008) with citric acid and capsaicin by far the most commonly 
documented. Citric acid inhalation produces a cough through stimulation of both C-fibres 




and cough receptors in the larynx, trachea and lungs (Wong, Matap, & Morice, 1999). 
Citric acid cough is diminished when compared with capsaicin in people after 
laryngectomy suggesting that citric acid sensitive neurones are more dominant in the larynx 
and that capsaicin sensitive receptors have a more peripheral distribution (Morice, 1996). 
However citric acid inhalation leads to cough even when the SLN is anesthetised 
suggesting that citric acid also stimulates receptors below the glottis (Stockwell et al., 
1993). No adverse reactions have been documented in using citric acid in CRT (Bickerman 
et al., 1954). Of importance, Pecova and colleagues compared citric acid to capsaicin 
challenges and found fewer healthy participants coughed on the citric acid concentrations. 
They warn that vital-capacity citric acid challenges may not be ideal when studying 
decreased cough sensitivity (Pecova et al., 2007).  
 In comparison, capsaicin is a pungent extract of peppers and induces cough through 
C-fibre sensory receptors stimulation (Midgren, Hansson, Karlsson, Simonsson, & Persson, 
1992; Morice, Kastelik, & Thompson, 2001). Capsaicin has little or no affect on 
mechanoreceptors (Canning, 2006; Ho et al., 2001; Mazzone, 2005; J Widdicombe, 2001). 
Capsaicin has also been proven to be a reliable tussive agent and produces no adverse 
reactions in CRT (Bickerman et al., 1954). Hansson and colleagues studied the difference 
in cough response to capsaicin between small droplet aerosols that deposit irritant to the 
lower airways compared with large droplet aerosols that deposit irritant primarily to the 
larynx. They found far more coughs produced with the small droplet aerosol again 
suggesting that capsaicin stimulates a more peripheral/ non-laryngeal, rather than laryngeal 
cough response (Hansson, Wollmer, Dahlback, & Karlsson, 1992).  
 Tartaric acid, although far less researched, is used by the Addington research group 
in their work on CRT in dysphagia after stroke and therefore requires mention (R. 




Addington et al., 2003; W. Addington, Stephens, & Gilliland, 1999; W. Addington, 
Stephens, Widdicombe, & Rekab, 2005). Like citric acid, tartaric acid has been used 
without adverse effect and likely triggers both cough receptors and C-fibres in the larynx 
(R. Addington et al., 2003). Laryngeal evoked potentials have been recorded in the internal 
SLN during tartaric acid cough testing and unlike citric acid and capsaicin, tartaric acid 
cough is abolished or severely diminished by bilateral anaesthesia of internal branch of 
SLN suggesting primarily laryngeal sensory receptor stimulation (R. Addington, Stephens, 
Gilliland, & Miller, 1998; W. Addington, Stephens, & Goulding, 1999). This does provide 
a compelling rationale for its use in the isolated testing of laryngeal sensitivity. 
 Ultrasonically nebulized distilled water delivers aerolised water to the airways 
through an ultrasonic nebuliser (PV Dicpinigaitis, 2007). It may be closer in relationship to 
aspiration of fluids than alternative tussive agents but has limitations. A significant 
percentage of subjects (15-20%) do not cough at the maximum possible water output from 
the nebuliser and clinically significant bronchoconstriction has been associated with the test 
(PV Dicpinigaitis, 2007).  
 Evidence suggests that these diverse agents stimulate cough through different 
mechanisms (Midgren et al., 1992). Researchers have found poor correlation between citric 
acid and capsaicin testing in normal subjects (Midgren et al., 1992; Wong et al., 1999). 
Midgren and colleagues report two out of three non-responders to citric acid responded to a 
mild-moderate capsaicin dose while the two low responders to low-moderate capsaicin 
dose also had a low response to the highest dose of citric acid (Midgren et al., 1992). In 
contrast, cross tachyphylaxis (blunting of response) does occur when citric acid and 
capsaicin are administrated in sequence (Morice, Higgins, & Yeo, 1992). Belvisi and Hele, 
in their review of the literature, found capsaicin more prone to tachyphylaxis and 




bronchoconstriction than citric acid with a slower recovery time for capsaicin than citric 
acid especially after higher doses (Belvisi & Hele, 2006; Morice et al., 1992). Other studies 
have shown tachyphylaxis after citric acid recovers faster (Morice et al., 1992). In one 
study evaluating the effect of one-minute of continuous inhalation, citric acid tachyphylaxis 
occurred within 1-minute and recovery was within 2 hours; while with capsaicin, 
tachyphylaxis occurred between 1-10 minutes and recovery was slower (still diminished at 
3 hours 20 minutes) (Morice et al., 1992). Morice and colleagues hypothesize a different 
mechanism of adaptation between the tussive agents with the rapid adaptation of 
extracellular pH the causal factor in the immediate tachyphylaxis and quicker recovery time 
with citric acid inhalations (see Chapter Four, Section 4.7 for further physiological 
discussion). 
 In using CRT in dysphagia assessment, a stable and safe agent is imperative. A 
consistent response between patients and repeated over time with the same patient is also 
vital. For the dysphagia researcher, capsaicin may hold less appeal. It is known to prompt 
longer-term tachyphylaxis than other tussive agents and primarily triggers cough in the 
lower airways (Hansson et al., 1992; Morice et al., 1992). Citric and tartaric acid have the 
advantage of stimulating both mechano- and chemo-receptors and are known to stimulate 
the cough receptors of the larynx, our primary airway protector from aspiration of food and 
fluids (Morice et al., 2007). Tartaric acid has received less attention and although has the 
potential advantage of triggering the larynx primarily, little is known about its vulnerability 
to tachyphylaxis or about the proportion of normal people who do not cough in response to 
it. Citric acid is unfortunately plagued with a small proportion of non-responders but it does 
trigger cough receptors in both the larynx and sub-glottis, and tachyphylaxis is quick to 
recover (Pecova et al., 2007). Although laryngeal sensory receptor activation is important, 




response to airway invasion can occur below the glottis and still clear the airway 




 There are two common methods of CRT administration: a vital-capacity breath 
inhalation or a tidal-breath inhalation over a fixed period of time (Morice, 1996). In a vital-
capacity breath inhalation, a subject’s nose is pinched or clipped and they are asked to exhale, 
insert a mouthpiece and then take in a deep breath. Nebuliser flow rate is controlled by a 
dosimeter, often with an inspiratory flow regulator valve. This ensures flow is controlled 
regardless of the inspiratory effort of the subject (PV Dicpinigaitis, 2007). Any cough 
response is recorded. In contrast, in a tidal-breathing method, a facemask is placed over the 
mouth and nose and a prescribed concentration of tussive agent is released from a nebuliser 
of prescribed flow rate over a prescribed period of time. A nose clip may or may not be 
utilised. Again, any cough response is recorded. The type of cough triggered by each method 
has not been investigated. It is possible that the slower tidal-breath method allows more 
opportunity for cortical modulation than the rapid intake of the vital-capacity method, 
which perhaps elicits a true ER, followed by a series of cough reflexes. The vital-capacity 
breath technique requires a subject to follow and perform specific instructions while the 
tidal breathing method does not require subject instruction compliance. Both of these 
methods have been used as a single-dose where only one concentration is given or with a 
dose-response method involving multiple inhalations of different concentrations (Morice, 
1996). All methods have proven reliability and reproducibility (PV Dicpinigaitis, 2007; 
Nejla, Fulimura, & Kamio, 2000). The single-dose method is quick and avoids tachyphylaxis, 




whereas more specific information can be derived from cough threshold testing.  
 Choice of equipment and mode of inhalation has been shown to impact on cough 
threshold results (Barros, Zammattio, & Rees, 1990; Wright, Jackson, Thompson, & 
Morice, 2010) and strict methodological control is needed. Drug output rates differ 
considerably between machines and determine the speed at which a drug is dispersed 
(Terzano, Petroianni, Parola, & Ricci, 2007). In respiratory medicine, a nebuliser’s ability to 
disperse a treatment quickly with diffuse coverage of lungs is critical (Terzano et al., 2007). 
Interestingly, significant differences in citric acid cough sensitivity have been reported when 
nebulisers with different inspiration flow rates are used (Barros et al., 1990). When using a 
vital-capacity breath inhalation test, Barros and colleagues advise control of nebuliser flow 
rate (Barros et al., 1990). However they also speculate limitations in the tidal-breath 
inhalation method where individual respiratory rate may impact on cough response (Barros et 
al., 1990). Pounsford and Saunders also comment on the effect of individual respiratory rate 
in tidal-breath inhalations. They caution that irritation and coughing can change an 
individual’s inhalation rate and in turn change the deposition of irritant throughout the test 
period (Pounsford & Saunders, 1985).  
 Nebulisers also administer different sizes of aerosol droplets. Particle size appears a 
crucial factor in determining the specificity of cough challenges with smaller particles 
better penetrating the peripheral airway (Terzano et al., 2007). Particles of 10 mm diameter 
are deposited mainly in the mouth and throat, 5-10 mm particles reach the throat and the 
lungs and particles of less than 5 mm mainly deposit in the lungs (Morice et al., 2001). 
Capsaicin inhaled in small particle size aerosol droplets at a low flow rate gives a two times 
larger deposited dose in intrapulmonary airways than fast flow, large droplet aerosols 
(Hansson et al., 1992). As discussed previously, Hansson and colleagues found four times 




higher capsaicin cough sensitivity using the small droplet aerosol technique highlighting 
the greater presence of C-fibres in the lower airways (Hansson et al., 1992). Notably, for 
CRT in dysphagia assessment, deposition to the larynx did not differ between methods. 
 The ERS guidelines recommend standardised use of the same nebuliser for all 
challenges, preferably a compressed air-driven nebuliser with a flow-limited dosimeter to 
control flow output regardless of patient inspiratory effort. However, a recent study found 
different yet correlating thresholds, and strong reproducibility for a simple hand-held 
nebuliser in comparison to the more conventional compressed air-driven nebuliser with a 
dosimeter (Barber et al., 2004). The issue may therefore be more about the ability to compare 
studies that use different methods rather than the reproducibility of each individual method. 
In CRT, when primarily interested in central laryngeal receptor stimulation and less 
interested in diffuse peripheral dispersion, the effect of nebuliser type is less clear and needs 
further investigation.  
 
5.1.2 Delivery method. 
 Delivery method choice varies between studies and also impacts on the deposition 
of vaporised particles. A common method for vital-capacity tests is a mouthpiece and an 
expiration-inspiration method which requires the subject to exhale and then deeply inhale 
through the mouthpiece with the nose occluded (W. Addington, Stephens, & Gilliland, 
1999; Leow et al., 2012). This is the recommended method by the ERC task force for most 
CRT situations (Morice et al., 2007). In the acute neurological population however, where 
co-existing impairments of cognition, language, apraxia or oro-motor weakness (i.e. lip 
seal) are present, this method may not be effective. A more applicable delivery method for 




the neurological population may be the passive tidal-breath facemask method (Monroe et 
al., 2010; Wakasugi et al., 2008). Breathing through the mouth with a mouth piece deposits 
more particles in the lower respiratory tract compared with nasal breathing and mouth 
breathing without a tube (Wolfsdorf, Swift, & Avery, 1969). The facemask approach leads 
to nose and mouth breathing and therefore, perhaps conveniently for dysphagia assessment, 
deposition of particles to the larynx rather than lower airway.  
 
5.1.3 Methodological issues. 
 A number of other methodological issues are worthy of discussion and control in 
CRT research and clinical practice: within subject test variability, suppression/learning effect 
and tachyphylaxis/ progressive test effect. The number of coughs produced on each trial has 
been shown to be variable and repeating each concentration a number of times is 
recommended to obtain the true cough frequency (Morice, 1996). From early in citric acid 
CRT research, within subject variability has been reported but rarely more than one dose 
above or below that subject’s determined threshold (Bickerman, German, Cohen, & Itkin, 
1957). Up to 10% of normal controls fail to cough on maximum doses of both citric acid 
and capsaicin in vital capacity breath experiments (Morice et al., 1992) though this does not 
appear to occur as frequently with the tidal breathing method (Barber et al., 2003; Fujimura 
et al., 1996; Monroe, Manco, & Huckabee, in preparation). Diurnal variability of cough 
sensitivity is a confounding issue with significantly decreased sensitivity throughout the 
day (Pounsford & Saunders, 1985). It is usually controlled in clinical trials by testing at the 
same time each day and if controlled, within subject threshold stability has been shown (P. 
Rees & Clark, 1983). However this has feasibility issues for acute diagnostic testing within 
a clinical environment and especially with repeat testing over time. At this point, no 




research has attempted re-testing of patients with dysphagia over time and the effect of 
diurnal variation on this clinical population has not been addressed. In a vulnerable 
population with decreased airway sensitivity, it is unknown if diurnal changes become 
clinically relevant. 
 Cough can be consciously suppressed and suppression is a natural response to the 
learning effect of irritation and subsequent coughing during cough testing (Bickerman et 
al., 1954; Midgren et al., 1992). To test for voluntary suppression and to increase challenge 
blindness the use of placebo inhalations has been encouraged (PV Dicpinigaitis, 2007; 
Morice, 1996; Morice et al., 2007). When attempting to assess natural reflexive cough, 
instructing participants to avoid suppressing the cough may be wise.  
Short-term tachyphylaxis is well documented in both citric acid and capsaicin cough 
testing when multiple inhalations over short periods of time are performed (Morice et al., 
1992). Randomised concentration administration, although a preferable option for 
blindness, is prone to short-term tachyphylaxis and blunting of lower concentrations 
(Morice, 1996; P. Rees & Clark, 1983). Incremental concentration administration 
interspersed with placebo saline inhalations and one-minute intervals is recommended 
(Morice et al., 2007). Long-term tachyphylaxis is also reported as much as one week after 
testing in capsaicin challenges. Morice and colleagues report the most significant adaption 
effect occurs between test one and two and recommend in research that all participants are 
accustomed with cough testing before measures are taken (Hoffmeyer et al., 2013; Morice 









5.1.4 Cough recording. 
 A variety of methods for recording cough response have been used previously. 
Methods include monitoring of chest movement and acoustic response via phonometer or 
audiovisual equipment or through pneumotachograph readings (Leow et al., 2012; Lin, Lai, 
Wu, Wang, & Wang, 1999; Nakajoh et al., 2000). Most clinical studies however simply 
count the number of coughs produced over the number of trials (Monroe et al., 2010; 
Wakasugi et al., 2008) and set a criteria for abnormal versus normal response (e.g., 5 coughs 
= passed test). The ERS Task Force recommend either the use of C2 (2 coughs within 15 
seconds of tussive stimuli) or C5 (5 coughs within 15 seconds of tussive agent stimuli) 
methods as reliable measures of cough response (Morice et al., 2007). Cough resulting from 
capsaicin and citric acid is usually immediate and counting only the number of coughs 
occurring in the initial 15 seconds after inhalation is strongly recommended (PV 
Dicpinigaitis, 2007). 
 
5.2 Influences on Cough Sensitivity 
5.2.1 Population variation on cough sensitivity. 
There is variation in cough response to irritant across the healthy population (Morice, 
1996). This needs consideration when using CRT diagnostically. Cough sensitivity appears to 
be weaker in premature infants (AB Chang & Widdicombe, 2007). It strengthens through 
childhood although children appear to have a more sensitive cough reflex than adults (A 
Chang, Phelan, Sawyer, Del-Brocco, & Robertson, 1996; AB Chang & Widdicombe, 2007). 
Natural cough thresholds in adults do not appear to change with advancing age (AB Chang & 
Widdicombe, 2007; Fujimura et al., 1996; Katsumata, Sekizawa, Ebihara, & Sasaki, 1995; 
Leow et al., 2012; Sams et al., 2005) though older people have shown lower thresholds on 
suppressed cough testing (Leow et al., 2012). Interestingly, Aviv and colleagues report 




significantly diminished laryngo-pharyngeal sensitivity using FEESST with increasing age 
(Aviv, Martin, & Jones, 1994). Young subjects between 20-40 years old had a mean 
threshold of 2.07mmHg ± 0.20 and subjects over 61 years old had a mean threshold of 
2.68mmHg ± 0.63 (p < .001). However, these may not be clinically significant differences 
as all thresholds sit well within the authors’ classification of normal (< 4mmHg). No 
ethnicity differences have been reported (P Dicpinigaitis, Allusson, Balanti, & Nalamati, 
2001) but women have repeatedly shown lower cough reflex thresholds, more frequent 
coughing and faster adaption to repeated inhalations than men (Becklake & Kauffmann, 
1999; PV Dicpinigaitis & Rauf, 1998; Kastelik et al., 2002; Kelsall, Decalmer, McGuinness, 
Woodcock, & Smith, 2008; Morice, Kastelic, & Thompson, 2000; Rostami-Hodjegan, 
Abdul-Manap, Wright, Tucker, & Morice, 2001). 
 
5.2.1.2 Normative data. 
 Until recently, no normative data has been available regarding the normal dosage of 
tussive agent that should elicit a cough response. Recent research established normative data 
from a sample of 160 healthy individuals across two studies (Monroe et al., 2010; Monroe et 
al., in preparation). Studies recruited equal proportions of young and elder (over 65 years) 
subjects with equal gender representation. In their first study, CRT threshold testing was 
performed on 80 participants using citric acid and passive respiration through a facemask, 
incrementally testing from 0.8mol/L up to 2.6mol/L. The majority of participants (95%) 
produced a natural cough at 0.8mol/L and 68% also demonstrated a suppressed cough (in 
those patients actively trying not to cough, a cough could be involuntarily evoked) at this 
level (Monroe et al., 2010). In view of the unfortunate flooring effect at 0.8mol/L, a further 
80 participants were recruited and the same CRT protocol was repeated with incremental 
testing from 0.1mol/L up to 1.2mol/L. Five percent of participants across both studies did not 




trigger a natural cough and 22% did not display a suppressed cough threshold at the highest 
concentration. The mean threshold for producing a natural cough was 0.4mol/L in both 
young and elder subjects. There was no significant age difference and natural cough was 
significantly lower than suppressed cough thresholds in both age groups. In line with the 
literature, females displayed significantly lower mean natural thresholds (female: 0.27mol/L; 
male: 0.53mol/L) and mean suppressed thresholds (female: 0.35mol/L; male: 0.57mol/L) 
than males (Monroe et al., in preparation). In using CRT in clinical populations, gender but 
not age specific thresholds may be advisable. In applying CRT into clinical diagnosis, 
normative data may not be as important as ascertaining the critical threshold for risk of silent 
aspiration. 
 
5.2.2 Disease and intervention influences on cough sensitivity. 
Activation at the vagal afferent nerve terminals is regulated by both neural and non-
neural elements leaving the cough reflex vulnerable to modulation through disease and 
pharmaceutical interventions (Canning, 2007). As such, cough sensitivity can either increase 
or decrease and needs attention in patients with dysphagia and when assessing cough reflex 
for clinical diagnosis and management.  
 
5.2.2.1 Decreased cough sensitivity. 
Pharmaceutical agents have been shown to decrease cough reflex sensitivity either 
centrally or peripherally. Antitussive agents such as codeine (Bickerman et al., 1954; P. Rees 
& Clark, 1983), opiates (Dilworth, Pounsford, & White, 1990), local anaesthetics such as 
lignocaine (Hansson, Midgren, & Karlsson, 1994) and antihistamines (Packman, Ciccone, 
Wilson, & Masurat, 1991; Tanaka, Hirata, Kurihara, Yoshika, & Yakeda, 1996) have all been 




managing patients with dysphagia. Decreased cough sensitivity has been found in sleep, 
coma, increased depth of anesthetic (J Widdicombe et al., 2006), diabetes with autonomic 
neuropathy (Vianna et al., 1988) and advanced Parkinson’s disease (S. Ebihara et al., 2003). 
This may relate to changes in cortical activation of inhibitory/ suppression pathways of cough 
and again needs consideration in managing patients with dysphagia (Pecova et al., 2007). For 
example, CRT may be used in a patient with a reduced level of consciousness but may not be 
representative of that patient’s cough reflex sensitivity once more alert. 
Decreased cough sensitivity found in bronchopulmonary diseases such as recurrent 
pneumonia (Niimi et al., 2003) may relate more to abnormal afferent inputs to the brainstem 
(Pecova et al., 2007; Yamaya et al., 2001). A small study compared the cough thresholds of 
seven patients with recurrent pneumonia and no underlying condition to seven controls and 
found a significant decrease in evoked capsaicin cough sensitivity in the recurrent 
pneumonia group (Niimi et al., 2003). Recurrent pneumonia was defined by number of 
previous pneumonias but testing was not conducted until antibiotic treatment for the latest 
event was completed to avoid the local inflammatory effects of chest infection on cough 
sensitivity. Whether reduced cough sensitivity leads to pneumonia or whether pneumonia 
leads to reduced cough sensitivity is unknown. In another small study (N=30) comparing 
cough reflex thresholds in normal subjects, patients with dementia and patients with 
aspiration pneumonia, patients with dementia had significantly higher citric acid cough 
thresholds (37.1±16.7mg/ml) than controls (2.6±0.4mg/ml). Seven out of ten patients with 
aspiration pneumonia did not trigger a reflexive cough at the highest citric acid 
concentration used (360mg/ml) (Nakazama, Sekizawa, Ujiie, Sasaki, & Takishima, 1993). 
Dementia, neurological disease, reduced level of consciousness, multiple medications and 
recurrent pneumonia are common to patients with dysphagia. Individual variation in cough 




sensitivity prevents strong conclusions from these smaller studies but influences on cough 
from such conditions are highly relevant and needs further investigation. 
Dystussia has frequently been identified in the acute stroke population (W. 
Addington, Stephens, & Gilliland, 1999; Kobayashi, Hoshino, Okayama, Sekizawa, & 
Sasaki, 1994). Addington and colleagues found 10% of their cohort of 818 patients following 
stroke failed a tartaric CRT (W. Addington et al., 2005). They hypothesised that the transient 
or permanent impairment of cough sensitivity, irrespective of the stroke location, relates to 
what they term ‘brainstem shock’. They define this as a global neurological response 
leading to reduced consciousness, reduced respiratory drive and impaired cough reflex and 
comment that this needs to be addressed in the acute stages of stroke management (W. 
Addington et al., 2005). Potentially, in contrast, Smith and Wiles found contradicting results 
with no impairment in evoked cough sensitivity in 28 patients on a neurological ward. In this 
pilot study of patients of mixed aetiology, only 13 patients had abnormal swallowing results 
and neither capsaicin cough thresholds nor numbers of coughs produced were significantly 
correlated with abnormal swallowing (as defined by speed on a validated water swallow test) 
(P. Smith & Wiles, 1998). Interestingly, abnormal swallowing was significantly associated 
with lower maximum inspiratory mouth pressures reflecting either impairments in reflexive 
cough strength or in patients’ ability to achieve an adequate seal of the mouthpiece. 
However, there are methodological limitations (lack of normal population comparison, lack 
of diagnostic swallowing assessment, low sample size and wide patient aetiology) but their 
discussion is worthy of mention. They hypothesise that damage to the corticobulbar 
pyramidal tract may, in fact, lead to hyper-excitable cough reflexes or reduced voluntary 
suppression of cough in comparison to damage to the brainstem where the cough centre itself 
may be impaired (P. Smith & Wiles, 1998). Patient aetiologies in the group classified as 
dysphagic ranged from encephalitis to motor neurone disease to bilateral partial tenth nerve 




palsy making it difficult to speculate the differences between cortical, brainstem and 
peripheral disease and cough sensitivity. In research looking at cough post stroke, this 
potential for reduced or perhaps heightened sensitivity needs to be considered. Does the 
average patient in the acute stages of stroke cough at the same level of tussive agent threshold 
as normal controls and at what level of difference is this clinically relevant? How long does 
the cough sensitivity remain reduced? Do some stroke lesions leave patients with hyper-
sensitive cough while others lead to dystussia? 
 
5.2.2.2 Heightened cough sensitivity. 
Conditions associated with chronic, prolonged coughing lead to increased cough 
sensitivity in adults and children: gastro-esophageal reflux (Irwin, Madison, & Armando, 
2000; Phua, McGarvey, Ngu, & Ing, 2004), allergic rhinitis and atopic dermatitis (Pecova et 
al., 2007), asthma (A Chang et al., 1996; Koskela, Purokivi, Kontra, Taivainen, & Tukiainen, 
2008) and acute viral upper respiratory tract infections (O’Connell 1996). Interestingly 
cessation in smoking is known to lead to a prompt, temporary enhancement in cough reflex 
sensitivity (PV Dicpinigaitis, 2007; Sitkauskiene & Dicpinigaitis, 2010). Patients with COPD 
have heightened cough reflex sensitivity and sensitivity is significantly related to the amount 
of time they spend coughing (J Smith et al., 2006; JA Smith & Calverley, 2004). ACE 
inhibiters have been shown to increase cough reflex sensitivity by decreasing substance P 
catabolism and show promising effects on reducing pneumonia risk after stroke (Arai et al., 
2005; Liu, Shau, Wu, & Lai, 2012; Sekizawa et al., 1996; Yamaya et al., 2001). Phua and 
colleagues found reduced mechanosensitivity (using FEESST) but heightened 
chemosensitivity (to hydrochloric acid infusion into the pyriform sinus) in patients with 
gastro-oesophageal reflux disease (Phua, McGarvey, Ngu, & Ing, 2010). They hypothesise 




that heightened chemosensitivity is a compensation for the desensitisation of the 
mechanoreceptors by reflux (Phua et al., 2010).  
 
5.2.3 Summary. 
In summary, cough reflex sensitivity is a dynamic phenomenon (PV Dicpinigaitis, 
2007; Sitkauskiene & Dicpinigaitis, 2010) with conditions common in patients with 
dysphagia such as neurological disease, dementia, recurrent pneumonia and multiple 
medication use associated with diminished cough sensitivity. In contrast, ACE inhibitors and 
diseases that lead to chronic cough may have the opposite effect and leave a patient with 
heightened sensitivity (Fox, 1996; Pecova et al., 2007). A comprehensive swallowing 
assessment should consider each of these potential influences on cough sensitivity when 
taking a clinical history. Despite these multiple influences on cough sensitivity, it seems 
likely that there remains a clinically significant cough sensitivity threshold for airway 
protection and that if a patient’s sensory system drops below this point, that silent aspiration 
may occur.  
 
5.3 Influences on Cough Strength 
5.3.1 Disease and intervention influences on cough strength. 
Cough strength can be defined as the amplitude of the motor output of coughing 
either in response to stimulation or under voluntary control. Decreased cough strength leads 
to a consequent inability to clear material from the airway and therefore likely exacerbates 
pulmonary sequelae resulting from penetration/aspiration (GA Fontana & Widdicombe, 
2007). Both cough sensitivity and cough strength are therefore important to the assessment 
of dysphagia and an assessment protocol which evaluates both may be advantageous (J 
Widdicombe et al., 2011).  




Diminished cough strength is prevalent in neurological disease including multiple 
sclerosis (Aiello et al., 2008), Parkinson disease (S. Ebihara et al., 2003; GA Fontana, 
Pantaleo, Benvenuti, & Gangemi, 1998; Pitts, Bolser, Rosenbek, Trache, & Sapienza, 2008; 
Pitts et al., 2010) and Duchenne muscular dystrophy (Bach, Ishikawa, & Kim, 1997). It is 
particularly prevalent in stroke (W. Addington et al., 2005; Smith-Hammond et al., 2001; 
Stephens, Addington, & Widdicombe, 2003) with up to 78% of patients with acute left 
middle cerebral artery infarcts presenting with an abnormal voluntary cough (Stephens et 
al., 2003). Stephens and colleagues collected cough assessment data on 30 patients 
following stroke: a voluntary cough judgement (normal vs. abnormal) and a CRT result 
(pass vs. fail on 20% tartaric acid inhalation). All 16 patients with right middle cerebral 
artery infarcts had normal voluntary cough and reflexive cough results. In the 14 patients 
with left middle cerebral artery infarcts, 11 had an abnormal voluntary cough with six 
unable to produce a cough and classified as having cough apraxia (Stephens et al., 2003). 
There are limitations to this small study. The CRT was a single-dose method limiting the 
conclusions that a threshold test may have allowed and the voluntary cough judgment was 
subjective. They also do not report if the six “cough apraxia” patients who were unable to 
produce a cough to command had been able to follow the instructions to exhale and then 
inhale deeply required for the CRT. 
In a more objective study, Ward and colleagues tested the expiratory muscle 
integrity of 45 patients following middle cerebral artery ischemic stroke using non-
volitional gastric pressure measures to 10th thoracic nerve root stimulation. Twenty healthy 
controls were assessed for comparison. Methods were tightly controlled with voluntary 
cough tests completed before CRT to avoid any effects of the tartaric acid and a facemask 
used to avoid impairments in lip seal influencing results. Their stroke patients had normal 
gastric pressure measures despite producing weaker reflexive and voluntary coughs (peak 




cough flow rate and gastric pressures) compared with controls. They suggest cortical 
damage impacting on the coordination of activation of the cough muscles in cortical stroke 
(K. Ward et al., 2010).  
In progressive neurological diseases, cough strength reduces with disease 
progression (S. Ebihara et al., 2003). Fifty percent of patients with multiple sclerosis and 
40% of those with Parkinson’s disease die from pulmonary complications, with dystussia 
considered to be a contributing factor (Aiello et al., 2008; Nakashima et al., 1997). In 
Parkinson’s disease, diminished motor cough response appears more problematic than 
impaired cough sensitivity in the early to middle stages of the disease (S. Ebihara et al., 
2003; GA Fontana et al., 1998). Similarly patients with amyotrophic lateral sclerosis often 
have an intact reflexive cough to stimuli but their cough peak flow becomes so poor that 
they are unable to clear secretions from the airways (Bach, Bianchi, & Aufiero, 2004). 
Voluntary and reflexive cough strength measured by internal electromyography (EMG) 
were assessed in ten subjects with Parkinson’s disease and compared with age-matched 
controls. Diminished expiratory muscle force was found in the patients with Parkinson’s 
disease with reflexive cough strength affected more than voluntary cough (GA Fontana et 
al., 1998). Like Ward and colleagues, these authors hypothesise that the decrease in EMG 
activity representing reduced expiratory muscle force is a result of a reduced cortical neural 
drive (GA Fontana et al., 1998).  
The same research group used a similar methodology to study cough in ten 
laryngectomised patients and ten age-matched controls. Reflexive cough thresholds were 
calculated at threshold and at supra-threshold using ultrasonic distilled water inhalation 
with the mouthpiece adapted to tightly cover the stoma in the laryngectomy patients. The 
authors do not specify that they investigated the impact of these adaptions on flow rate and 
cough thresholds and these differences in administration between groups may confound 




CRT results. Both indirect airflow measures and internal EMG measures were taken to 
assess cough intensity of voluntary cough, reflexive cough at threshold and reflexive cough 
at supra-threshold. In the absence of cough threshold differences, they found laryngectomy 
patients had significantly reduced abdominal muscle contraction and reduced cough peak 
flow during reflexive coughing at threshold, in comparison to both voluntary cough and 
reflexive coughing at supra-threshold. The authors’ suggest an important role for the larynx 
in conveying sensory information regarding low intensity irritation and in turn in the 
regulation of the expiratory muscle pattern (GA Fontana et al., 1999).  
 
5.4 Summary 
 Despite numerous issues with individual variation and methodology effects, 
replication of results has been demonstrated across methodologies (Morice et al., 2001). 
Females have been found to cough at lower concentrations using single dose vital capacity 
citric acid tests (Thompson, Wright, & Morice, 1999), single dose vital capacity capsaicin 
tests (Becklake & Kauffmann, 1999; PV Dicpinigaitis & Rauf, 1998) and 15-second tidal 
breath capsaicin cough challenges (Fujimura et al., 1996). Validation of CRT methodology 
for dysphagia assessment lags decades behind research motivated by anti-tussive and 
respiratory interventions. It is likely that some of the methodological differences relevant in 
respiratory medicine prove irrelevant in dysphagia assessment where focus is transient 
stimulation of the laryngeal receptors rather than deposition of medication throughout the 
central and lower airways. Citric acid appears a reasonable choice of tussive agent: i) it 
produces a cough through stimulation of C-fibres and cough receptors in the larynx, trachea 
and lungs, ii) but citric acid sensitive neurones are more dominant in the larynx and iii) it is 
well-established in respiratory medicine as a safe and stable agent. A tidal breath method 




may avoid some of the concerns regarding non-respondents and flow rate differences 
between nebulisers but comes with a risk of variability from individual respiratory rates. A 
fast flow nebuliser with large particle size droplets is certainly ideal for the upper airway. A 
facemask not only suits a neurological population but also likely again encourages deposition 
in the upper airways. In light of the evidence available, tightly controlled protocols are 
strongly advisable. 
Cough sensitivity is altered by a variety of pharmaceuticals and diseases influences. 
Knowledge of these influences is necessary in the assessment of cough in the dysphagic 
population. Both cough sensitivity (sensory integrity) and cough strength (motor integrity) 
are affected in neurological disease, suggesting their importance in dysphagia assessment 
and management. 
 
5.5 Cough Sensitivity, Dysphagia And Pneumonia 
Research has found significant relationships between pneumonia rates and both 
reduced ER/ LAR (Aviv et al., 1997) and reduced evoked cough sensitivity (W. Addington 
et al., 2005; Nakajoh et al., 2000; Niimi et al., 2003; Sekizawa, Ujiie, Itabashi, Sasaki, & 
Takishima, 1990) in patients with and without underlying neurological conditions. 
Addington and colleagues found a significant relationship between brainstem and cerebral 
strokes, pneumonia and cough reflex sensitivity (W. Addington et al., 2005). They used 
tartaric acid with an exhalation-inhalation method using a mouthpiece. They claim that this 
technique triggers ER followed by a laryngeal cough reflex (LCR). In their 818 stroke 
patients, 90% of patients had a normal cough reflex and only 3% of this group developed 
pneumonia. Of the 10% with an abnormal cough reflex, 11% developed pneumonia. The 




expiratory-inhalation mouthpiece method is potentially difficult for the neurologically 
impaired patient. It requires a good lip seal as well as the ability to comprehend and follow 
motor commands. The authors report that patients who were unable to achieve an adequate 
lip seal were excluded from analysis, perhaps unfortunately removing more severe strokes 
from the data pool. Nakajoh and colleagues prospectively studied the incidence of 
pneumonia in 143 patients over six months post stroke residing in a nursing home facility. 
They found a significant relationship between pneumonia rates, delayed swallowing 
response to water injected into the pharynx and cough thresholds with evoked citric acid 
testing. Patients with lower cough sensitivity and slower swallowing responses were more 
likely to develop pneumonia. All 14 tube-fed, bedridden patients had slower swallowing 
responses and none coughed at the highest citric acid concentration (Nakajoh et al., 2000). 
Unfortunately patients with brainstem strokes were excluded with the rationale that they 
were already known to be dysphagic and have a risk of pneumonia. Although the 
swallowing assessment choice was arguably subjective in comparison with an instrumental 
assessment, the CRT results retain interest in building the argument of this thesis. If cough 
sensitivity is reduced in neurological disease and is associated with increased risk of 
pneumonia, the addition of CRT has merit. 
 
5.6 Cough Reflex Testing and Dysphagia 
 A number of research groups have investigated CRT use in patients with dysphagia. 
Addington and colleagues studied the addition of a tartaric acid cough challenge to the 
swallowing assessment of 400 acute stroke patients (W. Addington, Stephens, & Gilliland, 
1999). Of 204 participants who did not receive a CRT at a sister hospital, 27 developed 
pneumonia compared with the 400 participants who received a CRT where only five 
developed pneumonia (p < .001). They utilised a clinical treatment algorithm for oral intake 




based on CRT results where a failed cough test resulted in no oral intake and a passed cough 
test resulted in oral intake. An algorithm with heavy reliance only on cough test findings for 
decision-making could be perceived as a limitation of this study as clinical management 
generally incorporates interpretation of other clinical indices. They concluded that an 
abnormal cough test post stroke indicates higher aspiration pneumonia risk and a normal 
CRT indicates low aspiration risk (W. Addington, Stephens, & Gilliland, 1999). This study 
did not justify their dosage of tartaric acid and make no mention of use of normative data 
trials. Cough sensitivity is highly variable across individuals as discussed previously, and in 
order for CRT to be clinically valid, a standardised dosage should be used that is based on 
normative testing. The number of coughs considered to be normal is not reported and 10% of 
participants were classified as having a weak or absent CRT but definition of ‘weak’ is not 
described. The Addington research group used a mouthpiece and the expiration-inspiration 
method (W. Addington, Stephens, & Gilliland, 1999). As discussed, there are 
disadvantages to the mouthpiece method in neurological patients. Addington and 
colleagues state that leakage around the mouthpiece and "puffing" the nebuliser were not 
considered effective inhalations but do not discuss how many of their acute stroke patients 
could not perform the task and were therefore excluded from analysis. Exclusion of the 
more severely impaired patients may have contributed to their low rates of pneumonia. 
A more recent study by Wakasugi and colleagues evaluated the validity of CRT using 
one-minute passive respiration of 1% w/v citric acid via a facemask (with a nose clip), paired 
with a water swallow test (Wakasugi et al., 2008). Same day videoendoscopy or 
videofluoroscopy was used to diagnose aspiration risk. When patients with trace silent 
aspiration were not included as silent aspirators, sensitivity of CRT for detection of aspiration 
was 89%, specificity was 89%; positive predictive value was 74%, and negative predictive 
value was 95%. When trace silent aspirators were included as silent aspirators, the sensitivity of 




CRT was 67%, specificity was 90%, positive predictive value was 77% and negative predictive 
value was 84% (Wakasugi et al., 2008). When the aspirators only were analysed and trace 
silent aspirators were not included as silent aspirators, sensitivity was 87%, specificity was 
95%, positive predictive value was 94% and negative predictive value was 88%. When CRT 
was combined with a water swallow test, 89.1% of those screened as ‘normal’ were ‘normal’ 
on instrumental assessment, 73.7% of those screened as ‘aspiration with cough’ aspirated and 
coughed on their instrumental assessment, and 88.2% of those screened as a ‘silent aspirator’ 
silently aspirated on their instrumental assessment. (Wakasugi et al., 2008). These results are 
promising but the justification for dosage of citric acid is not described and is referenced to a 
Japanese-language journal. Their use of a tidal breathing, facemask method may however 
ensure patients with poor lip seal, apraxia, cognitive and/or communication difficulties can 
perform the test. 
 In 2010, this Japanese research group presented two further studies as posters at the 
Annual Dysphagia Research Society Meeting. Using their previous citric acid test, they 
demonstrated in 40 patients, that if the patient coughed at 15-20 seconds, there was 93% 
sensitivity and 92% specificity for the CRT in identifying silent aspiration. They concluded 
that 20 seconds of tidal respiration rather than their original 60 seconds was sufficient to 
detect those at risk of silent aspiration (Takatoshi et al., 2010). They also reported satisfactory 
reproducibility and reliability with 129 consecutive patients suspected of dysphagia using a 
1% w/v citric acid method CRT and a simple hand-held nebuliser in comparison to their 
original jet nebuliser (sensiWLYLW\VSHFLILFLW\ț  .76) (Wakasugi et al., 2010). This 
technique no longer used a facemask and involved a patient inhaling deeply through the 
mouth (with a nose clip) over a 1-minute period until a cough occurs. Most recently, the same 
Japanese research group published a prospective validation study of 141 patients using their 
hand-held mesh nebuliser method (Sato et al., 2012). They found 30 seconds of mist provided 




the strongest diagnostic accuracy for detecting silent aspirators from all aspirators (sensitivity 
92%, specificity 94%). Sixty seconds of mist provided the strongest diagnostic accuracy for 
detecting silent aspirators from the full cohort (sensitivity 81%, specificity 65%). Despite 
these positive findings, limitations in the clinical utility of these results again lie in their 
failure to adequately justify concentration of tussive agent utilised and the move to a more 
complex methodological approach for neurological patients (the mouth piece, deep inhalation 
technique).  
 Imoto and colleagues attempted to determine the clinically significant cough 
threshold required to safely commence oral intake in 21 patients with neurogenic dysphagia 
(Imoto, Kojima, Osawa, Sunaga, & Fujieda, 2011). They used an incremental 15-second 
capsaicin threshold test followed by 45-second observation periods with a C5 primary end 
point. They do not discuss whether a facemask or mouthpiece was used or whether passive 
respiration or the exhalation-inspiration technique was employed. Dysphagia was classified 
by diet recommendation as mild (full oral intake), moderate (oral intake with supplements) or 
severe (alternative nutrition) based on videoendoscopy or videofluoroscopy. A significant 
correlation was found between the grade of dysphagia and the capsaicin threshold value (p < 
.001). Despite significant differences between mean concentrations across groups, the range 
of capsaicin thresholds within each severity group was extremely wide and overlapped 
considerably (normal 0.98-7.80, mild 1.95-15.6, moderate 15.6-62.5 and severe 31.2-250). 
This study lacked the methodological detail required for replication, used sub-optimal 
dysphagia diagnostics and made arguable conclusions based on the threshold overlaps 
between groups. Additionally, the researchers’ aim to use CRT to accurately assess safety of 
oral intake appears flawed. CRT assesses only sensory integrity and not dysphagia severity. 
 
 






CRT is not a novel technique and has been extensively researched in respiratory 
medicine. Strictly controlled methodology is required for CRT to be considered reliable and 
valid. CRT in dysphagic populations has received much less attention and the range of 
different methodologies used to date makes comparisons difficult. In using CRT in dysphagia 
assessment, the choice of tussive agent may be critical and choosing a method closely related 
to cough evoked by aspiration would be ideal. Promising results from the Addington research 
group suggest that the addition of CRT to dysphagia assessment could reduce pneumonia 
rates if the test results are integrated sufficiently into clinical decision-making (W. 
Addington, Stephens, & Gilliland, 1999). The research from Tokyo also provides promising 
diagnostic sensitivity of CRT for identifying silent aspirators especially when combined with 
a water swallow test (Sato et al., 2012; Wakasugi et al., 2008). However, previous research is 
limited by poor methodological control or reporting. Further research validating a strictly 
controlled CRT methodology with a justified dosage is warranted. 
 
5.7 Cough Strength, Dysphagia and Pneumonia 
Many researchers have investigated the relationship between objective measures of 
voluntary cough strength, aspiration and pneumonia risk (Pitts et al., 2010; Smith-
Hammond et al., 2009). Donha-Schwake and colleagues found inspiratory vital capacity to 
be the strongest predictor of pneumonia in their paediatric group (Dohna-Schwake, Ragette, 
Teschler, Voit, & Mellies, 2006). Bianchi and colleagues recently found that patients with 
dysphagia and pulmonary complications have significantly lower mean cough peak flow 
values than dysphagic patients without pulmonary complications. They report a cough peak 
flow of lower than 242 litres/min predicted the development of pneumonia with a 




sensitivity of 77% and specificity of 83% (Bianchi, Baiardi, Khirani, & Cantarella, 2012). 
This was a retrospective study (N: 55) with neurological dysphagia classified by 
penetration/ aspiration on VFSS and subsequent chest x-ray to examine tracheal aspiration 
severity. Vital capacity and peak expiratory flow were measured by portable spirometer and 
there was a 33% pneumonia rate. 
Smith-Hammond and colleagues have published various studies correlating 
abnormal voluntary cough with aspiration risk in dysphagia post-stroke using aerodynamic 
and sound pressure level measures (Smith-Hammond et al., 2009; Smith-Hammond et al., 
2001). Penetration/ aspiration risk was determined using the penetration-aspiration scale on 
FEES or VFSS. Detailed case histories were taken allowing the researchers to consider the 
impact of other health conditions and baseline characteristics on cough strength. They 
discovered that objective measures of cough, such as peak flow of inspiratory phase and 
expulsive phase and cough volume acceleration, are impaired in patients who aspirate. 
Although sound pressure levels were lower in aspirators, little difference was shown between 
mild and severe aspirators, perhaps reducing the clinical utility of objectively assessing 
loudness/ intensity of volitional cough as part of a CSE (Smith-Hammond et al., 2009; Smith-
Hammond et al., 2001). They found that the airflow pattern in aspirating patients was 
qualitatively different to controls with reduced inspiration and expiration flow rates and 
longer expulsive phase rise times (Smith-Hammond et al., 2001). Explosive phase rise time 
was independently associated with aspiration (Smith-Hammond et al., 2001). In a later 
study, expulsive phase rise time, volume acceleration and expulsive phase peak flow were 
all found to be sensitive predictors of aspiration risk (sensitivity 91%, 91%, 82% 
respectively and specificity 81%, 92%, 83% respectively) compared with a bedside water 
test (sensitivity 39%, specificity 82%) (Smith-Hammond et al., 2009). 




In a pilot study, Pitts and colleagues also found a modest relationship between 
voluntary cough strength (objective airflow measures) and aspiration on VFSS in 20 
patients with Parkinson’s disease. In a later larger study (N: 58), they found expiratory 
phase peak flow was significantly associated with aspiration on VFSS (area under the curve 
(AUC) = .88, sensitivity 57%, specificity 100%) (Pitts et al., 2010). The sample size of this 
study was small especially as only 5 patients aspirated on VFSS. Further work in this 
population group is required.  
 
5.8 Cough Strength Testing and Dysphagia 
Clinically, it is important to distinguish between cough sensitivity and cough 
strength as they are different neurophysiological processes and, although deficits in both 
may lead to an increased risk of pneumonia, assessment and management are significantly 
different. Objective cough strength measures appear to be strong predictors of aspiration 
risk and pneumonia but they do not distinguish between the audible aspirator and the silent 
aspirator and therefore hold a different value to that of cough reflex testing. Objective 
measures of cough intensity require additional equipment: ‘expiratory’ EMG, airflow 
measurements, respiratory pressures, sound pressure measurements and lung volume changes 
such as use of a pneumotachograph (GA Fontana et al., 1998; GA Fontana & Widdicombe, 
2007; Smith-Hammond et al., 2009). Equipment is expensive and cumbersome and requires 
specialist training. It cannot be taken to the bedside and may be impractical for routine 









5.8.1 Subjective cough judgements. 
There are differences of opinion among research groups on the adequacy of 
subjective cough measures, perhaps related to their primary research focuses. Addington 
and Widdecombe, who have focused their work on the sensory cough pathway, write “a 
subjective measurement of voluntary cough (VC) has not been shown to give less 
acceptable results than the objective method” (W. Addington & Widdecombe, 2009, p. 
647) but provide no empirical justification for this statement. In contrast, Gauld and 
colleagues and Smith-Hammond and Goldstein, whose work has focused on the motor 
cough pathway, write of their opinion that subjective assessment of cough is not accurate or 
reliable but again do not support this statement with data (Gauld, 2009; Smith-Hammond & 
Goldstein, 2006). 
 Objective cough strength measures are not a standard component of a bedside 
swallowing assessment whereas subjective cough strength judgements are common in 
clinical practice. However, there is a paucity of research looking specifically at the inter-
rater reliability of subjective judgements of either voluntary or reflexive cough. A number 
of research groups have assessed inter-rater reliability and the studies all investigated the 
clinical utility of CSE protocols with voluntary cough as one of many measures. Daniels 
and colleagues evaluated the reliability of clinical swallowing assessment measures, 
including normal versus abnormal voluntary cough and reported 95% inter-rater agreement 
for all binary measures (Daniels et al., 1998). In a subsequent publication, they described 
their definition of abnormal voluntary cough as “a weak response, verbalized response, or 
no response on [when] given the command to cough” (Daniels et al., 2000, p. 1031). Rater 
experience or training was not discussed. Rosenbek and colleagues also found acceptable 
inter-rater reliability (Kappa significant at p < .005) between three experienced judges 
across all aspects of a clinical swallowing evaluation, including voluntary cough strength 




(normal vs. abnormal) and quality (wet vs. dry) (Rosenbek et al., 2004). Again they give 
few details on the training of the clinicians but describe raters as trained to criterion 
(Rosenbek et al., 2004). In a later study, McCullough and colleagues, again, used only 
experienced judges who were trained to criterion. In this study, they judged voluntary 
cough strength (normal vs. abnormal) with 100% agreement, volitional cough quality (wet 
vs. dry) with 85% agreement, reflexive cough strength (normal vs. abnormal) with 85% 
agreement and reflexive cough quality (wet vs. dry) with 92% agreement (McCullough et 
al., 2005). All these studies utilised experienced, trained researchers; they do not provide 
evidence for the reliability of untrained, inexperienced clinicians. 
 Smeltzer and colleagues studied the reliability and validity of a cough strength 
index in people with multiple sclerosis (Smeltzer, Lavietes, Troiano, & Cook, 1989). The 
index includes a subjective voluntary cough strength rating (1-3) as well as a patient rating 
of mucus clearance and cough strength ability (Smeltzer et al., 1989). Independent, 
practising neurologists performed the tests. Their results were positive with high agreement 
ratings (intra-rater reliabilit\ț LQWHU-UDWHUUHOLDELOLW\ț .87). Sensitivity and 
specificity of the index for predicting those with a maximum expiratory pressure of < 50% 
was 81% and 79% respectively (Smeltzer et al., 1989). These data suggest that reliable 
subjective judgement of cough strength may be possible for patients and independent 
practising clinicians.  
 
5.8.2 Voluntary cough or reflexive cough strength? 
 Interestingly, some researchers have warned against the use of voluntary cough 
strength measures for judging a patient’s ability to clear the airway after aspiration of food 
and/or fluids (W. Addington, Stephens, Phelipa, Widdicombe, & Ockey, 2008). Voluntary 
and reflexive cough respond differently to disease (GA Fontana et al., 1998; Stephens et al., 




2003; K. Ward et al., 2010). Weakened expiratory cough strength clearly impacts a 
patient’s ability to clear the airway but involuntary reflexive pathways cannot be judged by 
a voluntary act (W. Addington et al., 2008). Although reflexive cough and voluntary cough 
are thought to be acoustically the same and both involve the same closed glottis and 
inspiration/expiration pattern, the motor component of voluntary cough is different to that 
of a reflexive cough with a suggestion of different underlying neural pathways (Lasserson 
et al., 2006; Magni, Chellini, Lavorini, Fontana, & Widdicombe, 2011).  
Typically a reflexive cough is approximately 80% of the intensity (as seen with 
expiratory flow rates and abdominal muscle EMG values) of a maximum voluntary cough 
regardless of the tussive agent used (Magni et al., 2011). Magni and colleagues hypothesize 
that it is produced consistently at a threshold sufficient to clear the airway (Magni et al., 
2011). Lasserson and colleagues studied the differences in motor activity between reflexive 
cough and voluntary cough in ten normal subjects (Lasserson et al., 2006). In this study, 
surface EMG and cough flow measures were taken and reflexive cough was evoked by 
one-minute intervals of passive tartaric acid inhalation through a facemask. Reflexive 
cough involved simultaneous, rapid and short-lived EMG activity of expiratory and 
accessory muscles; while during voluntary cough, EMG activity increased gradually 
starting with expiratory muscles with accessory muscles sequentially becoming involved 
(Lasserson et al., 2006). The authors acknowledge the limitations of surface EMG accuracy 
but all subjects were of average size and weight and all measures were taken within the 
same session.  
In a brief report of two healthy subjects, Stephens and colleagues demonstrated a 
difference in diaphragmatic movement using digital VFSS measurement between reflexive 
and voluntary cough. An increased upward movement of the diaphragm was seen with 
reflexive cough in keeping with its vital role in rapid removal of airway threat (Stephens, 




2003). Although only two subjects were tested, leading to questions regarding individual 
variability and statistical significance, the results correspond with other comparable studies. 
In a later study, intra-abdominal pressures were also found to be different between reflexive 
and voluntary cough in 11 subjects (W. Addington et al., 2008). Bladder and rectal 
pressures and urethral EMG were measured using an urodynamic system where a pressure 
catheter is inserted into the bladder and rectum. All subjects were female to avoid gender 
differences confounding results; nine subjects were healthy, one subject had multiple 
sclerosis and one subject had a T4 spinal cord injury. Protocols were detailed and controlled 
with instructions to produce a forced exhalation before each CRT to reflect the respiratory 
pattern of an aspiration event mid-swallow. Reflexive cough intra-abdominal pressures 
were significantly greater and more prolonged regardless of the duration of the coughing 
period in comparison to voluntary cough pressures (W. Addington et al., 2008).  
Although the term reflexive cough has been used in describing these studies, as 
discussed previously, Addington and colleagues believe ERs and cough reflexes cannot be 
separated in an aspiration event where the former always precedes the latter (W. Addington 
et al., 2003). They define the cough stimulated by their CRT as a series of ERs followed by 
cough reflexes “involuntary rapid synchronous expiratory muscle activation that causes and 
sustains an elevated intra-abdominal pressure event over time, sufficient for airway 
protection following a threatening supraglottic laryngeal stimulus” (W. Addington et al., 
2008, p. 9). They therefore discuss that this sustained, increased expiratory power triggered 
by their tartaric CRT is despite a lack of inspiratory effort (W. Addington et al., 2008). 
Inspiratory effort has a significant effect on cough strength and is absent in ER. Again, they 
suggest that this provides evidence for the protective nature of reflexive cough. 
Widdicombe and colleagues theorise greater neural facilitation leading to more rapid 
recruitment of muscle activity in the absence of the higher levels of subglottic pressures that 




occur with greater inspiratory effort (J Widdicombe et al., 2011). It should be noted that their 
justification for the trigger of ERs rather than cough reflexes with their CRT is based on 
clinical experience rather than empirical evidence (W. Addington et al., 2003). Irrespective 
of this debate, evidence is building for different motor patterns for ER and/or reflexive 
cough compared with voluntary cough with more rapid neural activation of muscles in the 
reflexive cough type. 
Finally, there are also practical limitations to voluntary cough testing in patients 
following stroke where level of consciousness, difficulties following instructions and 
apraxia can making execution difficult (Smith-Hammond et al., 2001). Measures of 
reflexive cough efficiency may be more feasible and more accurate for identifying at-risk 
patients for aspiration pneumonia in view of its importance as the initial airway protection 
mechanism (Magni et al., 2011). Little research has been published on objective or 
subjective reflexive cough strength. 
 
5.8.3 Summary. 
Cough strength testing has significant value in the assessment of a patient with 
dysphagia. Using objective cough measures, it has been shown that weakened cough is 
associated with aspiration and pneumonia. Yet, subjective cough judgements have received 
little investigative attention despite common usage. Assessment of the strength of reflexive 
cough rather than voluntary cough may prove more valuable in assessing a patient’s ability 
to clear aspirated materials. 
  
















6.1 Study I and II. Validation of CRT against instrumental assessment of aspiration 
 
Research question 
There is increasing evidence of the validity of CRT for identifying silent aspiration. 
Previous research has used sub-optimal methodology for the neurologically impaired 
patient and has not determined the dosage of tussive agent that best differentiates silent 
aspirators from audible aspirators and non-aspirators (Section 5.6). The following questions 
remain under-investigated: can CRT accurately predict patients who silently aspirate and 
what concentration of citric acid provides the best predictive measure? 
 
Hypotheses 
There will be a statistically significant agreement between CRT result and response to 
aspiration on instrumental assessment. More specifically, patients who fail their CRT will 
be significantly more likely to silently aspirate on instrumental assessment and patients 
who pass their CRT will be significantly more likely to cough in response to aspiration on 
instrumental assessment. There will be differences in sensitivity and specificity values for 
CRT in predicting silent aspiration at different concentrations of citric acid with high 




Silent aspiration is associated with increased prevalence of pneumonia and is poorly 
identified by traditional CSE (Section 3.2). CRT provides information about airway 




sensitivity and therefore may act as a surrogate for silent aspiration and identify those at 
most risk of not responding to airway irritation (Section 3.3). 
 
Proposed studies 
The aim of these studies was to validate CRT against instrumental observations of 
aspiration and to determine what concentration of citric acid provides the best predictive 
measurement of silent aspiration risk. In Study I, 80 patients participated in a single-blinded 
correlational study. All patients received a cough reflex threshold test and a VFSS. The 
validity of CRT was evaluated against response to aspiration on VFSS to find the optimal 
threshold for detecting silent aspiration (Chapter Seven). In Study II, 101 patients 
participated in a similar single-blinded correlational study but all patients received a FEES 
as well as a cough reflex threshold test. Again the validity of CRT was evaluated against 
response to aspiration on FEES to find the optimal threshold for detecting silent aspiration 
(Chapter Eight). 
 
6.2 Study III. Intra-and inter-rater reliability for judgement of cough following 
citric acid inhalation 
 
Research question 
There is evidence that the motor pathway of reflexive cough differs from that of voluntary 
cough and that measuring the strength of reflexive cough is more valuable than voluntary 
cough in judging a patient’s ability to protect the airway from aspirated material (Section 
5.8). There has been little investigation of the reliability of subjective cough judgements by 
SLTs (Section 5.8). Can SLTs reliably judge the strength of a patient’s cough induced by 
citric acid inhalation? 






SLTs will achieve a substantial level of intra and inter- agreement (ț = 0.61- 0.80) when 
judging the strength of coughs induced by citric acid inhalations (Landis & Koch, 1977).  
 
Rationale 
Cough strength, in addition to cough sensitivity, has been linked with increased aspiration 
and pneumonia risk (Section 5.7). Subjective cough judgement is relatively common in 
bedside CSE but the reliability of such judgements has not been investigated. 
 
Significance 
Objective cough assessment requires expensive, cumbersome equipment and specialised 
training and is not currently practical for clinical use. If SLTs can reliably make subjective 
judgements of cough strength, this equipment may not be necessary in the early assessment 
of cough at bedside. 
 
Proposed study 
The aim of this pilot study was to assess the inter- and intra-rater reliability of subjective 
judgements of cough following citric acid inhalation. Eleven SLTs using CRT clinically 
and 34 SLTs without CRT experience viewed ten videos of patients coughing following 
citric acid inhalation. They were asked to judge the cough as strong, weak or absent. They 
watched the videos twice with a short break between viewings. Inter- and intra-rater 
reliability was analysed and those with clinical experience of CRT were compared to those 
without (Chapter Nine). 
 




6.3 Study IV. Inter-rater reliability for judgement of cough following citric acid 
inhalation following training 
 
Research question 
In our earlier study, un-trained SLTs achieved only fair to moderate agreement in judging 
cough strength (Study III, Chapter Nine). With training, can SLTs reliably judge the 
strength of a patient’s cough induced by citric acid inhalation?  
 
Hypothesis 
Specific training in cough physiology and cough strength judgement will lead to substantial 
agreement (ț = 0.61 – 0.80) between SLTs in judging the strength of cough induced by 
citric acid inhalations (Landis & Koch, 1977).  
 
Rationale 
Measuring the strength of reflexive cough provides valuable information about a patient’s 
ability to protect the airway from aspirated material (Section 5.7). The reliability of 
subjective cough judgements by SLTs has received little research attention (Section 5.8). 
There is minimal formal training of cough physiology in undergraduate SLT programmes 
and no research on the effect of specific training on cough judgement. Study III found only 
fair to moderate agreement in untrained SLTs on judging reflexive cough strength (Study 










If training can lead to substantial agreement between SLTs in cough strength judgements, 
the inclusion of such training can be incorporated into undergraduate and in-house training 
and subjective cough strength judgements can be used in clinical practice. 
 
Proposed study 
The aim of this study was to assess the effect of specific cough judgement training on the 
inter-rater reliability of subjective judgements of cough following citric acid inhalation. 
Fifty-eight SLTs were trained specifically in cough physiology and cough strength 
judgement. Training included defining a cough from other respiratory responses/acts and 
judging the strength of a cough. The SLTs then watched ten videos and judged the coughs 
as i) present or absent and ii) strong or weak. Inter-rater reliability was analysed. Effect of 
years of experience in dysphagia management and experience in CRT on reliability was 
assessed (Chapter Ten). 
 
6.4 Study V. Clinical implications of CRT in dysphagia management following 
stroke: A randomised controlled trial 
 
Research question 
There is increasing evidence of the clinical utility of CRT in reducing pneumonia following 
stroke. However, methodological limitations in previous studies prevent CRT from being 
easily translated into clinical protocols. Researchers have used sub-optimal methods for the 
neurologically impaired patient and have not justified dose of tussive agent utilised 
(Section 5.6). Further investigation is needed to understand: does the inclusion of a 








The addition of CRT to a standard CSE will result in a statistically significant reduction in 
pneumonia and mortality rates compared with standard CSE alone. 
 
Rationale 
Significant health issues and service delivery costs are associated with post-stroke 
pneumonia related to dysphagia. Although the development of pneumonia is known to be 
multi-factorial, silent aspiration (aspiration without a cough response) has been linked to 
increased prevalence of pneumonia and mortality (Section 3.2). CSE is not, however, able 
to effectively identify patients who silently aspirate (Section 3.1). CRT provides 
information about airway sensitivity and therefore may indicate those at most risk of not 
responding to airway irritation such as silent aspiration (Section 3.3). 
 
Significance 
The addition of a validated test of ‘silent aspiration risk’ will significantly improve clinical 
assessment of dysphagia. Without a test for silent aspiration, many patients are either not 
referred to SLT or are managed incorrectly as non-aspirators. If identified early, patients at 
risk of silent aspiration can be referred for instrumental assessment. These patients, who are 
at heightened risk of pneumonia, can then be managed more appropriately and secondary 
complications can be avoided. 
 
 





The aim of this study was to evaluate the clinical utility of CRT for reducing pneumonia 
and other functional indices in acute stroke patients using a facemask method ideal for the 
neurologically impaired patient and a tussive agent concentration based on normative data. 
Three hundred and eleven participants were randomly assigned to a control group or an 
experimental group across four urban hospitals. For patients in the experimental group, 
CRT was added to the clinical swallowing evaluation. The primary outcome was proportion 
of patients with pneumonia within three months post stroke (Chapter Eleven). 
 
  
















STUDY I. VALIDATING COUGH REFLEX TESTING AGAINST 




7.1 Hypotheses and Rationale 
Silent aspiration is associated with increased prevalence of pneumonia and is poorly 
identified by traditional CSE. CRT provides information about airway sensitivity and 
therefore may act as a surrogate for silent aspiration and indicate those at most risk of not 
responding to airway irritation (Hypothesis 6.1).  
 
7.2 Methodology 
Eighty consecutive consenting patients (48 male, 32 female) referred for VFSS by 
their treating clinician as part of their standard inpatient or outpatient dysphagia 
management were recruited. The patients ranged in age from 22-100 years (mean 67 years, 
SD 18.75). Patients were excluded if they were tracheostomised or required oxygen support 
for respiratory and/ or spinal injuries. This study received appropriate regional ethics 
approval (Upper South B Regional Ethics Committee URB/10/06/019) and all participants 
                                                 
6 Miles, A., Moore, S., McFarlane, M., Lee, F., Allen, J. & Huckabee. ML. (early online) Validating cough 
reflex testing against instrumental assessment of aspiration. Journal of Physiology and Behavior. DOI: 
http://dx.doi.org/10.1016/j.physbeh.2013.05.004 
7 This study, alongside Study II, was designed by a research team including the PhD Candidate. The data for 
this study was collected by Sara Moore as part of her Masters Degree. With Sara’s consent, these data have 
been independently analysed with extended statistical procedures and reported in this thesis alongside Study II 
endoscopy data in view of its value to the discussion of CRT validation. 




gave informed consent independently or consent was gained by proxy. All patients 
completed a cough reflex threshold test and a VFSS. Independent researchers performed 
each test and were blinded to the result of the alternate test. Due to logistics of radiology 
booking schedules, CRT was performed within 30 minutes after completion of VFSS. All 




Patients were seated upright in a chair. Citric acid solutions diluted in 0.9% sodium 
chloride were prepared by hospital pharmacies on a weekly basis. Incremental concentrations 
of 0.4mol/L, 0.6mol/L and 0.8mol/L were chosen based on established normative data which 
identified that 92.5% of healthy individuals produce a natural cough at 0.8mol/L (Monroe et 
al., 2010). Citric acid concentrations were administered for 15 seconds via facemask using a 
PulmoMate Compressor/Nebuliser (Model 4650I, DeVilbiss Healthcare LLC, Pennsylvania, 
US) with a predetermined free-flow output of 8 litres and a restricted flow output of 6.6 litres 
per minute. Patients were asked to breathe normally and cough “if they felt the need to 
cough”. Initially a placebo dose of 0.9% NaCl was presented to accommodate the patient to 
the feel and noise of the nebuliser. Citric acid concentrations were administered 
incrementally from low to high in one-minute intervals. As recommended by the European 
Respiratory Society (ERS) Task Force, a placebo dose was interspersed between each change 
in citric acid dose to prevent tachyphylaxis and blunting of response to lower doses (Morice 
et al., 2007). Presence or absence of cough during the 15-second delivery period was 
documented. Cough response was considered positive if two or more consecutive coughs 
were triggered (C2 response threshold) (Morice et al., 2007). The test was repeated three 
times at each concentration with two out of three trials considered a positive result. If a 




positive result was achieved, further thresholds were not tested. If the patient passed the 
cough test, a subjective judgement of cough strength was recorded (strong or weak). Patients 
were therefore given two scores: a threshold (0.4, 0.6, 0.8, 1.2, or fail) and a cough strength 
judgement (strong pass, weak pass or fail). Researchers received on-site training in the cough 
threshold test protocol, which included tasks to achieve consensus on cough interpretation 
(present/absent, strong/weak). The definition for weak cough provided to clinicians was "a 
cough that does not appear strong enough to clear aspiration and is substantially weaker than 
their own reflexive cough." 
VFSS was conducted by hospital clinicians as per clinical protocol in the radiology 
suite (Philips, MultiDiagnost Eleva, Netherlands) and recorded at 30 frames/second onto 
videocassette recorder (Panasonic AG, 8700E, Japan) for frame-by-frame playback. Patients 
were administered a standard protocol of volumes and consistencies of barium contrast 
agents (Liquid Polibar, EZ paste, EZEM Canada Inc) (3 x 5ml apple sauce, 3 x sip of water, 3 
x sip of mildly thickened juice (as a compensatory strategy if aspirated on thin), 3 x bites of 
banana, 3 x bites of barium on white bread, 3 x bites of barium on hard cracker and 20ml 
continuous drinking). The protocol was modified as required for patient safety. Images were 
obtained in antero-posterior and lateral planes. Airway protection was evaluated using the 
validated 8-point PAS (Rosenbek et al., 1996). The highest PAS score in the full study was 
recorded. As the primary symptom of interest was silent aspiration rather than dysphagia 
severity, if the patient aspirated, the study was also scored as i) no aspiration, ii) audible 
cough (aspirated and coughed) regardless of the effectiveness of the cough iii) silent 
aspiration (no cough response) with any single silent aspiration event scored as ‘silent 
aspiration’ even if audible aspiration was also noted. Aspiration was defined as material that 
touched the vocal cords or below. 
 




7.2.2 Data analysis. 
Statistical analyses were completed using SPSS version 20 (SPSS, Chicago, IL, 
USA). Cohen’s kappa was used to assess rater agreement for PAS scores between the two 
researchers. Landis and Koch’s classification was used for analysis  (< 0 = no agreement, 0 
– .20 = slight, .21 – .40 = fair, .41 – .60 = moderate, .61 – .80 = substantial, and .81 – 1.0 = 
almost perfect agreement) (Landis & Koch, 1977). The correlation between cough reflex 
test and instrumental assessment was analysed using Pearson’s Chi-square test or Fisher’s 
Exact Test (where expected counts were low and assumptions for Chi-square test were 
violated). Effect sizes were calculated using ORs [with 95% confidence intervals (C.I.s)]. 
Demographic and clinical factors (gender, age, cause of dysphagia) were chosen through bi-
variable analysis against: i) CRT, ii) VFSS or iii) agreement between CRT and VFSS 
(agreed vs. did not agree regarding airway sensitivity). Firstly the full model with all 
significant confounding factors was fit, and a backward selection was used to select the 
main effect model. The significant two-way interactions (CRT and gender, CRT and cause 
of dysphagia) were then added in the main effect model one by one for the final model.  
Sensitivity, specificity, positive predictive (PPV) and negative predictive (NPV) 
values (with 95% C.I.s) were calculated. Positive likelihood ratios (LR+), negative likelihood 
ratios (LR-), pre-test and post-test odds and probabilities were also calculated. A first analysis 
compared silent aspirators to all other cohort participants (including audible aspirators and 
non-aspirators) to represent the capacity of CRT for accurately identifying silent aspiration 
during a clinical examination. The second analyses compared silent aspirators to audible 
aspirators (excluding non-aspirators from the cohort) to assess the true validity of CRT for 
identifying silent aspirators. Finally, validity was presented graphically as a receiver 
operating characteristic curve (ROC curve) demonstrating the trade off between sensitivity 
and specificity at different thresholds. Overall accuracy at each threshold was evaluated using 




AUC. This was considered a pilot study and no power calculation was made. A p value of < 
0.05 was considered significant.   
 
7.3 Results 
7.3.1 Patient characteristics. 
Eighty patients were recruited for the study; their primary aetiologies were stroke 
(18), head and neck (15), respiratory (12), progressive neurological disease (5), other 
neurological disease or injury (8) and other (22). Within the ‘other’ category, three patients 
were referred for dysphagia or oesophageal dysphagia with no other aetiology. 
 
7.3.2 Test results. 
During VFSS, 24/80 patients aspirated (30%), with 17/24 (70%) aspirating silently. 
The prevalence of silent aspiration was 21% (OR 0.28). Inter-rater agreement was high for 
PAS scores between two blinded raters (peUFHQWDJHDJUHHPHQWț ). Seventy-five 
percent of patients passed CRT half of whom had a cough rated as weak by raters (Table 
7.1).  
  
7.3.3 Validation of CRT. 
There was a significant association between CRT result (strong, weak or fail) and 
cough response to aspiration (no aspiration, aspiration with cough, aspiration without 
cough) (unadjusted X2 = 11.05, p = .003, adjusted X2 = 18.69, p < .001). Power was not 
sufficient to calculate the association between CRT result and PAS scores. The tabulated 
counts of CRT threshold results in comparison to cough response to aspiration and PAS 
scores are displayed in Table 7.2 and 7.3 respectively. 
 




Table 7.1 CRT and VFSS results 
  Number of patients 
Cough Reflex Test 
result 
 










fail 20/80 (25%) 
VFSS result 
no aspiration 56 (70%) 
aspirated and coughed 7 (9%) 
no cough to aspiration 17 (21%) 
 
Table 7.2 Association between CRT result and cough response to aspiration  
  Response to aspiration on VFSS 
  No aspiration Aspirated and 
coughed 
No cough to 
aspiration 
CRT result 
strong pass 27 2 1 
weak pass 20 4 6 
 fail 9 1 10 
 
Table 7.3 Association between CRT result and PAS score  
 
Highest Penetration Aspiration Score during VFSS 
1 2 3 4 5 6 7 8 
CRT 
result 
strong pass 14 13 0 0 0 0 2 1 
weak pass 4 13 3 1 0 0 4 5 
fail 2 7 0 0 0 0 1 10 
 




Although demographic and clinical variables did not significantly alter the final 
model between CRT and VFSS, CRT was significantly associated with cause of dysphagia, 
with 56% of stroke patients failing CRT compared with only 15% of respiratory patients (X2 
= 18.85, p = .011). Patients with a stroke had an OR of failing CRT of 16.7 (95% C.I. 2.27, 
122.21). CRT was also significantly associated with gender with 35% of males failing CRT 
compared with only 9% of females and an OR of failing CRT if you were male of 8.5 (95% 
C.I. 2.04, 35.46) (X2 = 10.96, p = .004). A significant association between lower cough 
threshold and female gender was also found with more females passing at 0.4mol/L  (male: 
fail 35%, 1.2mol/L 8%, 0.8mol/L 13%, 0.6mol/L 21%, 0.4mol/L 23%; female: fail 9%, 
1.2mol/L 6%, 0.8mol/L 16%, 0.6mol/L 22%, 0.4mol/L 47%, X2 (1-tailed) = 8.86, p = .033). 
There was a two-way interaction between gender and agreement between CRT and VFSS 
(X2 = 13.75, p = .022). Males had an OR of 6.2 (95% C.I. 1.30, 29.41) for having a 
disassociation between their CRT and VFSS result. 
The proportion of audible aspirators on instrumental assessment who passed CRT 
was high (6/7, 86%) with only one audible aspirator failing CRT. The proportion of silent 
aspirators on instrumental assessment who failed a CRT (at 1.2mol/L) was 7/10, 59%. If a 
weak CRT result was considered a failed cough test (i.e., a weak response to citric acid), the 
proportion of silent aspirators who fail a CRT was higher (16/17, 94%) but this trade-off 
conversely reduced the agreement between audible aspirator and a passed cough test (2/7, 
29%). Table 7.4 displays association test results and ORs for silent aspiration based on CRT 
threshold and classification of weak CRT result.  
Further analysis of instrumental assessment compared to CRT demonstrated a dose 
dependent change in OR for silent aspiration. For aspirators, OR = 9 for silent aspiration 
with failed CRT at 1.2mol/L (at 0.8mol/L OR = 11; at 0.6mol/L OR = 6; at 0.4mol/L OR = 
4). In the full cohort, patients who failed CRT at 1.2mol/L had an OR= 8 (at 0.8mol/L OR = 




6; at 0.6mol/L OR = 4; at 0.4mol/L OR = 2). Wide confidence intervals mean these ORs 
should be interpreted with caution. 
Sensitivity and specificity values for CRT were first calculated on data from the 
subgroup of patients who aspirated. For the aspirators only, sensitivity and specificity 
differed at different thresholds and was optimised at 0.6mol/L (71%, 71% respectively) 
(Table 7.5). AUC values were variable across thresholds and only 1.2mol/L reached 
significance: at 1.2mol/L AUC = .75 (95% C.I. .55, .96, p = .051); at 0.8mol/L AUC = .69 
(95% C.I. .46, .92, p = .143); at 0.6mol/L AUC = .56 (95% C.I. .31, .81, p = .621) and at 
0.4mol/L AUC = .63 (95% C.I. .38, .87, p = .333) (Figure 7.1). Likelihood ratios (with 95% 
C.I.s) and post-test probabilities across thresholds are found in Table 7.6. The LR+ for 
silently aspirating if a patient failed CRT (at 0.6mol/L) was 3.3 [with LR+ post-test odds 
rising to 7.9 (89% post-test probability) from pre-odds ratio of 2.4 (71% pre-test 
probability)]. The LR- for silently aspirating if a patient failed CRT (at 0.6mol/L) was 0.1 
with a post-test odds dropping to 0.2 (16% post-test probability). 




Table 7.4 Tests of association 
  Pearson’s Chi Squared Test p value Odds Ratio (95% C.I.) 
  Full cohort Aspirators only Full cohort Aspirators only Full cohort Aspirators only 
1.2 
strong weak/ fail 9.21 2.34 .002 .127  13.65 (1.71, 292.64) 6.4 (0.33, 229.56) 
strong/ weak vs. fail 13.17 3.96 < .001 .047 7.57 (2.03, 29.44) 8.57 (0.69, 236.61) 
0.8 
strong vs. weak/ fail 9.21 2.33 .002 .127  13.65 (1.71, 292.64) 6.4 (0.33, 229.56) 
strong/ weak vs. fail 10.21 5.04 < .001 .025  5.87 (1.63, 21.90) 11.0 (0.87, 308.99) 
0.6 
strong vs. weak/ fail 6.47 11.36 .011 < .001  9.85 (1.23, 211.73) 40.0 (2.19,1739.47) 
strong/ weak vs. fail 5.14 3.61 .023 .058  3.65 (1.02, 13.72) 6.0 (0.65, 68.63) 
0.4 
strong vs. weak/ fail 2.69 2.33 .101 .127  5.00 (0.60, 109.37) 6.4 (0.33, 229.56) 
strong/ weak vs. fail 0.79 2.52 .374 .112  1.74 (0.45, 7.26) 4.33 (0.49, 44.45) 




Table 7.5 Probability tests 
  
Sensitivity %  
(95% C.I.) 
Specificity  %  
(95% C.I.) 
Positive Predictive Value % 
(95% C.I.) 




































































































































































































Figure 7.1 ROC curve demonstrating the trade off for aspirators between sensitivity and 
specificity at different thresholds 
 
The validity of CRT was weaker when non-aspirators were added to the analysis 
compared with the aspirators-only analysis. The trade-off between sensitivity and specificity 
at different thresholds is still evident and reported in Table 7.5 with 0.4mol/L reaching the 
highest sensitivity (77%) and 1.2mol/L the highest specificity (84%). AUC values were again 
variable and only 0.8mol/L and 1.2mol/L reached significance: at 1.2mol/L AUC = .73 (95% 
C.I. .58, .89, p = .004); at 0.8mol/L AUC = .69 (95% C.I. .54, .84, p = .021); at 0.6mol/L 
AUC = .64 (95% C.I. .49, .79, p = .083) and at 0.4mol/L AUC = .55 (95% C.I. .39, .70, p = 
.564) (Figure 7.2). 





 Figure 7.2 ROC curve demonstrating the trade off between sensitivity and specificity at 
different thresholds 
 
Likelihood ratios (with 95% CIs) and post-test probabilities are displayed in Table 
7.6. The highest LR+ for silently aspirating if a patient failed CRT (at 0.8mol/L) was 2.7 
[with post-test odds rising to 0.8 (post-test probability 43%) from pre-odds ratio of 0.3 (pre-
test probability 21%)]. The LR- for silently aspirating if a patient failed CRT (at 0.6mol/L) 
was 0.2 with a post-test odds dropping to 0.2 (13% post-test probability) 




Table 7.6 Likelihood ratios (aspirators only) 
  
Prevalence of silent 
aspiration 
(pre-odds ratio) 
Likelihood Ratio of positive test  
results (LR+)  
Likelihood Ratio of negative test 
results (LR-)  











strong vs. weak/ fail 71% 1.32 (0.90, 1.72) 76% (3.17) 0.21 (0.01, 2.72) 33% (0.49) 
strong/ weak vs. fail 71%  (2.4) 4.12 (0.82, 84.89) 91% (9.89) 0.48 (0.36, 1.20) 54% (1.15) 
0.8 
strong vs. weak/ fail 71% (2.4) 1.32 (0.90, 1.72) 76% (3.17) 0.21 (0.01, 2.72) 33% (0.49) 
strong/ weak vs. fail 71% (2.4) 4.53 (0.93, 92.55) 92% (10.87) 0.41 (0.30, 1.08) 50% (0.99) 
0.6 
strong vs. weak/ fail 71% (2.4) 3.29 (1.24, 6.61) 89% (7.90) 0.08 (0.00, 0.57) 16% (0.20) 
strong/ weak vs. fail 71% (2.4) 2.47 (0.84, 14.48) 86% (5.93) 0.41 (0.21, 1.30) 50% (0.99) 
0.4 
strong vs. weak/ fail 71% (2.4) 1.32 (0.90, 1.72) 76% (3.16) 0.21 (0.01, 2.72) 33% (0.49) 
strong/ weak vs. fail 71% (2.4) 1.78 (0.81, 6.13) 81% (4.28) 0.41 (0.14, 1.65) 50% (0.99) 




Table 7.7 Likelihood ratios (full cohort analysis) 
  
Prevalence of silent 
aspiration  
(pre-odds ratio) 
Likelihood Ratio of positive test 
results (LR+)  
Likelihood Ratio of negative test 
results (LR-)  











strong vs. weak/ fail 21% (0.28) 1.74 (1.20, 1.90) 33% (0.48) 0.13 (0.01, 0.70) 3% (0.04) 
strong/ weak vs. fail 21% (0.28) 3.71 (1.65, 7.27) 51% (1.02) 0.49 (0.25, 0.82) 12% (0.14) 
0.8 
strong vs. weak/ fail 21% (0.28) 1.74 (1.20, 190) 33% (0.48) 0.13 (0.01, 0.70) 3% (0.04) 
strong/ weak vs. fail 21% (0.28) 2.72 (1.37, 4.45) 43% (0.75) 0.46 (0.20, 0.84) 11% (0.13) 
0.6 
strong vs. weak/ fail 21% (0.28) 1.52 (1.06, 1.65) 30% (0.42) 0.15 (0.01, 0.87) 13% (0.15) 
strong/ weak vs. fail 21% (0.28) 1.78 (1.01, 2.52) 33% (0.49) 0.49 (0.18, 0.99) 12% (0.14) 
0.4 
strong vs. weak/ fail 21% (0.28) 1.24 (0.89, 1.34) 25% (0.34) 0.25 (0.01, 1.49) 6% (0.07) 
strong/ weak vs. fail 21% (0.28) 1.18 (0.74, 1.51) 24% (0.32) 0.67 (0.21, 1.65) 16% (0.19) 















STUDY II. VALIDATING COUGH REFLEX TESTING AGAINST 
INSTRUMENTAL ASSESSMENT OF ASPIRATION 8
_______________________________________________________________ 
 - ENDOSCOPY 
8.1 Hypotheses and Rationale  
See 7.1 (6.1. Study I and II Hypotheses and rationale). 
 
8.2 Methodology 
The cohort consisted of 101 consecutive consenting inpatients (51 male, 50 female) 
ranging in age from 25-96 (mean 78 years, SD 12.6) referred to speech-language therapy for 
initial swallowing assessment. Patients were excluded if they were deemed by a researcher 
to be too drowsy or medically unstable for either of the investigations, were tracheostomised 
or where evaluation was contraindicated (e.g., nasal anatomical abnormalities, history of 
severe epistaxis, base of skull fractures). 
 
8.2.1 Study design. 
This study received appropriate regional ethics approval (Northern Y Ethics 
Committee NTY/11/04/038). All participants gave informed consent independently or 
consent was given by proxy. All patients completed CRT and FEES with two researchers 
blinded to the result of the other assessment. The order of CRT and FEES was alternated to 
                                                 
8 Miles, A., Moore, S., McFarlane, M., Lee, F., Allen, J. & Huckabee. ML. (early online) Validating cough 








avoid order bias and the tests were separated by one hour (range 45-90 minutes). All FEES 
assessments were recorded, stored on the hard drive of the DVD player and scored from the 
video recording by two researchers. In order to assess agreement of CRT scoring, all CRTs 
were also video-recorded using a Mino HD flip video camera (CISCO, Irvine, CA), stored 
on a laptop for playback and scored by two researchers. 
 
8.2.2 Protocol. 
CRT was administered as per the protocol described in Study I, Section 7.2. Citric 
acid solutions diluted in 0.9% sodium chloride for this study included 0.4mol/L, 0.6mol/L 
and 0.8mol/L. The endoscopic swallowing assessment was performed by one of the 
researchers at the patient’s bedside. A 3.2 mm diameter flexible video rhino-laryngoscope 
(Olympus, ENF V2) was passed through the nose and positioned in the pharynx. Using an 
integrated light source and video processor (Olympus, OTVS.I), the pharynx and larynx were 
viewed on an LCD Monitor (Olympus OEV203). The patient was given food and fluids (3 x 
5ml apple sauce, 3 x sip of milk, 3 x bites of cheese sandwich, 20ml continuous drinking of 
milk from a straw). If the patient aspirated on sips of milk, 3 x sips of mildly thickened fluids 
were given (Thickened Creamy Based Mildly Thick Nectar Level 1, Flavor Creations 
Australia) as a compensatory strategy. If the patient demonstrated significant aspiration 
during the study, the protocol was modified or truncated for safety reasons. To improve 
visualisation during the procedure, trials were mixed with blue food colouring (Hansells Blue 
Colouring Old Fashioned Foods Ltd NZ). Aspiration scoring is described in Study I, Section 
7.2. Subjective judgement of strength (strong vs. weak) and speed (prompt vs. latent) of 
response to aspiration was documented. Again, researchers developed consensus on cough 
judgements of both strong/weak cough and prompt/latent cough prior to recruitment. The 
definition for weak cough provided to clinicians was "a cough that does not appear strong 




enough to clear aspiration." Finally, subjective judgement of trace aspiration was 
documented, in line with previous research, as trace amounts of aspiration are easily 
visualised on endoscopic view but may not be clinically relevant (Wakasugi et al., 2008). 
 
8.2.3 Data analysis. 
Statistical analyses were completed using SPSS version 20 (SPSS, Chicago, IL, 
USA) and the analysis approach has been described previously. For details see Study I, 
Section 7.2. With a presumed overall agreement probability of 50% or more, a sample size 
of 100 patients was calculated with a relative error of 20% (Gwet, 2010). 
 
8.3 Results 
One hundred and one patients were recruited for the study (51 male, 50 female) with 
an average age of 77.96 years (range 25-96 years, SD 12.6). Most patients identified 
themselves as of New Zealand European (NZE) ethnicity (88), with 3 New Zealand Maori 
(NZM), 6 Asian, 1 Tongan, and 3 other. Their primary aetiologies were: stroke 50, 
progressive neurological disease 14, other neurological 8, head and neck 4, respiratory 18, 
other 7. Twenty-five percent of patients had respiratory comorbidities (COPD 15, smoker 1, 
asthma 6, bronchiolectisis 1, emphysema 2). Twenty-five percent of patients were taking 
ACE inhibitors. Seventy-one percent were new onset dysphagia while 29% had dysphagia 
prior to admission. 
Sixty-two percent of patients aspirated (63/101); 57% aspirated silently (36/63). The 
most frequently aspirated materials were continuous fluid drinking (26/59, 44% of those 
trialled at this level), sips of thin fluids (38/96, 40% of those trialled) and thickened fluids 
(13/32, 41% of those trialled) (Table 8.1). Eight aspiration events were classified as trace; 
none of these events led to a cough. Eight patients overtly aspirated on one trial but silently 




aspirated on another trial. Interestingly, four patients overtly aspirated on thin fluids but 
silently aspirated on thick fluids. All four of these patients had a weak cough reflex test 
result (Table 8.2). 
 
Table 8.1 Raw data for rates of aspiration and silent aspiration 
  Number of patients  (% of those tested) 
Aspirated on…     
(PAS score 4-8) 
sips of thin fluids 38/96 (40%) 
continuous thin fluids 26/59 (44%) 
thickened fluids 13/32 (41%) 
puree 9/101 (9%) 
solids 2/58 (3%) 
Silently aspirated 
on…  
(PAS score 5 or 8) 
sips of thin fluids 17/96 (18%) 
continuous thin fluids 12/59 (20%) 
thickened fluids 9/32 (28%) 
puree 4/101 (4%) 
solids 1/58 (2%) 
 
Table 8.2 Mixed aspirators 
Overt aspiration Silent aspiration CRT result 
thin & thick solids Fail 
puree thin Fail 
continuous thin thin and thick 0.4 strong 
thin  thin 0.4 strong 
thin and solids thick 0.4 weak 
thin thick 0.6 weak 
thin thick 0.6 weak 








8.3.1 Cough reflex test results. 
Seventy-eight patients passed the CRT (strong 53, weak 24) and 23 failed the CRT 
(Table 8.3). There was no significant association between CRT result and gender (male: fail 
23%, weak 30%, strong 47%; female: fail 22%, weak 24%, strong 54%; X2 (2) = 0.54, p = 
.762). Again, there was a significant association between lower cough thresholds and female 
gender (male: fail 23%, 0.8mol/L 10%, 0.6mol/L 18%, 0.4mol/L 49%; female: fail 22%, 
0.8mol/L 0%, 0.6mol/L 12%, 0.4mol/L 66%; X2 (1-tailed) = 6.74, p = .042).  
Forty-three patients completed their FEES prior to their CRT (15 did not aspirate, 12 
aspirated and coughed and 16 silently aspirated) while 58 patients completed the CRT first 
(24 did not aspirate, 15 aspirated and coughed and 19 silently aspirated). There was no 
significant difference in aspiration response depending on the order of tests (U = 1160, z = 
0.64, p = .529, r = .06). 
 
Table 8.3 CRT results 
CRT result 
 
pass 53/101 (52%) 
 0.4 42 
 0.6 10 
 0.8 1 
weak pass 24/101 (24%) 
 0.4 15 
 0.6 6 
 0.8 4 
fail 
 23/101 (23%) 
 
More detailed analysis of patients with active pneumonia found 33/101 patients had 
pneumonia on the day of assessment. In those with pneumonia, CRT results were fail 30.3% 




(10), weak 27.3% (9) and strong 42.4% (14) while in those who did not have pneumonia, 
CRT rates were fail 19.1% (13), weak 26.5% (18) and strong 54.4% (37). There was no 
significant association between cough result (strong pass, weak pass, fail) and pneumonia 
diagnosis (X2  = 1.86, p = .416). There was also no significant association between cough 
threshold (0.4mol/L, 0.6mol/L, 0.8mol/L, fail) and pneumonia diagnosis (X2  = 1.89, p = 
.631). No significant association was found between silent aspiration and pneumonia, with 
silent aspiration rates of 42.4% in the pneumonia group vs. 35.3% in the no pneumonia 
group (X2  = 0.48, p = .488).  
 
8.3.2 Inter-rater reliability. 
Inter-rater agreement was high between the two raters across nine ratings (range of 
percentage agreement 96-100%, rangHRIțYDOXHV.91-1.00) (Table 8.4).  
 
Table 8.4 Inter-rater reliability between judges’ ratings 
Rating Percentage Agreement Kappa 
cough reflex threshold (0.4, 0.6, 0.8, FAIL) 96% .98 
cough presence/ absence within CRT 99% .97 
cough strength (normal/ weak) within CRT 96% .94 
PAS scoring (thin) within FEES 98% .96 
PAS scoring (puree) within FEES 97% .91 
cough presence/ absence within FEES 98% .97 
cough strength (normal/ weak) within FEES 100% 1.00 
cough latency (prompt, latent) within FEES 97% .94 
trace aspiration vs. aspiration 100% 1.00 
 




8.3.3  Validation of the cough reflex test. 
Tables 8.5 and 8.6 contain the tabulated counts of CRT threshold results in 
comparison to cough response to aspiration and PAS scores respectively. There was a 
significant association between CRT result (strong, weak, fail) and cough response to 
aspiration (no aspiration, aspiration with cough, aspiration without cough) (unadjusted X2  = 
34.08, p < .001, adjusted X2 = 26.42, p < .001) (Table 8.7).  
 
Table 8.5 Association between cough reflex threshold and cough response to aspiration 
 













0.4 strong 20 16 2 4 
0.4 weak 4 6 2 3 
0.6 strong 4 2 2 2 
0.6 weak 2 1 3 0 
0.8 strong 1 0 0 0 
0.8 weak 1 1 2 0 
fail 6 1 16 0 
 
Table 8.6 Association between CRT result and PAS score 
 
Highest Penetration Aspiration Score during FEES 
1 2 3 4 5 6 7 8 
CRT Result 
strong pass 22 1 1 14 2 4 2 5 
weak pass 3 1 1 8 7 1 0 5 
fail 4 2 0 1 5 2 3 6 
 




Table 8.7 Association between silent aspiration and CRT result at 0.4mol/L 
  Wald statistic p value 
Odds 




pass CRT  10.18 < .001 0.2 0.05, 0.49 
weak CRT 10.18 < .001 6.3 2.04, 19.68 
fail CRT 4.74 .030 6.3 1.20, 33.38 
 
The proportion of overt aspirators on instrumental assessment who passed CRT (at 
0.8mol/L) was high (26/27, 96%) with only one overt aspirator failing CRT. The proportion 
of silent aspirators who failed CRT (at 0.8mol/L) was lower (16/36, 44%). Table 8.8 reports 
association test results and ORs for silent aspiration for the full cohort and for the aspirators 
only. Aspirators who failed CRT at 0.8mol/L had an OR of 38 for silently aspirating, an OR 
of 25 if failing the CRT at 0.6mol/L or 0.4mol/L (trace aspirators removed). Confidence 
intervals were wide and these ORs should be interpreted with caution. In the full cohort, 
patients who failed CRT at 0.8mol/L had an OR of 12 for silently aspirating, an OR of 11 
for failing the CRT at 0.6mol/L and 14 for failing the CRT at 0.4mol/L (trace aspirators 
removed). 




Table 8.8 Tests of association (aspirators only) 
 Chi Squared Test p value Odds Ratio (95% C.I.) 












strong (N:53) vs. weak/fail (N:48) 13.68 9.45 < .001 .002 5.08  (1.92, 13.76) 
5.20  
(1.56, 17.98) 




with trace aspirators removed, strong 





with trace aspirators removed, 






strong (N:52) vs. weak/fail (N:49) 12.59 15.03 < .001 < .001 4.75 (1.80,12.80) 
11.50 
(2.62,55.46) 
strong/weak (N:73) vs. fail (N:28) 13.86 12.92 < .001 < .001 5.50 (1.96,15.75) 
12.50 
(2.31,89.41) 
with trace aspirators removed, strong 









with trace aspirators removed, 






strong (N:42) vs. weak/fail (N:59) 14.30 12.32 < .001 < .001 6.21  (2.09, 19.33) 
7.27 
(1.99,27.99) 
strong/weak (N:57) vs. fail (N:34) 15.24 16.04 < .001 < .001 5.50  (2.08, 14.84) 
10.00 
(2.64,40.54) 
with trace aspirators removed, strong 














CRT result (at 0.4mol/L) was also significantly associated with age, with greater mean 
age for weak CRT (85 years, SD 6.6) than failed CRT (77.1 years, SD 13.3) and strong CRT 
(76.3 years, SD 13.0) (X2  = 22.12, p = .005). Although demographic and clinical variables 
did not alter the final model between CRT and FEES, there were a number of three-way 
interactions with adjusted odds ratios for weak and failed CRT results (Table 8.9).  
 
Table 8.9 Multiple logistic regression for the association between CRT result and 
response to aspiration adjusted demographic and clinical factors 
  Confirmed silent aspiration on FEES 
  Wald statistic p value 
Odds 
Ratio 95% C.I. 
Over 65 years old 
weak CRT 6.14 .013 10.8 1.64, 70.93 
fail CRT 11.71 < .001 8.6 2.51, 29.72 
Neurological cause 
of dysphagia fail CRT 4.07 .044 10.6 0.65, 154.40 
Respiratory 
comorbidities fail CRT 3.93 .047 15.0 1.03, 218.30 
 
8.3.4 Cough strength and latency. 
Subjective cough strength judgement on CRT (strong, weak or no cough) was 
significantly associated with subjective cough strength judgement in response to aspiration 
on FEES (X2  = 15.25, p = .003). Subjective cough strength judgement on CRT (strong, 
weak or no cough) was also significantly associated with subjective judgement of speed of 
cough response to aspiration on FEES (prompt response, subjectively latent response, no 








Table 8.10 Association between CRT result and subjective cough strength in patients 
who aspirated  
  Subjective strength of response to aspiration on FEES 
  Strong response to aspiration 
Weak response 
to aspiration 




strong pass 16 3 8 
weak pass  12 3 12 
fail  1 1 15 
 
Table 8.11 Association between CRT result and subjective cough latency in patients 
who aspirated 
   Subjective speed of response to aspiration on FEES 
  Prompt response to aspiration 
Latent response to 
aspiration 




strong pass 18 2 7 
weak pass  7 5 9 
fail 2 1 14 
 
8.3.5 Sensitivity/ specificity  
Table 8.12 reports sensitivity, specificity, positive predictive values and negative 
predictive values across thresholds. Sensitivity and specificity values for CRT were first 
calculated on data from the subgroup of patients who aspirated. For the subgroup who 
aspirated, the trade-off between sensitivity and specificity was optimised at 0.4mol/L (69%, 
71% respectively). Likelihood ratios (with 95% C.I.s) and post-test probabilities are found 
in Table 8.8. The likelihood ratio of a failed CRT if an aspirating patient silently aspirated 
was optimised at 0.4mol/L with a LR+ of 3.6 (with post odds ratio rising to 4.7 (82% 




prevalence) from pre-odds ratio of 0.4 (33% prevalence). The LR- of a failed CRT if an 
aspirating patient silently aspirated was 0.38 with a post-test probability of 33% (post odds 
ratio 0.49). 
The trade-off between sensitivity and specificity at different thresholds is 
demonstrated in Figure 8.1a with 0.4mol/L reaching the highest sensitivity (69%) and 
0.8mol/L the highest specificity (89%). At 0.4mol/L AUC = .76 (95% C.I. .64, .88, p < 
.001), at 0.6mol/L AUC = .74 (95% C.I. .62, .86, p < .001), and at 0.8mol/L AUC = .72 
(95% C.I. .60, .85, p < .001)].  




Table 8.12 Probability tests 
  Sensitivity %  (95% C.I.) 
Specificity  %  
(95% C.I.) 
Positive Predictive Value % 
(95% C.I.) 
Negative Predictive Value % 
(95% C.I.) 
  Full cohort Aspirators only Full cohort 
Aspirators 
only Full cohort 
Aspirators 




strong (N:53) vs. 

















strong/ weak (N:78)  



















with strong (N:47) 




















with strong/ weak 







































strong/ weak (N:73) 



















with strong (N: 46) 
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strong (N:42) vs. 

















strong/ weak (N:57) 



















with strong (N:38) 
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Figure 8.1 ROC curve plot demonstrating the trade-off between sensitivity and specificity at 
0.4mol/L, 0.6mol/L and 0.8mol/L a) aspirators only b) full cohort 











Likelihood Ratio of positive test 
results (LR+) 











(post test odds) 
0.8 
pass vs. fail 57% (1.3) 11 (1.98, 241.97) 93% (14.3) 0.58 (0.53, 0.79) 43% (0.75) 
with trace aspirators removed 50% (1) 16 (2.74, 321.98) 94% (14.75) 0.43 (0.37, 0.65) 30% (0.43) 
0.6 
pass vs. fail 57% (1.3) 6.8 (1.80, 41.17) 90% (8.77) 0.54 (0.46, 0.78) 41% (0.70) 
with trace aspirators removed 50% (1) 9.43 (2.50, 54.01) 90% (9.43) 0.37 (0.28, 0.60) 27% (0.37) 
0.4 
pass vs. fail 57% (1.3) 3.6 (1.699.91) 82% (4.68) 0.38 (0.24, 0.64)  33% (0.49) 
with trace aspirators removed 50% (1) 4.47 (2.179.71) 82% (4.47) 0.19 (0.07, 0.43) 16% (0.19) 




8.3.6 Weak classification. 
The trade-off between sensitivity and specificity when weak cough is classified as a 
fail rather than a pass is demonstrated in Figure 8.2 where classifying weak cough as a fail 
leads to a high sensitivity but a significant increase in false positives (at 0.4mol/L). The 
false positive rate when weak is classified as fail is 0.45; if weak is classified as a pass it is 
0.29 (Table 8.12 for sensitivity and specificity values). 
 
8.3.7 Trace aspirators. 
When trace silent aspirators were removed from analysis, the proportion of silent 
aspirators who fail CRT rises (16/27, 59%). Table 8.12 shows this increase in sensitivity 
with the highest sensitivity at 0.4mol/L (85%) and the highest specificity remaining at 
0.6mol/L (93%). Likelihood ratios (with 95% C.I.s) and post-test probabilities are found in 
Table 8.13. The LR+ of silently aspirating if a patient failed CRT was greatest at 0.4mol/L 
with trace aspirators removed; LR+ was 4.5 with LR+ post-test odds rising to 4.5 (82% 
post-test probability) from pre-odds ratio of 1 (50% pre-test probability). The LR- post-test 
odds dropped to 0.2 with a post-test probability of 16%.  
The diagnostic strength of CRT was weaker when non-aspirators were added to the 
analysis. The trade-offs between sensitivity and specificity at different thresholds are 
displayed in Table 8.12 and is again optimised at 0.4mol/L (69%, 71% respectively). The 
increase in sensitivity when trace aspirators are removed from analysis (85%) is apparent 
from reviewing the data. Likelihood ratios (with 95% C.I.s) and post-test probabilities are 
found on Table 8.14. The LR+ of silently aspirating if a patient failed CRT was greatest at 
0.4mol/L with trace aspirators removed). The LR+ was 2.9 [with post-test odds rising to 2.3 
(post-test probability 55%) from pre-odds ratio of 0.4 (pre-test probability 29%)]. The LR- 
was 0.2 (with a post-test odds of 0.09, post-test probability 8%). 




Sensitivity and specificity of CRT at differing thresholds (0.4mol/L, 0.6mol/L, 
0.8mol/L) is demonstrated in ROC curves with AUCs of .74 (95% C.I. .64, .84, p < .001), 
.77 (95% C.I. .67, .87, p < .001) and .77 (95% C.I. .67, .87, p < .001) respectively, 


















Figure 8.2 ROC curves demonstrating the difference in trade off of sensitivity and specificity 
for aspirators when weak is classified as a) a pass b) a fail.




Table 8.14 Likelihood ratios (full cohort analysis) 
 
Prevalence of silent 
aspiration 
(pre-odds ratio) 
Likelihood Ratio of positive test results  
(LR+) 











(post test odds) 
0.8 
pass vs. fail 36% (0.55) 4.13 (1.79, 10.18) 69% (2.27) 0.62 (0.48, 0.83) 26% (0.34) 
with trace aspirators removed, 
pass vs. fail 
29% (0.41) 5.50 (2.47, 12.77) 70% (2.28) 0.46 (0.30, 0.69) 16% (0.19) 
0.6 
pass vs. fail 36% (0.55) 3.3 (1.61, 6.71) 64% (1.79) 0.59 (0.43, 0.82) 25% (0.33) 
with trace aspirators removed, 
pass vs. fail 
29% (0.41) 4.33 (2.23, 8.09) 64% (1.79) 0.39 (0.22, 0.65) 14% (0.16) 
0.4 
pass vs. fail 36% (0.55) 2.38 (1.49, 3.59) 57% (1.31) 0.43 (0.24, 0.71) 19% (0.24) 
with trace aspirators removed 29% (0.41) 2.91(1.89, 3.77) 55% (1.21) 0.21 (0.07, 0.49) 8% (0.09) 

















STUDY III. INTRA- AND INTER-RATER RELIABILITY FOR 
JUDGEMENT OF COUGH FOLLOWING CITRIC ACID 
INHALATION- A PILOT STUDY 9
________________________________________________________________ 
 
9.1 Hypotheses and Rationale 
Cough strength, in addition to cough sensitivity, has been linked with increased 
aspiration and pneumonia risk. Subjective voluntary cough judgement is relatively common 




The reliability study, including use of video recordings of patients who provided 
informed consent, was reviewed and approved by an appropriate regional ethics committee 
(Human Ethics Committee, University of Canterbury, HEC Application 2011.01.LRPS). 
Participants included 11 SLTs who had received an eight-hour cough reflex testing training 
session and had been using cough reflex testing for one year (experienced raters) and 34 
SLTs with no experience or formal training with the cough reflex test (inexperienced raters). 
Recruitment represented a convenience sample of clinicians attending a number of 
professional development events. The SLTs ranged in clinical experience from new 
graduate to specialist and all reported working with adults with dysphagia. 
 
                                                 
9 Miles, A. & Huckabee, M-L. (2013) Intra and inter-rater reliability for judgement of cough following citric 
acid inhalation. International Journal of Speech-Language Pathology, 15 (2), 209-215. 





Informed consent for videotaping was secured from ten hospitalized adults (mixed 
gender, age range 24-91 years) at two urban hospitals to provide the data for reliability 
analysis. The videos represented 10 patients consecutively referred for swallowing 
assessments. Patient aetiology included progressive neurological disease, acute stroke, and 
frail elderly. Cough strength was not objectively assessed but the 10 patients were 
considered by consensus of the researchers to be representative of the range of responses 
seen in a hospital setting. Non-dysphagic patients were not selected so that the videos 
represented an ‘average’ caseload. Patients were video-recorded using a Mino HD flip video 
camera (CISCO, Irvine, CA) while undergoing a cough reflex test as part of their standard 
dysphagia assessment. The ten video clips were edited into a three-minute high-resolution 
movie using iMovie (Apple, Cupertino, CA). Each clip showed a patient receiving one 15-
second dose of nebulised citric acid solution (diluted in 0.9% sodium chloride) through a 
facemask using a PulmoMate Compressor/Nebuliser (model 4650I) (DeVilbiss Healthcare 
LLC, Pennsylvania, US). This movie was labelled ‘First Viewing’. The movie was then 
recreated, showing the same ten video clips in a randomly different order and labelled 
‘Second Viewing’. 
 
9.2.3 Data collection protocol.  
 Participants viewed the movies through Windows Media Player via projector onto a 
conference room screen. Participants were asked to independently rate the cough response 
seen in each video clip as strong (2 or more strong coughs), weak (2 or more weak coughs) 
or absent (1 or no coughs). The C2 scoring system was chosen for this study (Morice et al., 
2007). This system requires a response of two coughs within 15 seconds of presentation of 
tussive stimuli and is recommended by the European Respiratory Society (ERS) Guideline for 




Assessment of Cough (Morice et al., 2007). Participants were given no specific definition of a 
cough, but were told that a throat clear is not considered a cough response. They were 
provided with no further education about cough or cough strength judgement. After 
watching the ‘First Viewing’ of the movie they were given a 15-minute break where 
participants were discouraged from discussing the videos. They were then asked to watch 
the ‘Second Viewing’ of the movie. After the second viewing, participants were encouraged 
to discuss their experience of judging the videos with each other and the researchers. 
 
9.2.4 Data analysis. 
Data were analysed using SPSS version 20 (SPSS, Chicago, IL, USA). Fleiss’ 
generalized kappa measurement of agreement for multiple raters when assigning categorical 
ratings was used. The data from experienced raters and inexperienced raters were analysed 
as separate groups. Numerical coding for the three categories was defined as: strong (2), 
weak (1) and no cough (0). Additionally, within each group, each category was separately 
analysed for agreement. The Landis & Koch interpretation of Fleiss’ generalized kappa 
values was used (Landis & Koch, 1977). Descriptive data from the unstructured discussion 
between participants following completion of the viewings were collected. Using the theory 
of qualitative analysis, the individual comments were divided into meaning units and themes 
were derived (Graneheim & Lundman, 2004). This study was considered a pilot study and 
no power calculation was completed. 
  
9.3 Results 
 The raw agreement data for all raters for first viewing and second viewing are 
presented in Table 9.1 and Table 9.2. The inexperienced raters displayed an overall 
agreement of 69% (range across videos 47-97%) for the first viewing and 72% (range across 




videos 50-97%) for the second viewing. In comparison, the experienced raters displayed an 
overall agreement of 75% for both viewings (first viewing range 45-100%, second viewing 
range 55-100%) with three videos rated with 100% agreement in the second viewing.  
 
9.3.1 Inter-rater reliability. 
 Inter-rater reliability for inexperienced raters for the first viewing wDVFDOFXODWHGDWț
= .36 (p < .001, 95% C.I. .35, .38). For the second viewing, these raters achieved only a 
marJLQDOO\JUHDWHUț S&,). The experienced raters achieved a 
ț S&,) across the first viewing. This was marginally greater 
for the second viewiQJRIWKHYLGHRVZLWKDț S&,). There were 
marked differences in agreement between categories for both groups on both viewings. A 
summary of overall agreement is presented in Table 9.3LQFOXGLQJț-values, standard error 
values and 95% confidence intervals. Across both groups, agreement for strong cough 
UDQJHGIURPț WR, weak cougKDJUHHPHQWUDQJHGIURPț WR and absent 
cough agreement ranged IURPț WR. Confidence intervals for category agreement 
were wide, likely secondary to the small data set once the 10 items were analysed separately 
as three categories. 




Table 9.1 Raw agreement data (first viewing) 
 Experienced Raters Inexperienced Raters 
 absent weak  strong  % Agreement absent weak strong % Agreement 
Video 1 0 1 10 90 0 12 22 65 
Video 2 0 10 1 90 2 16 16 47 
Video 3 0 7 4 63 0 12 22 65 
Video 4 8 2 1 73 20 14 0 59 
Video 5 2 5 4 45 4 8 22 65 
Video 6 0 6 5 55 0 12 22 65 
Video 7 0 2 9 82 1 11 22 65 
Video 8 7 4 0 64 20 14 0 65 
Video 9 10 1 0 91 31 2 1 92 
Video 10 11 0 0 100 33 1 0 97 
Mean Agreement  75  69 
 
  




Table 9.2 Raw agreement data (second viewing) 
 
 Experienced Raters Inexperienced Raters 
 absent weak  strong  % Agreement absent weak strong % Agreement 
Video 1 0 0 11 100 0 5 29 85 
Video 2 0 7 4 64 0 18 16 53 
Video 3 0 7 4 64 1 16 17 50 
Video 4 7 4 0 64 28 6 0 82 
Video 5 1 4 6 55 4 7 23 68 
Video 6 0 4 7 64 0 16 18 53 
Video 7 0 3 8 73 0 9 25 73 
Video 8 4 7 0 64 22 12 0 65 
Video 9 11 0 0 100 31 3 0 92 
Video 10 11 0 0 100 33 1 0 97 
Mean Agreement  75  72 




Table 9.3 Overall agreement and category specific agreement 
 





Experienced raters  
(N: 34), viewing 1 
overall agreement .46 .03 <. 001 .40 .52 
strong cough rating .43 .15 .003 .13 .73 
weak cough rating .270 .16 .052 .05 .59 
absent cough rating .68 .16 <. 001 .36 1.00 
Experienced raters  
(N: 34), viewing 2 
 
overall agreement .49 .03 <. 001 .43 .55 
strong cough rating .49 .16 <. 001 .18 .80 
weak cough rating .29 .17 .044 .03 .62 
absent cough rating .69 .16 <. 001 .38 1.00 
Inexperienced raters 
(N: 11), viewing 1 
overall agreement .36 .009 <. 001 .35 .38 
strong cough agreement .38 .09 <. 001 .20 .55 
weak cough agreement .07 .08 .192 .08 .22 
absent cough agreement .63 .08 <. 001 .48 .79 
Inexperienced raters  
(N: 11), viewing 2 
overall agreement .41 .009 <. 001 .39 .43 
strong cough agreement .40 .09 <. 001 .23 .57 
weak cough agreement .08 .07 .122 .06 .22 
absent cough agreement .70 .08 <. 001 .53 .87 




9.3.2 Intra-rater reliability. 
 Intra-rater reliability was higher than inter-rater agreement with a ț = .62 (p < .001, 95% 
C.I. .54, .69) for inexperienced raters and a ț = .70 (p < .001, 95% C.I. .57, .81) for experienced 
raters. Again, differences in agreement across categories were seen. Intra-rater agreement for 
inexperienced raters ranged from: strong ț = .66 (p < .001, 95% C.I. .37, .95), weak ț = .41 (p < 
0.001, 95% C.I. .13, .69), no cough ț  = .76 (p < .001, 95% C.I. .48, 1.00). Experienced raters intra-
rater agreement ranged from: strong ț = .71 (p < .001, 95% C.I. .21, 1.00), weak ț = .58 (p = .012, 
95% C.I. .07, 1.00), no cough ț  = .82 (p <.001, 95% C.I. .31, 1.00).  
 
9.3.3 Descriptive data. 
 A list of qualitative responses is presented in Table 9.4. The raters’ responses were 
separated into three themes i) definition of cough ii) definition of weak cough iii) practice/ 
confidence. Participants discussed uncertainty in the definition of cough “he looked like he 
was coughing but I don’t know”, the definition of a weak cough “he looks very frail, does 
that make him weak?” and voiced increase in confidence between viewings “I had a better 
idea about what I was going to rate as a cough the second time”. 
 
  




Table 9.4 Themes of qualitative data with representative examples of comments 
Definition of a cough Definition of a weak cough Practice/ Confidence 
“I decided to close my eyes 
and just listen for the sound 
of a cough as the picture 
confused me” 
“That was much harder than I 
thought it would be, I think I 
judge it on the person’s general 
strength clinically, not their 
cough”. 
“It felt a lot easier the second 
time around” 
“He looked like he was 
coughing but I don’t know” 
“What is a weak cough… all 
my patients are weak?” 
“I remember when I first 
started using the cough reflex 
test, I was confused by weak 
vs. strong but now that it is 
something I focus on more, I 
feel more confident” 
“What is a cough?” 
“I don’t know… he didn’t 
cough as strong as I can but it 
seemed strong enough for his 
age” 
“I don’t think I thought about 
cough strength before I 
started using the cough reflex 
test” 
“His shoulders moved but I 
didn’t know if was a cough 
or not…I thought I’d just 
need to count the coughs 
but it was more 
complicated than that!” 
“He looked so weak…it had to 
be a weak”  
“What is the difference 

















STUDY IV.  INTER-RATER RELIABILITY FOR JUDGEMENT OF 




10.1 Hypotheses and Rationale 
Measuring the strength of reflexive cough provides valuable information about a patient’s 
ability to protect the airway from aspirated material. The reliability of subjective cough judgements 
by SLTs has received little research attention. There is minimal formal training in cough physiology 
in undergraduate SLT programmes and no research on the effect of specific training on cough 




The reliability study, including use of video recordings of patients who provided 
informed consent, was reviewed and approved by an appropriate regional ethics committee 
(Human Ethics Committee, University of Canterbury, HEC Application 2011.01.LRPS). 
Recruitment, consent and participation took place at a number of professional development 
events in New Zealand, Australia, UK, Ireland and USA.  
 
10.2.2 Materials. 
Informed consent for videotaping was secured from ten hospitalised adults (mixed 
gender, age range 59-91 years) at two urban hospitals to provide the data for reliability 
                                                 
10 Miles, A., McFarlane, M. & Huckabee, ML. (in review) Intra and inter-rater reliability for judgement of 
cough following citric acid inhalation with training. Dysphagia. Submitted 2nd August 2013.  




analysis. The strength of patients’ coughs was not objectively assessed but the ten patients 
were considered by consensus of the authors to be representative of the range of responses 
seen in a hospital setting. Eight videos of patients with dysphagia were selected from 15 
consecutive swallowing assessments. Patient aetiology included progressive neurological 
disease, acute stroke, frail elderly and orthopaedic. Two elderly non-dysphagic patients 
were selected from a non-neurological ward to ensure that the videos included a 
representative example of a normal elderly cough. Patients were video-recorded using a 
Mino HD flip video camera (CISCO, Irvine, CA) while undergoing a cough reflex test. The 
ten video clips were edited into a three-minute high-resolution movie using iMovie (Apple, 
Cupertino, CA). Each clip showed a patient receiving one 15-second dose of nebulised citric 
acid solution (diluted in 0.9% sodium chloride) through a facemask using a PulmoMate 
Compressor/Nebuliser (model 4650I) (DeVilbiss Healthcare LLC, Pennsylvania, US).  
 
10.2.3 Protocol.  
 Participants were given a 2-hour training session. This included an introduction to the 
use of cough reflex testing in dysphagia assessment, including rationale and protocols. A 
summary of cough physiology was provided including definitions of cough and cough 
strength. They were provided with videotaped examples of strong, weak and absent coughs 
and were encouraged to make subjective judgements and discuss their clinical reasoning 
leading to those judgements. The definition for weak cough suggested to participants was "a 
cough that does not appear strong enough to clear aspiration and is substantially weaker 
than their own reflexive cough." 
Participants viewed the movie through Windows Media Player via a data projector 
onto a conference room screen. Participants were asked to independently rate the cough 
response seen in each video clip as i) present (2 or more coughs) or absent (1 or no coughs); 




if the cough was present, they then rated the response as ii) strong (2 or more strong coughs) 
or weak (2 or more weak coughs). The C2 scoring system was chosen for this study (Morice 
et al., 2007). This system requires a response of two coughs within 15 seconds of presentation 
of tussive stimuli and is recommended by the European Respiratory Society (ERS) Guideline 
for Assessment of Cough (Morice et al., 2007). After the viewing, participants were asked to 
write any qualitative comments about their experience in interpreting the videos. They also 
provided their years of experience in working with patients with dysphagia, their primary 
caseload, any previous training or clinical experience in cough reflex testing and any 
hearing or visual impairments. 
 
10.2.4 Data analysis. 
Data were analysed using SPSS version 20 (SPSS, Chicago, IL, USA). Fleiss’ 
generalized kappa measurement of agreement for multiple raters when assigning categorical 
ratings was used. Two sets of numerical coding were made for each of the two ratings. The 
first rating was directed at presence of cough: cough (1), no cough (2). While the second 
rating considered cough strength: strong cough (1), weak cough (2) and no cough (3). 
Within each group, each category was separately analysed for agreement. Finally, videos 
where absent cough was predominately rated were then removed and the remaining six 
videos were numerically coded as strong (1) or weak cough (2) and analysed separately to 
exclusively assess the agreement of strength. Confidence intervals and standards errors are 
reported. The Landis & Koch interpretation of Fleiss’ generalized kappa values was used 
(Landis & Koch, 1977). Data were separated by experience level to assess the effect of 
years of experience in working with patient with dysphagia and experience in cough reflex 
testing on agreement. Written qualitative comments provided by participants following 
completion of the viewings were collated and transcribed. Using the theory of qualitative 




analysis, the individual comments were divided into meaning units and themes were derived 
(Graneheim & Lundman, 2004). With an estimated proportion of positive ratings of .50, a 
minimal sample size of 15 raters per experience group was calculated to detect a standard 
error of 0.13 (Reichenheim, 2004; Sim & Wright, 2005).  
  
10.3 Results 
Participants included a convenience sample of 58 SLTs with an average of nine 
years of dysphagia experience (range 0-32 years, SD 7.7) (Table 10.1). All reported 
currently working with adults with dysphagia and all reported primarily working with a 
neurological population except one who had a predominantly otorhinolaryngology caseload. 
Nine clinicians from a single workplace reported using cough reflex testing routinely in 
their clinical practice. One participant reported a hearing impairment in one ear; no visual 
impairments were reported. 
 
Table 10.1 Participants' levels of experience 
 UK NZ Australia USA Ireland 
Number of participants 19 9 12 8 10 
% of participants with over 
5 years experience 84% 56% 50% 88% 70% 
% of participants using 
CRT 0% 100% 0% 0% 0% 
 
The raw agreement data for all raters are presented in Table 10.2. Raters displayed an 
overall agreement of 91% (range across videos 64-100%) for cough presence and 82% 
(range across videos 55-97%) for cough strength. 
 
 




Table 10.2 Raw agreement data for full cohort 
 Cough Presence Cough Strength 
 absent present % agreement strong weak absent % agreement 
Video 1 42 16 72 0 16 42 72* 
Video 2 0 58 100 55 3 0 95 
Video 3 37 21 64 00 21 37 64* 
Video 4 0 58 100 11 47 0 81 
Video 5 0 58 100 10 48 0 83 
Video 6 0 58 100 55 3 0 95 
Video 7 0 58 100 26 32 0 55 
Video 8 45 13 78 0 13 45 78* 
Video 9 58 0 100 0 0 58 100* 
Video 10 0 58 100 56 2 0 97 
Mean 
Agreement  91%  82% 
* data report agreement for absence rather than strength 
 
10.3.1 Inter-rater reliability. 
 Inter-UDWHUUHOLDELOLW\IRUFRXJKSUHVHQFHZDVFDOFXODWHGDWț S < .001 95% C.I. 
.70, .73DQGIRUFRXJKVWUHQJWKDWț S < .001 95% C.I. .60, .62). A summary of 
overall agreement and category specific agreement is presented in Table 10.3 LQFOXGLQJț-
YDOXHVSYDOXHVVWDQGDUGHUURUVDQG&,V$JUHHPHQWIRUZHDNFRXJKZDVSRRUHUț 
.40, p < .001, 95% CI .28, .52) than strong cough (K= .70, p <.001, 95% C.I. .58, .83) and 
DEVHQWFRXJKț S .001, 95% C.I. .60, .83). When raters with practical cough reflex 
WHVWLQJH[SHULHQFHZHUHUHPRYHGIURPDQDO\VLVFRXJKVWUHQJWKDJUHHPHQWGHFUHDVHGWRț 
.68 (p < .001, 95% C.I. .67, .70) and cough strength judgement GHFUHDVHGWRț S
.001, 95% C.I. .56, .58).  




When videos judged predominately as ‘no cough’ were removed from analysis (Video 
1, 3, 8 and 9), strength judgement agreement was poorer with inter-rater reliability for cough 
VWUHQJWKDWț S.001, 95% C.I. .47, .53) (Table 10.4). 
 
10.3.2 Experience levels. 
Raw data and agreement levels for cough presence and cough strength based on 
experience levels are presented in Table 10.5 and Table 10.6 respectively. Agreement of 
cough presence was, according to the Landis and Koch classification, substantial for those 
with CRT H[SHULHQFHț &,1.00, 1.00) and stronger for those with less clinical 
dysphagia H[SHULHQFHț S< .001, 95% C.I. .73, .84) than those with more clinical 
dysphagia H[SHULHQFHț S< .001, 95% C.I. .66, .71) (Table 10.3). Cough strength 
agreement was also ‘substantial’ for those with CRT exSHULHQFHț &,, 
1.00EXWPRGHUDWHIRUERWKLQH[SHULHQFHGț S< .001, 95% C.I. .17, .61) and 
H[SHULHQFHGFOLQLFLDQVț S< .001, 95% C.I. .26, .54) (Table 10.3). Overlapping 
confidence intervals should be taken into account in this interpretation. Wide confidence 
intervals (due to small sample sizes) for the under 5 years experience cohort and cough 
reflex testing experience cohort should also be considered.  
 




Table 10.3 Overall agreement and category specific agreement 





All participants  
(N: 58) 
overall agreement presence  .71 < .001 .008 .70 .73 
overall agreement strength  .61 < .001 .006 .60 .62 
strong cough rating .70 < .001 .065 .58 .83 
weak cough rating .40 < .001 .059 .28 .52 
absent cough rating .71 < .001 .058 .60 .83 
Participants with over 
5 years dysphagia 
experience  
(N: 41) 
overall agreement presence .68 < .001 .011 .66 .71 
overall agreement strength .60 < .001 .008 .58 .61 
strong cough rating .71 < .001 .078 .56 .86 
weak cough rating .40 < .001 .073 .26 .54 
absent cough rating .68 < .001 0.69 .55 .82 
Participants with 
under 5 years 
dysphagia experience 
(N: 17) 
overall agreement presence .78 < .001 .027 .73 .84 
overall agreement strength .62 < .001 .019 .59 .66 
strong cough agreement .68 < .001 .132 .43 .94 
weak cough agreement .39 < .001 .112 .17 .61 









cough reflex testing 
experience  
(N: 9) 
overall agreement presence 1.0 < .001 .053 1.00 1.00 
overall agreement strength .92 < .001 .038 .85 1.00 
strong cough agreement .89 < .001 .185 .53 1.00 
weak cough agreement .87 < .001 .166 .55 1.00 
absent cough agreement 1.0 < .001 .206 .60 1.00 
All participants except 
those with cough reflex 
testing experience  
(N: 49) 
overall agreement presence .68 < .001 .009 .67 .70 
overall agreement strength .57 < .001 .007 .56 .58 
strong cough agreement .68 < .001 .072 .54 .82 
weak cough agreement .35 < .001 .066 .22 .48 
absent cough agreement .68 < .001 .061 .56 .80 




Table 10.4 Overall agreement for strength rating with absent cough videos removed 
from analysis 







All participants  
(N: 58) .52 < .001 .010 .50 .54 
Participants with over 5 
years dysphagia experience 
(N: 41) 
.50 < .001 .014 .47 .53 
Participants with under 5 
years dysphagia experience 
(N: 17) 
.47 < .001 .035 .40 .54 
Participants with cough 
reflex testing experience 
(N: 9) 
.38 < .001 .068 .25 .51 
Participants without cough 
reflex testing experience 
(N: 49) 
.46 < .001 .012 .44 .49 
 
Table 10.5 Raw agreement data for cough presence categorised by experience level 
 Cough Presence 
 absent present  % agreement 

















Video 1 14 28 9 3 13 0 82 68 100 
Video 2 0 0 0 17 41 9 100 100 100 
Video 3 12 25 9 5 16 0 71 61 100 
Video 4 0 0 0 17 41 9 100 100 100 
Video 5 0 0 0 17 41 9 100 100 100 
Video 6 0 0 0 17 41 9 100 100 100 
Video 7 0 0 0 17 41 9 100 100 100 
Video 8 15 30 9 2 11 0 88 73 100 
Video 9 17 41 9 0 0 0 100 100 100 
Video 10 0 0 0 17 41 9 100 100 100 
Mean Agreement 94% 92% 100% 
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Table 10.6 Raw agreement data for cough strength categorised by experience level 
 Cough Strength 
 absent strong  weak % agreement 























Video 1 14 28 9 0 0 0 3 13 0 82 68 100* 
Video 2 0 0 0 16 39 9 1 2 0 94 95 100 
Video 3 11 25 9 0 0 0 6 16 0 65 61 100* 
Video 4 0 0 0 3 8 0 14 33 9 82 80 100 
Video 5 0 0 0 3 7 2 14 34 7 82 83 100 
Video 6 0 0 0 16 39 9 1 2 0 94 95 100 
Video 7 0 0 0 10 16 0 7 25 9 59 61 66 
Video 8 15 30 9 0 0 0 2 11 0 88 73 100* 
Video 9 17 41 9 0 0 0 0 0 0 100 100 100* 
Video 10 0 0 0 16 40 9 1 1 0 94 98 100 
Mean Agreement 84% 81% 96% 
* figures report agreement for absence rather than strength 
 
158
COUGH REFLEX TESTING IN DYSPHAGIA 159 
10.3.3 Descriptive data. 
 Qualitative comments given by participants were again divided into four themes. In 
this study, themes included: the training, using cues, uncertainty around the subjectivity of 
strength and uncertainty around cough presence (Table 10.7). Participants were positive 
about the training and described cues they used in their ratings. As in Study III, uncertainty 
about the subjectivity of strength was the most frequent comment with 15 participants 
commenting on it. 
 
Table 10.7 Themes of qualitative data with representative examples of written 
comments  




opportunity to train 
clinicians in cough 
strength” 
 
“I was influenced by 
visually seeing the 
patient e.g., if the patient 
appeared weak and 
unwell or looked strong” 
“I wonder if there 
should be a middle 
point between strong 
and weak” 
 
“Some do a double 
cough 2 in 1, not sure if 









“Lateral view was easier 
I could see the chest 
more” 
 
“Absent vs. present 
easy” 
 
“Difficult rating a 
cough as absent when 
subject makes a 
physical movement but 
it’s not accompanied by 
an explosive sound” 
“Interpreting the 




can be especially 
strong vs. weak” 
“I tried not to look, just 
listen” 
 
“Strong/ weak very 
subjective”  
 
“The first video was 
hard as I couldn’t hear a 
response but they were 
moving” 
 




“I don’t feel I know 
enough about 
cough now… weak, 
chesty, wheezy” 
“Video clip 3 was hard, 
I couldn’t see the face” 
 
“I found I put weak if 
it wasn’t strong rather 
than knowing what 
weak looked like” 
 
 
“It would have 





“As an acute clinician, 
definition of weak 
differs i.e., low 












PART D: RANDOMISED CONTROLLED TRIAL 
 
 
CHAPTER ELEVEN  




STUDY V. CLINICAL IMPLICATIONS OF COUGH REFLEX 
TESTING IN DYSPHAGIA MANAGEMENT FOLLOWING STROKE: 
A RANDOMISED CONTROLLED TRIAL 11
__________________________________________________________________________ 
 
11.1 Hypothesis and Rationale 
Significant health issues and service delivery costs are associated with post-stroke 
pneumonia related to dysphagia. Although the development of pneumonia is known to be 
multi-factorial, silent aspiration (aspiration without a cough response) has been linked to 
increased prevalence of pneumonia and mortality. There is increasing evidence of the 
clinical utility of CRT for identifying silent aspiration and reducing pneumonia following 
stroke (Hypothesis 6.4).  
 
11.2 Methodology 
11.2.1 Patient selection. 
 Three hundred and eleven acute stroke patients (165 females, 146 males) 
consecutively referred to SLT for swallowing assessment were recruited from four urban 
hospitals. At all four hospitals, patients were referred following a failed nurse-administered 
dysphagia screen. For details of recruitment see Figure 11.1. Patients were excluded if 
palliative swallowing advice was requested rather than active treatment, as these patients do 
not routinely receive full assessment protocols and pneumonia is not actively prevented. The 
                                                 
11 Miles, A., Zeng, I.S.L, McLauchlan, H. & Huckabee, ML. (2013) Cough reflex testing in dysphagia 
following stroke: A randomized controlled trial. Journal of Clinical Medicine Research; 5 (3), 222-233. 
 




patients’ ages ranged from 22-102 years (mean of 78 years, SD 13.5). Initial CT scans 
classified lesions as follows: 212 cortical, 48 subcortical, 8 brainstem, 12 cerebellar, 8 
multi-level, 5 small vessel disease, and 18 with no new abnormalities detected on CT scan.  
 
 
Figure 11.1 Clinical trial patient allocation 
 




11.2.2 Study design. 
 This study received appropriate national ethics approval (Northern Y Regional 
Ethics Committee NTY/09/11/113) and individual site approval at each of the four 
hospitals. All participants gave informed consent independently or consent was gained by 
proxy. Participants were randomly assigned to the control group or the experimental group 
based on a simple randomisation procedure using one computer generated random numbers 
list held in the research office remote from the study environments. Participating clinicians 
at each research site telephoned the research office after gaining consent from each patient 
and were immediately given a randomisation assignment to either the control group or the 
experimental group. The non-blinded study design was unavoidable for patients, the ward 
clinicians, multidisciplinary team and the researcher collecting the outcome data. It was 
essential that the results of the cough reflex test were incorporated into management 
decisions in order to translate to change in outcomes. Documentation of cough reflex test 
results in a patient’s clinical notes was therefore an integral component of the protocol. The 
research office providing the randomisation code was blinded to research site, clinician and 
any patient details. Clinicians who recruited, assessed and treated the participants in the 
study received eight hours of formal teaching regarding CRT procedures and interpretation, 
as well as the opportunity for reflection in practice on a regular basis throughout the 




 For those in the control group, CSE was executed as defined by local clinical 
protocols. At all sites, this involved a case history, cognitive/communication screen, cranial 
nerve examination and observation of oral ingestion of foods and fluids. For patients in the 




experimental group, the standard evaluation was augmented with the inclusion of CRT prior 
to any oral trials. Citric acid solutions diluted in 0.9% sodium chloride were prepared by 
each hospital pharmacy on a weekly basis. These included a lower dose of 0.8mol/L at 
which 92.5% of healthy individuals produced a natural cough and a higher dose of 1.2mol/L 
at which 80% of healthy individuals were no longer able to suppress a cough (Monroe et al., 
2010). CRT was administered using a PulmoMate Compressor/Nebuliser (model 4650I) 
(DeVilbiss Healthcare LLC, Pennsylvania, US) with a predetermined free-flow output of 8 
litres per minute and a restricted flow output of 6.6 litres per minute. A facemask method 
was used (Figure 7.2), as was described in prior research (Wakasugi et al., 2008) and 
utilised in establishing normative data on which this study was based (Monroe et al., 2010).  
 
Figure 11.2 Cough reflex testing equipment 
 
Patients were told that they were participating in a cough test and they were asked to 
cough “if they felt the need to cough”. Initially a placebo of 0.9% NaCl without citric acid 
was presented to coach the participant on task completion. Presence or absence of cough 
during a 15-second delivery period was documented. Cough response was considered 
positive if two or more coughs were triggered (C2 response threshold) as recommended by 




the ERS Task Force (Morice et al., 2007). The test was repeated three times at the low 
concentration, with a 30-second interval between each inhalation to prevent tachyphylaxis 
(Morice et al., 2007). If a patient coughed on this initial test, the clinician then asked the 
patient to “try to suppress the cough as much as you can” while the same low dose was 
administered. If they were able to suppress a cough at 0.8mol/L (2 out of 3 trials), the higher 
concentration was administered (1.2mol/L). The suppressed cough test was passed when 
participants coughed on at least two out of three trials of that dose. Absence of a natural 
cough at 0.8mol/L or the ability to suppress a cough at the higher dose was considered a 
failed test (Figure 11.3). If the patient passed the suppressed cough test, clinicians were also 
asked to subjectively judge whether the cough response was strong or weak.  
 
Figure 11.3 Flow chart of CRT procedure provided to SLTs during recruitment period 
 




 Subsequent management decisions were not prescribed, but were left to the 
judgment of the treating clinician. In the control group, clinicians were encouraged to follow 
their standard clinical decision making processes. In the experimental group, clinicians were 
encouraged to incorporate the combined results of the CSE and the CRT into 
multidisciplinary dysphagia management such as dietary recommendations, instrumental 
assessment referrals, compensatory and rehabilitation approaches. Multidisciplinary 
information sheets and training sessions were used to support carryover of a treatment plan. 
Stickers containing information for the multidisciplinary team were placed in patients’ 
clinical notes (Figure 11.4). If the patient failed the CRT, the team was advised that s/he 
may not show overt signs of aspiration and would be at high risk of aspiration pneumonia. If 
the patient presented with a weak cough, the team was advised that the patient has a cough 
response, but that if the patient coughed, the cough may not be sufficient to clear aspiration. 
When a patient passed the CRT, the multidisciplinary team was advised that the patient was 
likely to show overt signs of aspiration if s/he was aspirating and therefore had a better 
chance of protecting the airway if they aspirated.  
 
11.2.4 Outcome measures 
 The primary outcome measure was the proportion of patients with confirmed 
pneumonia within three months post stroke using the criteria described by Mann and 
colleagues where three or more of the following variables constitute a diagnosis: fever 
(>38°C), productive cough with purulent sputum, abnormal respiratory examination 
[tachypnea (>22/min), tachycardia, inspiratory crackles, bronchial breathing], abnormal chest 
radiograph, arterial hypoxemia (PO2 <70 mm Hg), and isolation of a relevant pathogen 
(positive gram stain and culture) (Mann et al., 1999). A distinction between pneumonia and 
aspiration pneumonia was not attempted. Secondary patient outcome measures included 




length of acute hospital stay in days and the percentage of patients with readmissions for 
chest infection within three months post recruitment to the study. Clinical decision 
parameters were also collected, including percentage of patients with completed VFSS or 
FEES during acute admission or three month post evaluation (i.e., change in frequency in 
referral rates with addition of CRT) and route and type of intake at three month review 
using the Functional Oral Intake Scale (FOIS) (Crary, Carnaby-Mann, & Groher, 2005). 
Outcomes were assessed via phone call with patients, next-of-kin, residential care staff 
and/or general practitioners and a chart review at three months post recruitment. 
 
Figure 11.4 Stickers placed in clinical notes after completing a cough reflex test 




11.2.5 Data analysis 
 Statistical analyses were completed using SAS version 9.3 (SAS, Cary, NC, USA) 
and SPSS version 20 (SPSS, Chicago, IL, USA). A two-sample t-test was used to compare 
the mean length of stay (LOS) between the control group and experimental group; data were 
log transformed for analysis due to skewed distribution. Welch’s analysis of variance for 
groups with unequal variance was used for comparing the diets between experimental group 
and control group. Chi square test was used to assess the associations between categorical 
data outcomes between control and experimental groups. Exact Cochran-Armitage Trend 
Test was used to assess the associations between mortality, pneumonia, readmission and the 
CRT results. Multiple logistic regressions were applied to evaluate the efficacy of the cough 
reflex test adjusted by confounding variables (gender, site, ACE inhibitors, cardiac 
comorbidities, previous stroke history, respiratory comorbidities, instrumental assessment 
and lesion locations), and the two-way interactions including CRT and cardiac 
comorbidities, CRT and previous stroke history, CRT and respiratory comorbidities, CRT 
and lesion locations, CRT and sites.  
The model selections used Akaike information criterion (AIC). Firstly the full model 
with all confounding factors was fit, and a backward selection with AIC were used to select 
the main effect model. The two-way interactions were then added to the main effect model 
one by one for the final model. All analyses were based on intention-to-treat principle. An a 
priori minimal sample size of 268 participants (134 per experimental group) was calculated 









11.2.6 Clinician survey. 
 Following the completion of patient recruitment, all participating health 
professionals (recruiting SLTs, Allied Health managers, stroke unit nursing and medical 
staff) were sent a written survey. The anonymous survey was a combination of forced 
choice and open questions. The survey inquired about their experience during the clinical 
trial, the effect of CRT on their clinical practice, their opinions on continuing use of CRT, 
and their perceived impact of CRT on patients’ outcomes. Answers to forced choice 
questions were tallied for analysis. Qualitative comments provided by participants in open 
questions were collated. Using the theory of qualitative analysis, the individual comments 




 One hundred and sixty three patients were randomised to the control group. One 
hundred and forty eight patients were randomised to the experimental group. An analysis of 
baseline characteristics found no significant differences between groups except for a larger 
proportion of males in the experimental group (control 43%, experimental 53%, p = .053) 
(Table 11.1). Within the experimental group, 91 passed CRT with a strong cough (61%), 31 
passed with a weak cough (21%) and 26 failed CRT (18%). There was variation across sites, 
especially with regards to the category of pass with a weak cough (range across sites, pass 
with strong cough = 56-69%, pass with weak cough = 6-33%, fail = 12-25%, X2 = 18.80, p 
= .592). Although patients in both groups were referred to SLT with suspected swallowing 
difficulties, 45 (14%) patients were placed on a normal diet (FOIS 7) after the first 
assessment, 182 (59%) were placed on a full, modified diet (FOIS 4-6), and 84 (27%) were 
recommended to remain NBM or have oral trials only (FOIS 1-3). There was minimal 




variation in diet recommendation across sites (range across sites, FOIS 1-3= 20-32%, FOIS 
4-6= 57-63%, FOIS 7= 10-21%).  
 
11.3.1 Reducing secondary complications. 
 A summary of outcome differences between the experimental group and control 
group are displayed in Table 11.2 and a summary of odds ratios for development of 
pneumonia and mortality between groups, adjusted for demographic and clinical factors, are 
displayed in Table 11.3. In the unadjusted and covariate-adjusted results, there were no 
significant differences in pneumonia rates between the control group and experimental 
group (unadjusted: control 21%, experimental 26%, X2 = 0.76, p = .380; covariate-adjusted 
odds ratio: 1.7 (95% C.I. 0.9, 3.0, p = .100). There was a non-significant trend that 
pneumonia was associated with an adverse response on CRT (fail 35%, weak 32%, pass 
21%, Z = 1.63, p = .112) with odds ratios of fail vs. pass 2.0 (95% C.I. 0.8, 5.2) and weak 
vs. fail 1.1 (95% C.I. 0.4, 3.4). Irrespective of randomisation, the variables of age, gender, 
hospital site, cardiac comorbidities and respiratory comorbidities were all associated with 
increased pneumonia risk and will be discussed in Study VI.  
In the unadjusted and covariate-adjusted results, there were no significant 
differences in mortality rates in the experimental group compared with the control group 
(unadjusted: control 14%, experimental 20%, X2 = 2.11, p = .151; covariate-adjusted odds 
ratio: 0.7 (95% C.I. 0.4, 1.3, p = 0.230). There was a non-significant trend that higher 
mortality was associated with adverse response on CRT (fail 23%, weak 16%, pass 10%, Z 
= 1.82, p = .071) with odds ratio of fail vs. pass 2.7 (95% C.I. 0.9, 8.5) and weak vs. fail 1.6 
(95% C.I. 0.4, 5.8). Age and not taking ACE-inhibitors were associated with increased risk 
of mortality and will be discussed in Study VI. 
 


















age 76 (15) 79 (12) .063 
male 78 (53%) 68 (42%) .053 
Ethnicity 
Caucasian 111 (75%) 125 (77%) 
.550 
Maori 16 (11%) 11 (7%) 
Pacific Islander 13 (9%) 18 (11%) 
other 8 (5%) 9 (6%) 
Hospital Site 
Hospital A 43 (29%) 49 (30%) 
.793 
Hospital B 37 (25%) 33 (20%) 
Hospital C 52 (35%) 62 (38%) 
Hospital D 16 (11%) 19 (12%) 
Comorbidities 
previous stroke 
history 44 (30%) 46 (28%) .769 
respiratory 
comorbidities 15 (10%) 26 (16%) .089 
cardiac 
comorbidities 103 (70%) 116 (71%) .762 
Site of Lesion 
cortical 102 (69%) 110 (67%) 
.949 
subcortical 34 (23%) 34 (21%) 
other 4 (3%) 9 (6%) 
NAD 8 (5%) 10 (6%) 
Laterality of Lesion 
left 69 (47%) 83 (51%) 
.493 right 64 (43%) 60 (37%) 
other 15 (10%) 18 (11%) 
Diet after initial 
assessment mean (se) 
(13= non-oral feeding, 
47= oral diets) 
 4.4 (0.2) 4.1 (0.2) .180 
Domicile on admission 
public hospital 7 (5%) 6 (4%) 
.650 residential care facility 13 (9%) 19 (12%) 
home 128 (86%) 138 (85%) 




Table 11.2 Outcome comparison between experimental group and control group 
  Experimental Group 
Control 
Group p value 
Domicile at 3 months post 
assessment 
public hospital 12 (8%) 16 (10%) 
.753 residential care facility 64 (43%) 74 (45%) 
home 72 (49%) 73 (45%) 
Mortality 20 (14%) 32 (20%) .150 
Confirmed pneumonia 38 (26%) 35 (21%) .384 
Readmission for pneumonia 7 (5%) 4 (2%) .276 
Diet at 3 months mean (se) 6.2 (0.1) 6.0 (0.1) .218 
Length of stay in acute ward median (IQR) 7 (5, 12) 6 (4.5, 11.5) .582 
Instrumental swallowing assessment completed  27 (18%) 12 (7%) .004 
 
There were no significant differences in length of stay, independence at three months 
and pneumonia readmissions to hospital between the two study groups (Table 11.2 & 11.3). 
Only one three-way interaction was found between CRT, respiratory comorbidities and 
pneumonia (p = .043) with lower pneumonia rates in those with respiratory comorbidities in 
the experimental group (5/15, 33%) compared with those with respiratory comorbidities in 
the control group (14/ 26, 54%).  
 
11.3.2 Association of CRT result with other clinical factors. 
There were no significant differences in age, gender, ethnicity, stroke history, 
cardiac comorbidities, stroke type or independence on admission across CRT results (Table 
11.4). There was a significant difference in the incidence of respiratory comorbidities across 
CRT results with a larger proportion of patients with respiratory comorbidities having a 
weak CRT (fail 8%, weak 23%, pass 7%, X2 
 
= 6.70, p = .044).  




Table 11.3 Multiple logistic regression analyses for pneumonia and mortality between 












Received CRT vs. did not receive 
CRT 1.7 (0.9, 3.0) .101 0.7 (0.4, 1.3) .230 
Age 1.4 (1.1, 1.9) .011 1.7 (1.2, 2.3) .003 
Gender (male vs. female) 1.9 (1.0, 3.5) .042 0.9 (0.5, 1.8) .764 
Study Sites 
Hospital A vs. 
Hospital C 0.6 (0.3, 1.2) .169 0.7 (0.3, 1.5) .331 
Hospital B vs. 
Hospital C 0.4 (0.2, 0.9) .032 0.8 (0.3, 1.8) .509 
Hospital D vs. 
Hospital C 0.3 (0.09, 0.8) .021 0.2 (0.05, 1.1) .062 
ACE inhibitors  
(not taking vs. taking) 1.6 (0.9, 3.1) .127 2.7 (1.2, 5.8) .011 
Comorbidities 
cardiac 3.0 (1.4, 6.5) .011 1.9 (0.9, 4.2) .124 
respiratory 4.3 (2.0, 9.1) < .001 0.6 (0.2, 1.6) .290 
previous stroke 1.8 (1.0, 3.3) .074 1.4 (0.7, 2.8) .348 
Site of lesion 
NAD vs. 
subcortical 0.9 (0.2, 3.7) .881 1.5 (0.3, 7.6) .619 
other vs. 
subcortical 3.1 (0.7, 13.2) .119 1.3 (0.2, 8.5) .773 
cortical vs. 
subcortical 0.81 (0.4, 1.7) .564 1.9 (0.8, 4.6) .172 
Interaction between CRT and 













Table 11.4 Baseline characteristics and outcomes in the experimental group by CRT 
result 
 Fail (N: 26) Weak (N: 31) Strong (N: 91) p value 
Age mean (se) 77 (3.0) 79 (2.0) 75 (2.0) .624 
Gender (male) 15 (58%) 17 (55%) 46 (51%) .781 
Ethnicity 
NZ European 16 (62%) 25 (81%) 70 (77%) 
.670 
Maori 4 (15%) 3 (10%) 9 (10%) 
Pacific 
Islander 3 (12%) 2 (6%) 8 (9%) 
other 3 (12%) 1 (3%) 4 (4%) 
Site of lesion 
cortical 18 (69%) 21 (68%) 63 (69%) 
.593 
subcortical 7 (27%) 5 (16%) 22 (24%) 
other 0 (0%) 2 (6%) 2 (2%) 
NAD 1 (4%) 3 (10%) 4 (4%) 
Previous stroke history 7 (27%) 8 (26%) 29 (32%) .769 
Respiratory comorbidities 2 (8%) 7 (23%) 6 (7%) .043 
Cardiac comorbidities 21 (81%) 20 (65%) 62 (68%) .374 
Laterality of 
lesion 
left 12 (46%) 10 (32%) 47 (52%) 
.271 right 13 (50%) 17 (55%) 34 (37%) 




hospital 0 (0%) 
4 (13%) 
 3 (3%) 
.164 residential 
care facility 2 (8%) 2 (6%) 9 (10%) 
home 24 (92%) 25 (81%) 79 (87%) 
Diet after 1st SLT assessment 
mean FOIS score (se) 2.8 (0.4) 3.3 (0.4) 4.8 (0.2) < .001 




hospital 5 (19%) 2 (6%) 5 (5%) 
.251 residential 
care facility 9 (35%) 14 (45%) 41 (45%) 
home 12 (46%) 15 (48%) 45 (49%) 
Readmission (pneumonia) 1 (4%) 2 (6%) 4 (4%) .903 
Mortality 6 (23%) 5 (16%) 9 (10%) .071 





 9 (35%) 10 (32%) 19 (21%) .111 
Diet at 3 months mean FOIS 
score (se) 6.0 (0.3) 5.6 (0.4) 6.2 (0.1) .342 

























5.6 (3.1) 3.9 (2.6) 3.4 (2.7) - 
 
The numbers of referrals for instrumental assessment were too small for statistical 
analysis but descriptive analysis suggests a positive association between i) failed CRT result 
and silent aspiration and ii) weak CRT result and weak response to aspiration (Figure 11.5). 
The mean penetration/aspiration scores across CRT results suggests a trend towards more 
severe dysphagia leading to an increased chance of a failed CRT (fail 5.6, weak 3.9, pass 
3.4). 





Figure 11.5 Association between CRT result and response to aspiration on instrumental 
assessment 
 
11.3.3 Changes in clinical practice. 
 CRT results were associated with diet recommendations following initial swallowing 
assessment. Higher scores on the 7-point FOIS (Crary et al., 2005) were associated with 
better cough test results with a mean score of 2.8 for the fail group, 3.3 for the weak group 
and 4.8 for the pass group (F = 13.8, p < .001), mean difference and its 95% confidence 
interval of fail vs. pass is 2.0 (1.1, 2.9), and weak vs. pass is 1.5 (0.68, 2.3) (Table 11.4).  
Overall, referral rates for instrumental assessment were 12%. The experimental 
group had a significantly higher proportion of patients referred for instrumental assessment 
than the control group (experimental 18%, control 7% with a proportion difference of 10.4% 
with 95% C.I. 2.9%, 17.9%, p = .004). The adverse responses to the CRT test were 
positively associated with a higher rate of referral (pass 8%, weak 26%, fail 46%, p < .001). 




The numbers of referrals for instrumental assessment were too small for further statistical 
analysis but descriptive comparisons reveal a median number of days between cough test 
and instrumental assessment of 8.5 days in the control group compared with 3 days in the 
experimental group (pass 11, weak 2.5, fail 3).  
There was a significant association between receiving an instrumental assessment 
DQGGHYHORSLQJSQHXPRQLDLQWKHFRQWUROJURXSȋ2 = 3.98, p = .052) with an odds ratio of 
developing pneumonia of 3.2 (95% C.I. 0.85, 12.11). Whereas in the experimental group, 
WKHUHZDVQRVLJQLILFDQWDVVRFLDWLRQȋ2 = 0.52, p = .47 with an odds ratio of 1.4 (95% C.I. 
0.52, 3.70). The odds ratios for developing pneumonia based on CRT result were more 
favourable for those who failed CRT: pass 3.0 (95% C.I. 0.47, 17.92), weak 1.1 (95% C.I. 
0.16, 7.83) and fail 0.33 (95% C.I. 0.04, 2.31). Although there was still a surprisingly low 
referral rate of 46% for the fail CRT group and only 30% of those who developed 
pneumonia received an instrumental assessment, the odds ratio for developing pneumonia if 
a patient failed the cough test and had an instrumental assessment was reduced in 
comparison to other groups. Unlike all other groups, there was a difference in instrumental 
assessment referral rates in patients of the failed CRT group who did not develop 
pneumonia (no instrumental assessment 44%, instrumental assessment 66%) compared with 
those who developed pneumonia (no instrumental assessment 70%, instrumental assessment 
30%) (Figure 11.6).  
The timing of instrumental assessment differed depending on CRT result again 
suggesting changes in clinical decision-making. The five patients in the control group and 
two patients in the pass CRT group who received an instrumental assessment and developed 
pneumonia, developed this complication prior to instrumental assessment (Figure 11.6). 
Whereas the three patients in the failed CRT groups who received an instrumental 
assessment, developed their pneumonia after their instrumental assessment.  






Figure 11.6 Relationship between developing pneumonia an instrumental assessment 
 




11.3.4 Clinician survey. 
Fourteen surveys were completed (8 SLTs, 2 SLT managers, 1 nursing manager, 3 
staff nurses). Table 11.5 shows the tallied responses to the forced choice questions as well 
as extra comments provided. Four themes were derived from the qualitative comments 
provided by health professionals: assimilation of CRT results into decision-making, 
skepticism in the tool, difficulties changing habits and difficulties assimilating the new tool 
into decision-making (Table 11.6). Themes suggest that some SLTs perceived that they 
were successfully assimilating the results into their clinical decision-making. Others 
however, verbalised scepticism in the new tool and felt unable to justify its value to their 
patients without stronger evidence. Other themes suggest difficulties changing habits despite 
good intentions and difficulties integrating the cough test result with the rest of the CSE 
findings. 
 
Table 11.5 Responses to forced choice questions 




Not a problem 1 “It was especially difficult because you 
didn’t know the patient and you were 
needing to build rapport and gain 
confidence.”  
“Staff reported that it frequently took greater 
than 20 minutes per patient.” 
“If family not around, having to ring but if 
couldn’t get hold of them, have to wait. This 
would result in doctors and nurses getting 












Did you find 
CRT a useful 
addition to 
CSE? 
Yes 8 “Occasionally felt unnecessary with some 
stroke patients that did not need a full 
assessment.” No 0 








“From what I understand, it is a potentially 
more useful (and cheaper) adjunct to the 
clinical swallowing evaluation than for 
example cervical auscultation which we 
funded stethoscopes in the past for.” 
“Will be useful after initial ax. Also easier to 
implement if not first session. Will be useful 
Gave me 
confidence to 5 







if pt inconsistent, presents with 












Did you find 
it easy to 
incorporate 
into CSE? 
Yes 6 “I understand that some staff found this 
okay, others found it difficult.” 
 “Yes, as long as I had all the gear with me” 
“I heard reports that getting everything 









“As I understand it, some of the SLTs are 
keen to use it a lot of the time and some are 
only thinking they might use it occasionally. 
One has expressed a preference for waiting 
till results are published about its value.” 
“Yes, however it would be to supplement a 
bedside ax and be used after trials of food if 








“When a patient shows no cough response 
during a bedside ax when there are other 
clinical signs of aspiration/penetration” 
“Gives me more information to base 
decisions on. Weak/ fail go to VFSS” 
“By catching silent aspirators early there’s a 
reduced chance of aspiration, likely to do an 
instrumental ax. More likely to put a patient 
on a diet they can manage sooner e.g., thin 








Table 11.6 Themes of implementation of CRT with representative examples of 
comments 
Assimilation of 
results of CRT into 
clinical decision 
making  
Scepticism of tool 
and evidence base 





new tool into 
clinical decision 
making 
“It provided me with 
more information 
about my patient’s 
dysphagia” 
“Didn’t want to put 
family member 
through the test as 
too much going on” 
 
“The doctors aren’t 
happy with the 
increase in patient’s 
being placed NBM 
for VFSS” 
“I feel more 
confused now. I 
used to feel 
confident in my 
decision 
making” 
“It gave me more 
confidence to feed 
patients if they 
passed the test” 
“I’d feel more 
confident if there 
was evidence for its 
use. I feel like my 
patients are guinea 
pigs” 
“It was a bit difficult 
to implement in the 
very first meeting 
with family. I can see 
it being easier in a 
successive session/ 
assessement. There is 
far too much to do in 
an initial assessment 





CRT but the 
oral trials were 
all fine so I’ve 
asked said thick 
fluids/ puree 
and asked the 
nurse to observe 
for signs of 
chest 
deterioration” 
“I feel more 
confident saying 
NBM now I have a 
test to prove it” 
“I’ll wait until the 
results come out 
before I’ll use it 
again” 




“What do I do if 
they fail the 
cough test but 
everything else 
is fine?” 
“Now I think twice 
when a patient 
doesn’t cough during 
oral trials. It’s made 
me less trusting of 
my old bedside 
assessment” 
“I found the ethical 
dilemma of causing 
my patients 
discomfort for the 
sake of research 
difficult. I couldn’t 
tell them it would be 
better for them.” 
 
“If they are too 
drowsy to eat, 
should I still do 
CRT?” 
“I think this has 
changed the team’s 
practice & it has 
made me feel more 
confident about my 
clinical decision 
making.” 
“I hardly ever see a 
patient who silently 
aspirates anyway so 
it seems a bit over 
the top” 
  


















12.1 Validation of CRT 
These are the first studies to evaluate the validity of CRT at multiple concentrations 
of citric acid against instrumental assessment of aspiration. CRT results were significantly 
associated with aspiration response on instrumental assessment with reasonable levels of 
sensitivity and specificity. Not surprisingly, sensitivity and specificity of the CRT for 
discriminating silent aspirators from overt aspirators (representing the true validity of CRT 
for identifying silent aspirators) was stronger than sensitivity and specificity of the CRT for 
identifying silent aspirators from the entire cohort of dysphagic patients (representing the 
capacity of CRT for accurately identifying silent aspiration during a clinical examination). 
There are no published data documenting sensitivity and specificity for identification of silent 
aspiration during CSE for comparison. However, sensitivity and specificity for identifying 
silent aspiration in the studies reported herein are considerably better than other individual 
components of current bedside examinations for identifying aspiration: jaw strength 
(sensitivity 26%, specificity 96%), wet voice (sensitivity 22%, specificity 96%) and soft 
palate structure (sensitivity 24%, specificity 93%) (McCullough et al., 2005). A 5ml water 
test provided 81% sensitivity but only 47% specificity while a 10ml water test provided only 
37% sensitivity and 96% specificity for identifying aspiration (McCullough et al., 2005; 
McCullough et al., 2001). Similar levels of diagnostic accuracy were found by other 
researchers with low sensitivity (45%, 40% respectively) and high specificity (96%, 93% 
respectively) for the identification of aspiration with a water test (Mann et al., 2000; Smithard 
et al., 1998). Undoubtedly, sensitivity and specificity values of identifying aspiration improve 
when clinical observations are combined. Logemann and colleagues assessed the sensitivity 
and specificity of a 28-point screening tool against VFSS results. The screening test had a 




sensitivity of 69% and specificity of 71% if a patient was classified unsafe on more than 8 of 
the 28 observations (Logemann et al., 1999). Interestingly these values for identifying 
aspiration from 28 observations are no greater than the values for identifying silent aspiration in 
Study I and II using CRT in isolation. 
As well as the traditional criteria of counting coughs in CRT, cough strength was also 
recorded. Promising findings have been previously reported for sensitivity and specificity of 
objective measures of voluntary cough strength for identifying aspiration risk (Pitts et al., 
2010; Smith-Hammond et al., 2009). It is not clear whether a weak cough following citric 
acid inhalation represents a reduced sensory receptor response to irritation or a weakened 
motor response. In the validity studies, when weak was classified as a fail, the sensitivity of 
picking up silent aspirators was improved but specificity was reduced. Overall diagnostic 
accuracy was greater when a weak response was not considered a failed result. Although 
weak cough has been shown to indicate aspiration risk, this study does not provide conclusive 
evidence regarding the clinical sensitivity of a weak cough response for identifying silent 
aspiration.  
Wakasugi and colleagues found that patients who silently aspirated trace amounts 
were more likely to pass their CRT than patients who silently aspirated larger amounts 
(Wakasugi et al., 2008). Similarly in the current validity studies, sensitivity improved when 
trace aspirators were not classified as silent aspirators (Wakasugi et al., 2008). Trace 
penetration and aspiration is relatively common in healthy individuals of all ages (Allen et 
al., 2010) and it is also possible that FEES, where the airway to easily visualised, over-detects 
aspiration in comparison to VFSS. The consistent findings between these studies suggest that 
the presence of trace silent aspiration may not be clinically relevant. 
In line with published data, more patients aspirated on fluid consistencies than solids 
(Daniels et al., 1998) and a number of patients silently aspirated thickened fluids but audibly 




aspirated on thin fluids. These findings are clinically relevant in view of the international 
common use of thickened fluids as an intervention for preventing aspiration. A previous 
randomised controlled trial found honey thickened fluids to be the most successful 
intervention for preventing aspiration in 711 patients with dementia and Parkinson’s disease 
when compared with nectar thickened fluids and chin tuck posture (Logemann et al., 2008). 
Further study of these mixed aspirators is required. If aspiration of thickened fluids can lead 
to insufficient summation to result in a cough response and small amounts of thickened fluids 
regularly enter the airway and are not removed, the consequences may be serious. It should 
be noted that in Study II, thickened fluids were tested at room temperature yet the milk used 
for the thin fluids was fridge-cold perhaps suggesting that stimulation of cold receptors may 
have led to coughing on thin fluids. Nevertheless, further investigation of the response to 
aspiration of thin fluids versus thickened fluids and its consequences would be valuable.  
 
12.1.1 Failing CRT. 
The CRT fail rate of these cohorts of patients with suspected dysphagia of mixed 
aetiology was 25% (VFSS) and 23% (FEES). This is higher than the CRT fail rate in the 
stroke patients in Study V (18%) and lower than the fail rate in the patients with suspected 
dysphagia of mixed aetiology in the Wakasugi study (30%) (Wakasugi et al., 2008). 
Addington and colleagues, in their study of stroke patients, found a fail rate of only 10% but 
their criteria was classified as “weak or absent LCR”, their irritant and method of 
administration differed to these other studies and they do not discuss exclusion of those who 
were unable to achieve adequate lip seal or follow the test instructions (W. Addington, 
Stephens, & Gilliland, 1999, p. 1204). Of interest, if these rates are compared to the rates of 
silent aspiration found in our studies [21% VFSS, 36% FEES (27% with trace aspirators 
excluded)] and published mixed aetiology cohort studies (26%, 25%, 35% respectively) 




they correlate with the CRT fail rate of the passive respiration method closely (Garon et al., 
1996; C. Smith et al., 1999; Wakasugi et al., 2008). Daniels and colleagues found a similar 
rate of 25% in their cohort of unselected acute stroke patients (Daniels et al., 1998).  
Lower concentrations of citric acid appear a better predictive measure of silent 
aspiration. Citric acid concentrations used in this study provide a useful working range but 
further testing of other concentrations may improve detection of subtle sensory deficits. 
Sensitivity and specificity values across different concentrations of citric acid may prove 
useful in different situations. Clinicians working with high risk populations may prefer 
concentrations that provide high sensitivity over specificity (e.g., 0.4mol/L); while clinicians 
using CRT as a screening tool in a low risk population may prefer to use a concentration with 
higher specificity (e.g., 0.8mol/L). Given the inability to identify silent aspiration by any 
previously mentioned criteria, CRT offers a safe, manageable tool that can be incorporated 
into CSE to enhance detection of silent aspiration. CRT holds promise as a swallowing 
screening test. CRT is safe and can be standardised, and therefore is not as susceptible to 
interpretative variance that plagues much of bedside clinical swallowing evaluation. The data 
provided in this manuscript can be used by clinicians to adapt the test to suit their clinical 
identification needs and allows incorporation of CRT into a dysphagia test battery. 
 
12.1.2 Limitations. 
Methodological differences between the two studies prevented pooling of data. 
Although the proportion of patients who passed CRT was similar between groups, a larger 
proportion of patients were judged as having a weak cough in the VFSS cohort (VFSS 
cohort 37.5%, FEES cohort 24%).  This judgement was subjective. Although there was 
strong agreement between the two researchers at the FEES site on cough strength, 
differences between researchers’ judgement across sites may be questioned. It is possible 




that clinicians working together develop a subconscious schema for judgement over time 
and perhaps this differed between sites. 
Despite similarities in CRT fail rates, age and aspiration rates differed across 
methodologies. This perhaps reflects the difference in subject selection for the clinical 
studies. The VFSS cohort were known to be dysphagic and were under the care of SLTs. 
They represented a mixture of hospitalised patients and outpatients while the FEES group 
were all inpatients in their first days of acute admission. Referral to VFSS requires patients 
to be medically stable enough to leave a ward and tolerate the radiology suite procedure 
while the FEES is performed at bedside perhaps allowing more unwell patients to 
participate. These differences in recruitment methods may have led to the differences in 
dysphagia severity and age. It must also be acknowledged that the cohorts were recruited 
from different hospitals and as well as the methodological differences, the populations may 
also be inherently different at the two geographically distinct sites. 
As previously discussed it is also possible that FEES, where the airway to easily 
visualised, over-detects aspiration in comparison to VFSS. Unlike the FEES protocol, the 
VFSS protocol was performed by treating clinicians and was not controlled. The protocol 
was often truncated or terminated early. This hesitancy led to limited video-footage and 
perhaps patients were not challenged sufficiently leading to lower aspiration rates. The 
sample size for the VFSS study limited the power of some of the analysis with wide 
confidence intervals observed at times. Larger studies of this kind may add to the field of 
knowledge. The concentration of citric acid for optimal sensitivity and specificity differed 
between cohorts. Possible causes of this discrepancy include: cohort differences, differences 
in protocols and methodologies or rater reliability across sites. 
Statistical limitations are worthy of discussion. Diagnostic precision is dependent on 
prevalence of disease and silent aspiration has a relatively low prevalence even in a selected 




dysphagic population (Bender, Lange, Freitag, & Trampisch, 1997; Brenner & Gefeller, 
1997). The dependence of positive predictive values and negative predictive values on 
disease prevalence suggests that these may be of little value in this study. Sensitivity, 
specificity and likelihood ratios are not influenced by prevalence and therefore may provide a 
more reliable measure of validity in this situation. However, caution should still be taken in 
comparing sensitivity and specificity values across different population groups.  
The use of VFSS and FEES as a ‘gold standard’ assessment of silent aspiration also 
needs discussion. Some patients did not aspirate but perhaps if challenged more, may have 
aspirated (silently or audibly). An instrumental assessment does not replicate a patient’s risk 
of aspiration throughout a meal or over the course of a day. In this study, silent aspiration was 
classified as at least one incident of silent aspiration observed during the assessment. Some 
patients silently aspirated on one occasion and audibly aspirated on another (mixed 
aspirators). Silent aspiration is unlikely a definable binary state. A lack of observed silent 
aspiration may not equate to a true gold standard for ‘no silent aspiration risk.’  
Finally, it is important to acknowledge some of the methodological limitations of 
CRT. There is inter-individual variation in cough response to irritants in the healthy population. 
Researchers warn that some people, without pathology, either cough excessively on very low 
doses of tussive agent or do not cough even on extremely high doses (Morice, 1996). Up to 
10% of normal controls fail to cough on maximum doses of both citric acid and capsaicin in 
vital capacity breath experiments though this does not appear to occur as frequently with a 
15-second tidal breathing method (Barber et al., 2003; Fujimura et al., 1996; Morice et al., 
1992). This likely contributes to the calculated validity of the test and needs to be considered 
when using cough reflex testing diagnostically. Women have repeatedly shown lower cough 
reflex test thresholds than men (Becklake & Kauffmann, 1999; PV Dicpinigaitis & Rauf, 1998; 
Kastelik et al., 2002; Kelsall et al., 2008; Morice et al., 2000; Rostami-Hodjegan et al., 2001). 




In both cohorts, females were found to pass CRT at lower thresholds than males with no 
females coughing for the first time at the highest threshold in the FEES cohort. In the VFSS 
cohort, males were also significantly more likely to fail CRT. This gender difference did not 
alter the final model in either cohort. However, a concentration specific to gender may prove to 
be a more sensitive clinical tool and deserves consideration.  
 
12.1.3 Summary. 
CRT results are significantly associated with aspiration response on instrumental 
assessment. Lower concentrations of citric acid provide a better predictive measure of silent 
aspiration. CRT can be standardised and therefore is not as susceptible to the interpretative 
variance that plagues much of CSE. Citric acid concentrations used in this study provide a 
useful working range but further testing of other concentrations may improve detection of 
subtle sensory deficits. Sensitivity and specificity values across different concentrations of 
citric acid allow clinicians to make decisions based on their clinical need. 
 
12.2 Reliability of CRT 
The CRT method in this research programme relies on assessors’ ability to 
consistently rate cough presence and strength. It is of concern that SLTs in Study III 
achieved only ‘fair’ to ‘moderate’ agreement when making subjective judgements of 
reflexive cough without training or experience (Landis & Koch, 1977). This agreement is, 
nevertheless, comparable to other areas of SLT where subjective judgements are used. Inter- 
and intra-rater reliability in VFSS interpretation has received substantial attention (Ekberg et 
al., 1988; Kuhlemeier, Yates, & Palmer, 1998; Logemann, Lazarus, Keeley, Sanchez, & 
Rademaker, 2000; McCullough et al., 2001; Scott et al., 1998). Rosenbek and colleagues 
found high agreement for experienced judges using the PAS (ICC .96) (Rosenbek et al., 




1996) but many other researchers have described lower levels of agreement. Ekberg and 
colleagues report large variation across VFSS measures with a Kappa value of .57 for 
presence of penetration and Kuhlemeier and colleagues found only 30% agreement for 
abnormal ratings and 78% agreement for normal ratings of VFSS analysis (Ekberg et al., 
1988; Kuhlemeier et al., 1998). Similar variations in agreement levels have been seen in 
perceptual voice assessment, where agreement can range from high to low depending on the 
measure, the type of rating (i.e., binary vs. rating scale) and the training/ experience of the 
rater (Kreiman, Gerratt, Kempster, Erman, & Berke, 1993; Oates, 2009; Webb et al., 2004). 
  
12.2.1 Training effect. 
The impact of training on reflexive cough judgement is more encouraging. 
Considerably stronger agreement was found in Study IV when specific cough physiology 
and cough judgement training was provided. Despite higher agreement levels with training, 
cough presence was still more consistently judged than cough strength with qualitative 
comments strongly reflecting continued uncertainty regarding the subjective nature of the 
strength rating. In Study III, clinicians appeared to lack a clear understanding of the 
definition of a cough and it is possible that internationally SLTs do not consistently receive 
training in cough physiology at an undergraduate level. Similar positive outcomes from 
education and training have been achieved in other areas of SLT such as voice (Oates, 2009) 
and VFSS analysis (Logemann et al., 2000). Logemann and colleagues studied the 
effectiveness of four hours of training on the VFSS interpretation of 90 SLTs (Logemann et 
al., 2000). They found a significant reduction in incorrect responses (using an expert 
researcher as the gold standard) with the training. There are therefore potential benefits of 
in-house training for strengthening clinician agreement regarding subjective cough 
judgements.  




Comparable to other recent data from our laboratory, SLTs with CRT experience did 
not have stronger agreement than those with no CRT experience in Study III (Teng & 
Huckabee, 2012). Yet, SLTs with CRT experience and specific cough judgement training 
had more agreement than those with cough physiology training alone. Experience would be 
expected to lead to improved agreement. The theories of experiential learning suggest that 
advanced cognitive processing comes from repeated experience, reflection, generalization 
and application over time (Kolb & Fry, 1975). It must be acknowledged that the cohort with 
CRT experience also worked as a clinical team. Previously research with high levels of 
cough judgement agreement have been found in research teams where perhaps a ‘team-
schema’ for rating occurs over time and through constant peer review (Daniels et al., 1998; 
McCullough et al., 2005; Rosenbek et al., 2004). The two researchers in Study II who had 
spent considerable amounts of time developing study protocols and criterion also achieved 
high levels of agreement on cough strength judgement. Scott and colleagues report similar 
improvements in VFSS analysis agreement when participants were able to discuss videos 
prior to independently rating them (Scott et al., 1998). This improvement in agreement with 
a combination of specific training, experiential learning and peer review holds promise for 
the use of cough judgement in clinical practice. With more directed training, all clinicians 
may reach greater agreement in reflexive cough judgement. 
 
12.2.2 Years of dysphagia management experience. 
An educated yet arbitrary split of those with under and over five years of experience 
in working with patients with dysphagia was made in order to investigate the effect of 
experience on agreement. Cough presence judgement was stronger for those with under five 
years experience compared with those with over five years. Although changes in 
undergraduate training of cough physiology over time may account for this difference, it 




must be noted that the CRT experienced cohort were less experienced than other site groups 
and this may be a confounding variable impacting on these statistics. The theory of 
experiential learning would suggest that those with more years of experience would be more 
reliable in their judgements and this has been found in the VFSS reliability literature 
(Logemann et al., 2000). Conversely, if cough judgement is not a routine component of a 
SLT’s CSE then experience in dysphagia management may not necessarily equate to any 
experience in judging cough. Finally, the majority of participants in this study were 
relatively experienced and further studies with less experienced participants and perhaps 
SLT students would allow for stronger conclusions regarding the impact of experience on 
cough judgements. Comparing SLT agreement with the agreement of medical professionals 
with specialist skills in cough physiology and assessment such as respiratory physicians and 
respiratory physiotherapists would add value. 
  
12.2.3 Limitations. 
 There were a number of limitations to the pilot study, Study III. Although experience 
in CRT was documented, information regarding the overall clinical experience of the 
participants was not collected. The impact of clinical dysphagia experience on intra- and 
inter-rater reliability cannot therefore be determined. Videos were consecutively obtained 
and were not systematically selected. In allowing participants to talk after the first viewing, 
bias could have been added but there is clearly little impact of this, as participants did not 
markedly change their ratings across viewings. It could be argued that the intra-rater 
reliability is more a representation of the SLTs’ confidence in their decision-making than a 
measure of intra-rater reliability. With only ten videos and a 15-minute break between 
viewings, even with an altered order of presentation, SLTs may have recalled the rating they 
had made previously for each clip. The higher agreement values for intra-rater reliability 




therefore may demonstrate that the raters were not particularly indecisive and remained 
confident in their original decisions during the first viewing when they rated the second 
viewing videos.  
A number of the limitations of Study III, were improved upon in Study IV. The 
sample size had adequate power to allow more confident interpretation of kappa coefficient 
scores across experience subgroups. Data on clinical experience in dysphagia were collected 
allowing discussion of the impact of experience levels on rater agreement. The Kappa 
statistic has some methodological issues that are worthy of discussion. Kappa coefficient is 
influenced by prevalence of the disease. This was controlled through a balanced selection of 
cough samples including the addition of two videos thought to represent normal elderly 
coughs. Different videos were used in the two studies and the impact of this on prevalence 
and comparability must be considered. The number of categories available to raters also 
influences kappa coefficients. The more categories available, the larger the likelihood for 
disagreement, resulting in lower kappa coefficients. Guarded interpretation is needed when 
comparing kappa values from studies with differing category numbers. To allow 
comparison between studies and within studies, this statistical limitation was controlled 
through the use of both two-category and three-category analysis. 
Shoukri warns against increasing raters to maximise power in agreement studies and 
states that having more than three raters makes little difference to power (Shoukri, 2010). 
Increasing the number of subjects, in this case, videotaped examples of coughs, is 
considered to be more appropriate. In fact, in Study II, the FEES validation study, inter-rater 
reliability was ‘almost perfect’ for both cough presence (CRT threshold) and cough strength 
for the two researchers across 100 videos. The use of professional development events for 
recruitment in the reliability studies necessitated the researchers to minimize the amount of 
time required for participation and therefore increasing the number of videos was not 




feasible. This first statistical approach, however, appears appropriate where reliability of a 
specific test is in question. Where overall group agreement is of interest, numbers of raters 
becomes more relevant. Limiting the number of raters to two or three would limit the 
opportunity to consider the impact of experience levels and training on agreement or the 
generalisability of the results.  
In keeping with the C2 scoring method, video clips showed only 15 seconds of a 
patient’s response to tussive stimuli. Agreement in judgements may have been better if 
longer observation periods were given. In clinical practice, consistency of response would 
be determined over three trials before making a final judgement. It is important to 
acknowledge the potential auditory barrier in the use of cough reflex testing to judge cough. 
The noise of the nebuliser was mentioned in the qualitative data as affecting the ability to 
hear the cough clearly. 
The patient’s physical appearance may adversely affect judgement of strength. One 
video presented a frail gentleman lying in bed. He was judged by the researchers to have a 
strong, prompt cough but raters showed significant variability in their judgements between 
strong and weak. At a perceptual level, decision-making of sensory information is thought 
to involve multi-sensory perception and attention. This can be complimentary in that 
additional sensory information (e.g., visual) may aid another ambiguous input (e.g., 
auditory) (Alais, Newell, & Mamassian, 2010). However, one sensory input can also bias 
another and visual modalities are thought to be more dominant than other inputs (Alais et 
al., 2010). This may explain the possible visual response bias of the sick elderly gentleman. 
In another video, a young man produces large amounts of extraneous cough-like movements 
of his upper body, yet there is no audible cough. Responses again were mixed between weak 
and absent cough suggesting a possible visual bias in decision-making at the perceptual 
level or perhaps more cognitively driven. A recent study in our laboratory investigating the 




influence of visual versus auditory cues on cough judgement in 111 SLTs did not find a 
significant difference in cough presence agreement when SLTs had access to auditory cues 
(ț RQO\RUDXGLWRU\DQGvisual cues (ț = 0.76) (Teng & Huckabee, 2012). However, 
as with the present studies, SLTs regularly commented on using visual information 
including perceived distress and body movements when making their judgements. 
Ratings were independent in the present studies but the influence of professional 
bias is unknown. Weak cough was poorly agreed upon and less frequently chosen. Clinician 
caseload and experience could impact on judgements. Qualitative comments suggest 
uncertainty about ‘weak’ and an awareness in some clinicians that they were accepting less 
than adequate coughs as strong due to their environmental bias. A clinician’s own ‘internal 
standards’ and how this influences clinical judgement has been extensively researched in the 
area of the perceptual evaluation of voice (Gerratt, Krieman, Antonanzas-Barroso, & Berke, 
1993; Oates, 2009). Clinicians’ experience and training could likewise influence cough 
strength judgement. A clinician who works with a neurologically impaired and/or elderly 
population is likely to perceive strength of cough differently to a clinician working in an 
outpatient ENT clinic. Bias influences kappa coefficient with larger levels of bias leading to 
strong kappa scores. It must be acknowledged that strong agreement in ratings only provides 
information about inter-rater reliability and does not provide any information about the 
validity of these ratings. It is not possible to make conclusions regarding accuracy of 
judgements in these studies. 
 
12.2.4 Summary. 
Untrained SLTs were only fair to moderately reliable in subjectively judging cough. 
However, when SLTs were given a two-hour training session on cough physiology and 
cough judgement, substantial agreement was achieved for both cough presence and cough 




strength especially in those with previous clinical CRT experience. Objective cough 
strength measures were not used in this study so no conclusion can be made about the 
accuracy of SLTs judgements, only their agreement. A comparison of an objective reflexive 
cough measure (such as airflow measures) versus subjective judgement of cough strength 
would add further to this area of research. Research has shown both abnormal voluntary 
cough strength and reduced cough sensitivity as risk factors for pneumonia (W. Addington, 
Stephens, & Gilliland, 1999; Smith-Hammond et al., 2009). A reliable cough reflex test 
(pass/ fail) with a subjective strength rating (weak/ strong) may prove a beneficial additional 
tool to the clinical swallowing evaluation. Clinically, there are difficulties in assessing 
voluntary cough in patients after stroke secondary to barriers of impaired cognition, 
communication and apraxia (W. Addington & Widdecombe, 2009; Stephens et al., 2003). A 
judgement of reflexive cough strength may certainly be more useful for identifying those at 
risk of being unable to clear aspirated material than a voluntary cough judgement (Magni et 
al., 2011). Undergraduate programmes and in-house training should ensure SLTs have a 
good understanding of cough physiology and have the opportunity to develop confidence in 
subjective weak cough judgement in order to guarantee that this component of the CSE is 
reliable and clinically relevant. 
 
12.3 Clinical Utility of CRT 
Study V assessed the utility of CRT for changing functional outcomes in patients 
with dysphagia following stroke. The CRT used a stable tussive agent of controlled doseage 
and a passive facemask method appropriate for a neurologically impaired population. The 
test involved a citric acid evoked cough test, a suppressed cough test that was hypothesised 
to represent a true reflex cough and a subjective test of cough strength (R. Eccles, 2009; 
Hegland et al., 2012). Based on prior research (W. Addington, Stephens, & Gilliland, 1999; 




Wakasugi et al., 2008), we hypothesised that inclusion of CRT in a CSE protocol would 
provide clinicians with critical information that would subsequently alter management plans 
sufficiently to reduce the end outcome of pneumonia. Our data suggest that clinicians did 
integrate information into diet selection as well as frequency and timing of referrals for 
instrumental assessment. However, incorporation of the test results into multidisciplinary 
practice was insufficient to change health outcomes.  
 The development of pneumonia is multi-factorial (Langmore et al., 1998). A single 
change in the course of a patient’s assessment may not to be powerful enough to alter this 
primary endpoint unless that change strictly controls a host of consequent management 
practices. Addington and colleagues did find a difference in pneumonia rates between their 
hospital with CRT and their ‘control’ hospital without CRT, but there is significant bias 
introduced to their study. By using the mouthpiece method of delivery, they likely limited 
participation to patients who were able to form sufficient lip seal, control respiration and 
follow instructions, perhaps excluding those most at risk of pneumonia from the 
experimental group. In using a sister hospital for comparison, control is compromised for 
inclusion criteria in the study sample in terms of both geographical differences between 
hospitals and clinical practice differences.  
Despite the concerning gaps in CSE in the acute inpatient setting, studies have 
successfully documented reduced pneumonia rates through SLT involvement. In 2010, Matrix 
Evidence published a report stating the annual cost benefit of SLT for post-stroke dysphagia 
exceeds the annual cost of therapy by £13.3 million in the UK (Marsh, Bertranou, Suominen, & 
Venkatachalam, 2010). They calculated that every £1 invested in SLT generates savings of 
£2.3 in healthcare costs through avoided chest infections (Marsh et al., 2010). The Matrix 
Evidence report was based on the results of a published randomised controlled trial (Carnaby, 
Hankey, & Pizzi, 2006). This trial compared physician-only care to low intensity SLT and high 




intensity SLT in 306 patients post stroke and found improved outcomes for patients who 
received more SLT input. The probability of developing pneumonia with SLT involvement was 
25% compared with 47% without SLT and high intensity therapy was significantly associated 
with return to normal diet by 6 months (Carnaby et al., 2006). The term “SLT intervention” 
was used broadly and was not standardised or controlled. Low intensity input was described as 
three times weekly compensatory strategy advice and diet modification review; while high 
intensity input was described as daily direct swallowing exercises. The broadness of these 
definitions makes it difficult to extrapolate the causal factors for change in outcomes. It is 
unclear from this paper how this difficult blinding of staff from the daily interventions could be 
successfully accomplished.  What it does suggest is that frequent review and reassessment of 
patients offers the best chance of detecting changes or deterioration. 
Other studies have documented reduced pneumonia rates by the simple addition of 
dysphagia assessment protocols (Hinchley et al., 2005) and clinical dysphagia pathways 
(Odderson, Keaton, & McKenna, 1995). In both of these studies, a variety of assessment 
tasks were introduced and subsequent clinical decisions were strictly controlled. Hinchley 
and colleagues collected data at 15 institutions and found reduced pneumonia rates in 
patients who received formal nurse-led swallowing assessments (formal swallowing 
assessment 2.4% vs. no formal swallowing assessment 5.4%, p = .002) (Hinchley et al., 
2005). The assessments included clear actions depending on the response to each task in the 
assessment. The lack of a control group and the variations between assessment protocols 
used across institutions perhaps limits the power of these results.  
Odderson and colleagues introduced an initial swallowing assessment in their 
hospital and none of their 124 patients developed pneumonia compared to the stroke 
pneumonia rate prior to its introduction of 6.7% (Odderson et al., 1995). Again the 
assessment covered a range of criteria (following commands, voice, cough, water test, 




secretion management) and was accompanied by a strict clinical decision pathway. A 
registered nurse or SLT completed the assessment. The study was small and pre-pathway 
data were not collected other than hospital statistics on pneumonia rates making inferences 
about homogeneity of groups difficult.  
Dictating clinical behaviour due to one variable may be short sighted and may not 
represent the whole clinical picture. Pneumonia is an inherently complex outcome to 
manipulate secondary to its multifactorial causes. Studies with a more objective diagnostic 
assessment of pneumonia may allow for the detection of aspiration pneumonia and 
exclusion of other types of pneumonia from analysis. In contrast, studies controlling for 
other causes of aspiration pneumonia such as poor oral hygiene and poor dentition may also 
lead to more positive results. Perhaps developing protocols that account for many variables, 
like these successful examples, may be more effective in reducing secondary complications 
(Hinchley et al., 2005; Odderson et al., 1995). Further investigation into the integration of 
information in multi-disciplinary decision-making and clinical pathways is warranted to 
assess the true benefits of cough testing on patient outcome. 
 
12.3.1 Changing clinical practice. 
 The complexity of changing clinical practice at the individual or group level is well 
documented (M. Eccles, Grimshaw, Walker, Johnston, & Pitts, 2005; Grol & Grimshaw, 
2003). SLTs in this study were expected to incorporate a new tool, the CRT, into their 
current bedside swallowing assessment protocol. Although some significant changes in 
clinical decision-making were reported, qualitative remarks made by clinicians after the 
recruitment period suggest difficulties in assimilating the new tool into service delivery. In 
this study, it was acknowledged that development of pneumonia is dependent on a number 
of factors and individual clinicians were permitted to integrate this new information from 




the cough test into their existing decision making construct. However, in doing so, it 
allowed for significantly greater degrees of freedom in leading to final outcomes: that of 
clinician skill and choice. This may account for the lack of difference in outcomes between 
our cohorts.  
Applying research evidence into practice improves patient outcomes; yet, the 
challenges of changing clinical practice have been deliberated by many healthcare 
professions for a number of decades (Benner, Hughes, & Sutphen, 2008; Dopson, 
Fitzgerald, Ferlie, Gabbay, & Locock, 2010; Grol, 1997). In 1997, there were 15 published 
systematic reviews on changing clinical practice and/or implementing clinical guidelines 
and new research (Grol, 1997). In a systematic review, Grilli and Lomas found the 
compliance rate of clinical recommendations in clinical guidelines was only 54.5% (Grilli & 
Lomas, 1994) emphasising that publication of guidelines and research is not sufficient to 
change practice (Freemantle et al., 2000). The strength of evidence for a new practice is 
clearly important yet it has not been proven sufficient to lead to clinical change (Dopson et 
al., 2010).  
Implementation of research and evidence based guidelines have been described as 
haphazard in the past and without scientific approach (M. Eccles et al., 2005). A great range 
of implementation approaches has been recounted, perhaps reflecting the different theories 
underpinning different professional groups. The most common implementation approaches 
reported in the literature are: education, audit, email reminders, development of new roles 
with designated novel tasks, media campaigns, institution-led quality initiatives and 
financial interventions (Grol & Grimshaw, 2003). Dopson and colleagues describe the 
success in adoption of new ideas as the interaction between the innovation (the complexity 
of the new tool, the strength of evidence behind it), the adopter (personal attitudes, skills) 
and the environment (the organisational support) (Dopson et al., 2010). No one 




implementation approach has been proven superior to another and different approaches 
work in different settings and with different professionals (Grol, 1997). Many experts 
conclude that a multi-facetted approach is the most likely to succeed (Feder, Eccles, Grol, 
Griffiths, & Grimshaw, 1999; Grol & Grimshaw, 2003).  
 
12.3.2 Barriers to changing clinical practice. 
Barriers to changing clinical practice have been frequently reported as related to 
either the organisational context (financial or organizational constraints, influence of 
opinion leaders) or the knowledge and attitudes of the health professionals (clinical 
uncertainty, self confidence, information overload, habit) (Grol & Grimshaw, 2003). 
McCaughan and colleagues examined nurses’ perception of barriers to implementing new 
research into practice (McCaughan, Thompson, Cullum, Sheldon, & Thompson, 2002). 
They interviewed 108 acute hospital nurses and found nurses lacked confidence in 
interpreting published research findings and in their own skills to use new information. 
They felt unsupported by their organisation to change practice and were sceptical of the 
research findings or their applicability in clinical practice (McCaughan et al., 2002). Green 
and Seifert argue that most implementation approaches focus on the dissemination and 
translation of information and pay little attention to the adoption of new procedures that 
incorporate the new information into practice (L. Green & Siefert, 2005). It has been 
demonstrated that overcoming habits or well-established practices to integrate new 
knowledge is hugely challenging (Anderson, 1982).  
Organisational implementation barriers were not reported in Study V but personal 
barriers were evident. Clinicians reported being confused and lacking confidence in their 
decision-making. The fact that only 50% of patients who failed CRT received an 
instrumental assessment and only 46% of them were placed nil-by-mouth indicates distrust 




in the new tool and lack of incorporation of CRT results in clinical decisions. There were 
requests for more evidence and reports of hesitancy to place patients nil-by-mouth by SLTs 
and doctors. SLTs had received training in the theory of CRT and the current literature. 
They had a practical session on using the equipment and carrying out a CRT protocol and 
clinicians were encouraged to provide each other with peer support. The researchers were 
available via email and phone and were on-site regularly to provide ongoing guidance on 
implementation of cough test results into clinical practice. Yet, when the clinician survey 
was given out after recruitment was completed and the clinicians had been using CRT for 
nine months, some of the comments suggested faulty theoretical knowledge and clinical 
reasoning. For example, one clinician stated that she doesn’t see many patients with silent 
aspiration; others wanted to use CRT at their own discretion. A number of clinicians, when 
faced with a failed CRT but no coughing on oral trials, chose to trust the oral trials and 
discount CRT results. Many of these remarks suggest that clinicians still did not understand 
or did not agree with the concerning lack of indicators of silent aspiration at bedside and the 
unique addition that CRT could make. Alternatively, clinicians may have been reluctant to 
be led by the CRT result as it suggested faults in their current practice that they were 
uncomfortable to consider. 
 
12.3.3 Clinical decision-making. 
 The intricacy of integrating new information into a clinician’s imbedded practice 
may be a genuine barrier to changing clinical practice in response to a new tool such as 
CRT. Clinical decision-making is “the ability to sift and synthesize information, make 
decisions and appropriately implement these decisions in the clinical environment” 
(O'Reilly, 1993, p. 2). This is a complex process involving observation skills, solid clinical 
knowledge, previous experience, problem-solving, creative thinking skills and self-belief 




(O'Reilly, 1993). Hardy and Smith describe clinical decision-making as the process of 
making informed judgements by following the overt and covert ‘clues’ in the case history, 
patient report and clinical presentation (Hardy & Smith, 2008). Knowledge and experience 
are critical to this deductive cognitive skill (Benner et al., 2008).  
Green and Seifert describe the cognitive process by which a clinician i) constructs 
the new knowledge as memory ii) translates this into procedural rules then finally, iii) 
rehearses the new procedural rules until they become automatic and synthesized into 
practice (L. Green & Siefert, 2005). It is not surprising that this intuitive synthesis of 
information becomes more skilful and swift with experience and that absolute integration of 
a new tool takes time (L. Green & Siefert, 2005; O'Reilly, 1993). As a cognitive 
psychologist, Anderson states, it takes “at least 100 hours of learning and practice to acquire 
any significant cognitive skill to a reasonable degree of proficiency”(Anderson, 1982, p. 
369). The complexity of clinical decision-making lies in the absence of clear-cut rules. This 
need for complex interpretation puts a heavy burden on working memory and requires 
repetition over time to become efficient (Anderson, 1982). The difference between novice 
and expert is that the expert no longer needs to rely on rules and logical thought and can see 
a clinical presentation as a complex whole (Benner et al., 2008). This is often referred to as 
clinical intuition (Benner et al., 2008).  
  
12.3.3.1 Challenging old habits. 
The clinician survey brought up a strong theme of difficulties changing habits. All 
SLTs reported CRT useful and 75% reported that it was easy to incorporate into their 
practice; yet, many complained about the additional equipment and additional time taken 
with the test. The challenge of changing their assessment routine was evident in the survey 
and during ward observations. Regularly clinicians verbalised a desire to trust their clinical 




intuition and oral trials observations; “I know he failed CRT but he did really well on the 
oral trials, he didn’t cough” rather than trust that CRT was adding more information to the 
clinical picture than they’d previously had available. This again perhaps suggests a feeling 
of personal failure if they were to change their usual practice rather than an openness to 
change and improve their assessment tools. 
 
12.3.3.2 Developing a new schema. 
Clinical decision-making is complex and with any new test comes new ‘clues’ for 
the clinician to decipher. Development of a new schema of patient responses, which 
incorporates CRT responses, takes time. Qualitative remarks from the SLTs involved in the 
clinical trial suggest some embraced the new knowledge and incorporated it well into their 
swallowing assessment ‘schema.’ Some were resistant to change or sceptical of novel 
approaches. While others, despite good intentions, struggled to reach the final cognitive 
process of a new automatic procedural schema with cough reflex testing integrated. It could 
be predicted that clinicians during the recruitment period were still relying on procedural 
rules and logic (at a novice level) rather than being able to fully incorporate CRT as a 
complex whole (at an expert level). It is highly probable that one limitation in this study was 
that the clinicians were expected to embed a new tool into their clinical decision-making 
without a sufficient period of adaption. Although the clinicians performed the CRT during 
the trial period, their skills in interpreting the results were perhaps not optimal. Further 
research in this area would be beneficial. Future directions may include re-evaluation of the 
same clinicians after a longer period of assimilation and the impact on functional outcomes 
with strict clinical pathways in place. 
 
 





12.3.4 Association between CRT result and other clinical factors. 
Reduced cough sensitivity and silent aspiration have been associated with poor 
functional outcomes (W. Addington et al., 2005; Pikus et al., 2003). Eighteen percent of 
patients in the experimental group failed CRT. This is similar to the proportion of silent 
aspirators reported in previous unselected acute stroke cohorts (25%) (Daniels et al., 1998). 
However, contrary to published data on cough sensitivity and silent aspiration, failing CRT 
was not significantly associated with poorer outcomes (initial diet recommendations, 
pneumonia and mortality) although trends for pneumonia and mortality were noted 
(Schmidt et al., 1994; Teasell et al., 1996). In Study V, CRT results were not significantly 
associated with age, gender, ethnicity, stroke history, cardiac comorbidities, stroke type or 
independence on admission. Conversely, in Study II, patients who failed or had a weak CRT 
were significantly older than those who passed CRT. Both neurological origin of dysphagia, 
respiratory comorbidities and being male (in Study I) led to increased odds of failing CRT 
in patients who silently aspirated. This perhaps reiterates the difficulty in predicting those 
most at risk of diminished cough sensitivity or silent aspiration at bedside. There may be 
clear clinical predictors for dysphagia in a patient’s clinical history but a clear predictor of 
silent aspiration has proven more difficult to calculate.  
 
12.3.5 Weak cough. 
Weak voluntary cough has been associated with aspiration and pneumonia (Pitts et 
al., 2010; Smith-Hammond et al., 2009). The strength of a reflexive cough response to citric 
acid may provide vital information about the extent to which the sensory receptors 
responded to the irritant (sensory impairment) or may indicate weakened inspiratory and/or 
expiratory muscles (motor impairment). In the validity studies, weak cough was 




significantly associated with silent aspiration but overall classifying weak cough as a failed 
CRT did not optimise sensitivity and specificity values. Study V, however, shows a 
difference in functional outcome for those in the weak cough group compared with both the 
pass group and fail group. As well as significantly higher respiratory comorbidities, patients 
in the weak group had a trend towards higher mortality and higher pneumonia rates than 
those in the pass group. Interestingly, clinicians treated patients with a weak cough result 
differently. They had a higher rate of instrumental assessment than the pass group, lower 
FOIS diet recommendations on admission and the fastest referral rate to instrumental 
assessment of all groups. Patients with respiratory comorbidities in the experimental group 
had significantly lower pneumonia rates than those in the control group. This proposes that 
clinicians treat patients with weak reflexive cough differently and that CRT may be a useful 
tool in identifying those with compromised ability to clear aspiration. It also implies that 
patients with weak reflexive coughs, when managed more cautiously, may have more 
positive outcomes. Respiratory comorbidities were significantly associated with weak 
cough, giving strength to the reliability of weak cough judgements by SLTs. However, the 
proportion of patients rated as weak differed greatly across research sites and although this 
may be due to geographical differences in patients’ clinical presentation, it must be 
acknowledged that this judgement was subjective. Clinical protocols that attend to weak 
reflexive cough independently of presence/ absence of reflexive cough may prove more 
clinically useful. A clinician should first attend to risk of silent aspiration by counting 
coughs then judge risk of weakened ability to clear aspirated material by judging cough 
strength. This would provide a more considered assessment of pneumonia risk and allow 
informed early dietary recommendations to be made. 
 
 





12.3.6 Clinician behaviours. 
 The data show that pneumonia rates for those who passed CRT were as poor as for 
those in the control group. This may suggest an over-reliance on the result of the CRT in 
clinical decision-making in patients who passed CRT, perhaps overlooking other assessment 
findings. The CRT is a simple test of airway sensitivity and does not answer clinical questions 
regarding dysphagia severity. For patients in the control group and patients in the 
experimental group who passed the CRT, clinicians were using pneumonia as a clinical 
indicator of aspiration and only referring for diagnostic assessment when pneumonia 
developed. In view of the increased risk of mortality and increased LOS associated with the 
development of pneumonia after stroke, this reactive rather than proactive practice in clinical 
reasoning is of serious concern (Aslanyan, Weir, Diener, Kaste, & Lees, 2004). In the failed 
cough test group, although only half of patients were referred for instrumental assessment, 
different clinical decisions were being made. Instrumental assessment occurred earlier and 
without waiting for the development of pneumonia and for those referred for instrumental 
assessment, clinical outcomes were more positive. Very little has been published on the 
impact of instrumental assessment on pneumonia rates and further research into the effects 
of early instrumental assessment referral could support clinical protocol development. 
 
12.3.7 Limitations. 
There are a number of limitations to this clinical trial. The experimental group and 
control group did not differ in age, LOS, comorbidities, stroke type or site or initial diet 
recommendation. This strongly suggests homogeneity between groups but the addition of an 
accepted stroke severity or handicap measure would have added to this comparison and to 
the overall interpretation of clinical outcomes. The primary and secondary outcome 




measures were gathered by telephone and chart review, therefore running a risk of recall and 
surveillance bias. Information was gathered from GPs, residential care staff, patients, 
families and clinical records in an attempt to reduce this risk. Aspiration pneumonia was not 
distinguished from pneumonias of other causes and a more objective diagnostic assessment 
of aspiration pneumonia may have led to different results. However, this more complex 
testing is not commonplace in stroke or dysphagia studies. 
The use of more controlled management protocols, including a validated CSE and a 
strict clinical pathway, may have led to a clearer reduction in pneumonia rates. All 
clinicians received the same training, followed the same CRT protocol and were given the 
same guidelines for integration of the CRT results into management decisions but followed 
local policies and procedures. Reliability of clinician assessment, interpretation and action is 
uncertain and this is emphasised in some of the responses provided in the survey. 
 
12.3.8 Summary. 
 There is great interest in the development of a bedside test for ‘silent aspiration’ in the 
field of acute dysphagia management. In this study, knowledge of cough response did not 
decrease pneumonia rates, suggesting that inclusion of CRT alone is not sufficient to change 
clinical outcomes. Although the findings that negative CRT outcomes were associated with 
higher risk of mortality and pneumonia did not reach statistical significance, they very likely 
are clinically significant. Management was not controlled and integration of CRT into a 
clinical pathway that also controls for the other known predictors of pneumonia and specifies 
the clinical decisions of clinicians may prove more successful. CRT is a test solely of airway 
sensitivity and may be useful as a screening tool or integrated into a comprehensive, 
validated CSE. The positive validation results in Study I and II suggests that with the 
addition of CRT, the diagnostic accuracy of the CSE for detecting silent aspiration would 




improve. Further research into the clinical utility of this clinical tool would add value to the 
clinical field. Consistent implementation of CRT results into clinical decision-making was not 
investigated in this study and may have influenced subsequent patient outcomes. Research 
looking at controlled integration of information into multidisciplinary clinical decision-






















STUDY VI. CLINICAL OUTCOMES FOR PATIENTS WITH 
DYSPHAGIA AFTER STROKE IN NEW ZEALAND: A DESCRIPTIVE 
STUDY 12 
__________________________________________________________________________ 
13.1 Research Question 
Through the collection of data for Study V, an incidental sample of patients with 
dysphagia after stroke in New Zealand was obtained. The clinical outcomes of patients with 
dysphagia after stroke in New Zealand have not been previously reported or benchmarked 
against international standards. No specific hypotheses were proposed or evaluated in this 
study but the questions remain unanswered: what are the clinical characteristics and clinical 
outcomes for patients with dysphagia after stroke in New Zealand and how do they 
compare internationally? Defining New Zealand-specific characteristics and outcomes will 
guide nationally based research and health care initiatives that will in turn improve clinical 
outcomes and streamline health costs. The aim of this descriptive study was to define the 
clinical characteristics and clinical outcomes for patients with dysphagia after stroke in 





                                                
12#Miles, A., McLauchlan, H. & Huckabee, ML. (under revision) Clinical outcomes for patients with dysphagia 
after stroke in New Zealand: original article. Speech, Language & Hearing. Revision submitted 21st March 
2013.#
#





13.2.1 Patient selection. 
Three hundred and eleven acute stroke patients (165 females, 146 males) 
consecutively referred to speech-language therapy for swallowing assessment were recruited 
from four urban hospitals. Patients were referred following a failed dysphagia screen and 
the number of stroke patients per site who were not referred to SLT is unknown. All 
participants gave informed consent independently or consent was gained by proxy. Due to 
the purpose of the concurrent clinical trial, patients were excluded if palliative swallowing 
advice was requested rather than active treatment on admission. 
 
13.2.2 Study design. 
 This study received appropriate national ethics approval (NTY/09/11/113) as a 
randomised control trial looking at the clinical utility of cough reflex testing after stroke. 
Detailed results of this experimental trial are reported in Study V. This chapter will focus 
strictly on identifying the characteristics and outcomes associated with dysphagia secondary 
to stroke in New Zealand; the full cohort of participants (irrespective of their randomisation) 
will be discussed. Details of patient information and outcomes collected are described in 
Study V, Section 11.2. Costs associated with stroke admissions in 2011 were also requested 
from each DHB. DHBs were asked to provide three pieces of financial information: i) cost 
of 24-hour stay on a stroke ward, ii) average cost of a stroke admission and iii) average cost 
of a stroke admission if pneumonia also present. 
  
13.2.3 Data analysis. 
Statistical analysis was completed using SAS version 9.3 (SAS, Cary, NC, USA) 
and SPSS version 20 (SPSS, Chicago, IL, USA). Two-sample t-test (t) was used to compare 




the median length of stay (LOS) between those who developed pneumonia and those who 
did not. ANOVA was used to evaluate age across ethnicities. Chi square test was used to 
assess the associations between binary and categorical outcomes. Multiple logistic 
regressions were applied to evaluate the effect of confounding variables on pneumonia and 
mortality (gender, hospital site, ACE inhibitors, cardiac comorbidities, previous stroke 
history, respiratory comorbidities, instrument assessment and lesion locations). AIC was 
used as the selection criteria. Firstly the full model with all confounding factors was fit, and 
a backward selection was used to select the main effect model.  
The results from the current study are compared to the National Acute Stroke 
Service Audit 2009 allowing a comparison of the outcomes of patients with dysphagia with 
local data (Stroke Foundation of New Zealand, 2010). This audit was published by Stroke 
Foundation New Zealand and comprised of an organisational survey of all 21 New Zealand 
District Health Boards and a clinical audit at 20 New Zealand District Health Boards. As 
part of the clinical audit, the records of 40 consecutive patients admitted with a diagnosis of 
stroke from each District Health Board were reviewed. The report describes the clinical 
management and characteristics and outcomes for 832 patients during their acute 




13.3.1 Patient characteristics. 
 Fifty-three percent of patients were female. The patients’ ages ranged from 22-102 
years (mean of 78 years, SD 13.5). The majority of the patients were New Zealand 
European (NZE) 66%, followed by Pacific Island 10%, New Zealand Maori (NZM) 9%, 
Asian 5%, European 8%, and other 3% (of whom 2 were South African, 3 Russian, 2 




Canadian and 2 Australian). All patients presented clinically with an acute stroke. Initial CT 
scans classified lesions as follows: cortical 68%, subcortical 15%, brainstem 3%, cerebellar 
4%, multilevel 3%, small vessel disease 2%; no new abnormalities detected on CT scan 6%. 
The pre-morbid health conditions and risk factors for participants included respiratory 
comorbidities 13%, diabetes 15% and previous stroke 29%. ACE inhibitor prescription rates 
were 35%. At the time of admission, 86% of patients lived at home and 14% lived in 
residential care.  
 
13.3.2 Ethnicity. 
 Gender, previous stroke history, cardiac comorbidities, respiratory comorbidities, 
diabetes, site of lesion, pneumonia, mortality, independence at 3 months and CRT result 
were not significantly associated with ethnicity (Table 13.1). Hospital site was significantly 
associated with ethnicity with 80% of patients identifying as New Zealand European at 
Hospital B compared with only 50% at Hospital C (X2 = 44.90, p < .001). Age was also 
significantly associated with ethnicity (F (4) = 10.5, p < .001). When compared to New 
Zealand European, there was a mean difference of 13 years younger (95% C.I. 5.8, 20.1) for 
New Zealand Maori patients, 10 years younger (95% C.I. 3.1, 16.6) for Pacific Island 












Table 13.1 Comparison of baseline characteristics and outcomes across ethnicities 





Hospital A 67 (73%) 7 (8%) 10 (11%) 2 (2%) 6 (7%) <.001 
Hospital B 56 (80%) 1 (1%) 0 (0%) 1 (1%) 12 (17%) 
 Hospital C 57 (50%) 14 (12%) 21 (18%) 10 (9%) 
12 
(11%) 
Hospital D 25 (71%) 5 (14%) 0 (0%) 1 (3%) 4 (11%) 
Gender 




female 91(44%) 13(48%) 14(45%) 8 (57%) 20 (59%) 
Age mean (sd) (mean 






















Previous stroke 58 (28%) 9 (33%) 8 (26%) 3 (21%) 12 (35%) .833 
Cardiac Comorbidities 142 (69%) 23 (85%) 23 (74%) 8 (57%) 
23 
(68%) .354 
Diabetes 25 (12%) 7 (26%) 8 (26%) 1 (7%) 5 (15%) .119 
Respiratory comorbidities 22 (11%) 6 (22%) 7 (23%) 2 (14%) 4 (12%) .242 
Site of 
lesion 






subcortical 36 (18%) 1 (4%) 7 (23%) 1 (7%) 6 (18%) 
other 19 (9%) 5 (19%) 3 (10%) 1 (7%) 2 (6%) 





hospital 9 (10%) 1 (6%) 1 (61%) 0 (0%) 1 (6%) 
.524 
residential 
care facility 47 (50%) 4 (25%) 4 (31%) 3 (43%) 6 (35%) 
                                                 
13 New Zealand European 
14 New Zealand Maori 




home 39 (41%) 11 (69%) 8 (8%) 4 (57%) 10 (59%) 
CRT result 
strong 60 (63%) 9 (56%) 8 (62%) 3 (42%) 11 (65%) 
.753 weak 21 (22%) 3 (19%) 2 (15%) 1 (14%) 4 (24%) 
fail 14 (15%) 4 (25%) 3 (23%) 3 (43%) 2 (12%) 
Mortality 41 (20%) 3 (11%) 2 (7%) 0 (0%) 6 (18%) .116 
Confirmed pneumonia 28 (14%) 3 (11%) 3 (10%) 2 (14%) 3 (9%) .911 
 
13.3.3 Pneumonia. 
The overall pneumonia rate was 27%. There was a higher risk of pneumonia with 
elder age, with each additional decade of life associated with 1.4 times higher risk in 
pneumonia (95% C.I. 1.1, 1.8, p = .011). Male patients were associated with 2 times higher 
risk in pneumonia (95% C.I. 1.0, 3.5, p = .043). Cardiac comorbidities were associated with 
3.0 times higher risk of pneumonia (95% C.I. 1.4, 6.5, p = .005); while respiratory 
comorbidities were associated with 4.3 times higher risk of developing pneumonia (95% 
C.I. 2.0, 9.1, p < .001). There were differences between study sites, with a higher risk of 
pneumonia at Hospital C in comparison to both Hospital B and Hospital D [Hospital D vs. 
Hospital C, (odds ratio 0.3, 95% C.I. 0.09, 0.8), p = .021] and Hospital B vs. Hospital C 0.4 
(95% C.I. 0.2, 0.9, p = .033).  
 Patients with confirmed pneumonia had higher mortality rates than patients without 
(35.6% vs. 10.9%, X2 = 24.46, p < .001). Additionally, patients who developed pneumonia 
had significantly prolonged acute ward length of stays (median length of stay of 10 vs. 6 
days, t = 3.91, p < .001). Of all patients who developed pneumonia (27%), the average 
number of days before commencing first course of antibiotics was 7.9 days after admission. 
Eleven percent of patients developed their first pneumonia once discharged and the average 




number of days to development of pneumonia was 4 days if post-discharge pneumonia 
events were excluded. Thirty-five percent of patients experienced more than one pneumonia 
event of which 12% occurred in their initial inpatient admission and 23% occurred once 
discharged (with one patient experiencing further pneumonia events both in hospital and on 
discharge). Thirty seven percent of patients with pneumonia were nil by mouth and 63% 
patients were on oral diets. Six percent of the full cohort died from pneumonia (53% while 
in their initial inpatient admission, 47% following discharge).  
 
13.3.4 Mortality. 
Mortality rate was 16% with 44% of these deaths occurring during the hospital stay 
(90% acute ward, 10% rehabilitation ward). Forty two percent of patients died in a 
residential care facility, 7% at home and 7% following readmission to hospital. Reported 
causes of death were stroke 53%, pneumonia 27%, other 20%. Age was significantly 
associated with mortality (X2 = 9.92, p < .001). Each additional decade of life was positively 
associated with 60% higher risk of mortality (95% C.I. 1.2, 2.3). ACE inhibitor use was 
significantly associated with mortality (X2 = 6.14, p = .011); not taking ACE inhibitors was 
associated with 2.7 times higher risk of mortality (95% C.I. 1.2, 5.7). Cardiac comorbidity 
(previous cardiac surgery, idiopathic heart disease, atrial fibrillation or hypertension) was 
negatively associated with mortality with 2.0 times higher risk of mortality (95% C.I. 0.9, 
4.3). Mortality rates did not differ significantly across sites (Hospital A 15%, Hospital B 
17%, Hospital C 21%, Hospital D 6%). 
 
13.3.5 Length of stay (LOS). 
 The median LOS (excluding those who died during admission) was 24 days with a 
median of six days on an acute ward, and a median of 31 days on a rehabilitation ward for 




those who received rehabilitation. Fifty-seven percent of patients were accepted into an 
inpatient rehabilitation ward. Community-based rehabilitation was not documented and only 
21% of patients returned home straight from an acute ward. 
 
13.3.6 Domicile by 3 months. 
  By three months after their stroke, 45% of patients were living at home, 38% were 
in residential care, 16% were deceased and 1% was still in hospital. In this cohort, 19% of 
patients were readmitted within three months after their stroke. Causes of readmission were 
pneumonia 19%, stroke 15%, cardiac problems (e.g., chest pain, AF, CHF) 24%, 
orthopaedic 9%, other infection (e.g., UTI) 16% and other medical problems 17%. 
 
13.3.7 Instrumental assessment use. 
Referral rates for instrumental assessment (VFSS or FEES) were 13% (range 7%-
18% across sites). Time to instrumental assessment was a mean of 6.5 days (range 1-30). 
Sixty seven percent of these patients received their instrumental assessment after developing 
pneumonia (Figure 13.1). There was a non-significant association between developing 
pneumonia and receiving an instrumental assessment (38% instrumental, 25% no 
LQVWUXPHQWDOȋ2 = 2.44, p = .122) with the odds of developing pneumonia 1.87 times higher 
if you had an instrumental assessment.  





Figure 13.1 Instrumental assessment referrals and pneumonia 
 
13.3.8 Cost implications (based on selected DHB data). 
Three DHBs provided detailed information regarding costs of stroke admission and 
treatment of pneumonia. Although considerable differences were noted in costs between the 
three sites, the mean length of stay without pneumonia was 6 days (range 6.3-6.8). This rose 
to a mean of 10 days (range 10.0-10.1) if pneumonia was reported, with a 24-hour bed stay 
to the stroke unit costing on average $514.60 ($405.12-$589.43). The average overall cost 




across sites for hospitalisation subsequent to stroke in 2011 was $9,946.41 (range $6,458-
$13,066.87). This figure increased to an average of $13,800.46 (range $8,659-$22,319.84) 
when stroke was associated with pneumonia. 
 
13.4 Comparative discussion 
 This prospective cohort study identified the characteristics and outcomes for patients 
with dysphagia after stroke in New Zealand with the purpose of comparing these data with a 
recent national stroke audit and benchmarking the outcomes for New Zealander’s with 
dysphagia against published international data. The outcomes for New Zealand stroke 
patients with dysphagia were poor with a high risk of pneumonia and long hospital stays. 
Ethnicity was associated with younger age of stroke but no difference in functional 
outcome. Inversely, older age was associated with increased pneumonia and mortality. 
Pneumonia incurred significantly increased costs during hospitalisation. Caution must be 
taken when comparing one data set to another where different methodologies are used but 
careful comparisons are of interest as a means of benchmarking clinical services to 
international standards. 
 
13.4.1 Comparison to national stroke data. 
Patient characteristics between our dysphagic stroke group and The Stroke 
Foundation National Acute Stroke Audit 2009 (Stroke Foundation of New Zealand, 2010) 
appear similar (Table 13.2). The larger Pacific Island population in the dysphagia group (10% 
vs. 3%) perhaps reflects the impact of one of the hospital’s population demographics (where 
18% identified themselves as Pacific Islander). The dysphagic stroke group presented fewer 
comorbidities than the national data, perhaps reflecting the exclusion criteria of palliation.  




Table 13.2 Comparison of baseline characteristics between the dysphagic stroke data 
and the national stroke data 
 
National Acute Stroke Audit Data 
2009 (Stroke Foundation of New 
Zealand, 2010) 
Dysphagic Stroke data 2011 
Females 52% 53% 
Mean Age 77 78 
New Zealand European - 66% 
Maori 13% 9% 
Pacific Island 3% 10% 
Respiratory 
Comorbidities - 13% 
Diabetes 23% 15% 
Previous Stroke 45% 29% 
ACE inhibitor 
prescription - 35% 
Living a home 90% 86% 
 
Inpatient rehabilitation provision was similar across New Zealand cohorts (dysphagic 
cohort 57%, National Acute Stroke Audit cohort 56%) but the proportion of patients who 
returned to their own home from acute hospital in the dysphagic group was less than the 
national data (dysphagic cohort 21%, National Acute Stroke Audit cohort 37%). The median 
LOS on acute wards is similar across cohorts (dysphagic cohort 6 days, National Acute 
Stroke Audit cohort 5 days) but duration of rehabilitation stay was not recorded in the 
national audit. The National Acute Stroke Services Audit 2009 found 14% of patients died 
during their acute hospital stay and of these 87% died within a week of admission. In our 
study, 16% died of whom only 44% of these were during their hospital stay and 56% were 
after discharge. Our acute ward mortality rate was only 7% with only 15% of these within a 
week of admission. These data are not surprising in view of the exclusion of palliative 
patients on admission and longer follow-up into the community in the current study. The high 




incidence of death in residential care facilities (42% of all deaths) perhaps reflects the New 
Zealand trend for discharging palliative patients to residential care facilities rather than 
managing them in an acute hospital. Although palliation on admission was an exclusion 
criteria, many patients were deemed palliative after recruitment to the study.  
 
13.4.2 Comparison to international data. 
The association between dysphagia, aspiration pneumonia and mortality has 
attracted large-scale investigation and is well documented (Finlayson et al., 2011; 
Guyomard et al., 2009; Ingeman, Andersen, Hundborg, Svendsen, & Johnsen, 2011; 
Koennecke et al., 2011; WF Westendorp et al., 2011). International benchmarking is 
important for judging service delivery and there are studies that are comparable to the current 
data. The incidence of pneumonia in patients with dysphagia post-stroke can, however, be 
difficult to extrapolate from the literature for comparison with local data. Studies often use 
differing participant criteria for inclusion (acute vs. chronic, dysphagic vs. non-dysphagic) and 
differing criteria for diagnosis of pneumonia. Westerdorf and colleagues recently conducted a 
large systematic review and meta-analysis of literature (including 87 studies and 137817 
patients) summarising post-stroke infection and found a 10% pneumonia rate in the general 
stroke population (WF Westendorp et al., 2011). This is comparable with the New Zealand 
general stroke data. A recent multi-centre retrospective cohort study of 8,251 stroke patients 
admitted to hospital in Canada found that 7% developed pneumonia (Finlayson et al., 2011). 
In this study, predictors for pneumonia included old age, male gender, stroke severity, 
dysphagia, respiratory comorbidities, cardiac comorbidities and previous level of 
independence (Finlayson et al., 2011). In a large, recent American study of 18,017 patients 
with stroke discharged from 222 hospitals, 4% of patients who were not screened for 
dysphagia developed pneumonia, 2% of patients who received and passed a dysphagia screen 




developed pneumonia, and 7% of patients who failed a dysphagia screen developed 
pneumonia (Lakshminarayan et al., 2010). An unfortunate exclusion criteria for the study was 
patients who remained nil by mouth throughout their hospital stay perhaps excluding some of 
the most severe dysphagics and therefore those at higher risk of developing pneumonia. The 
pneumonia rates in this study are disproportionate low in comparison with those of Study VI, 
where all patients received a swallowing assessment and 26% developed pneumonia.  
In comparison to these lower general stroke pneumonia rates, Martino and colleagues 
found seven studies that assessed incidence of pneumonia in stroke patients with dysphagia in 
their systematic literature review. In studies of acute patients, pneumonia rates ranged from 
16% to 19% with the exception of one study with 33% (Martino et al., 2005). They 
hypothesise differences in patient acuity and definitions of pneumonia as the cause of the 
differences (Martino et al., 2005). The New Zealand general stroke pneumonia rates (New 
Zealand Acute Stroke Audit 10%) appear comparable to this international data (range 2-16%) 
(Finlayson et al., 2011; Martino et al., 2005; WF Westendorp et al., 2011), however 
pneumonia rates in our dysphagic cohort (27%) are at the high end of the range for patients 
with dysphagia after stroke (range 16-33%). Interestingly, Hilker and colleagues reported 
44% of their stroke patients who were tube fed developed pneumonia (Hilker et al., 2003) and 
Langdon and colleagues found a 37% pneumonia rate in tube-fed stroke patients (Langdon et 
al., 2009). Tube feeding was not recorded in the current study, but a comparable 55% of 
patients placed NBM after swallowing assessment developed pneumonia but only 37% of 
patients who developed pneumonia were placed NBM after their swallowing assessment. 
Koennecke and colleagues found mortality rates of 5.4% in their large cohort of 
16,518 patients after stroke (Koennecke et al., 2011). In comparison, mortality rates were 
higher in our New Zealand studies (dysphagic cohort 16%, National Acute Stroke Services 
Audit cohort 14%). Without the exclusion of palliative patients, mortality in the dysphagia 




cohort may in fact have been substantially higher. This would correspond more closely with 
international benchmarking where dysphagia and pneumonia lead to increased mortality 
rates. In a large community study (N=14,293), pneumonia resulted in a three-fold increased 
risk of 30-day death (Katzan et al., 2003). 
Dysphagia has been associated with a 30% increase in LOS after ischemic stroke 
(Altman et al., 2010). A recent European study of 16,518 consecutive patients admitted with 
stroke found a median length of total hospital stay including rehabilitation of eight days 
(interquartile range 5-12 days) (Koennecke et al., 2011). Although differences in healthcare 
systems must be considered, this may suggest that our total LOS is high with a median of 24 
days (interquartile range 9.5-42 days) if rehabilitation stay is included. The dysphagic 
cohort, who received inpatient rehabilitation, spent a long period of time (median of 31 
days) in rehabilitation wards. In comparison, Altman and colleagues found a lower median 
LOS of 12.53 days for rehabilitation patients with dysphagia and a comparable 9.40 days for 
those without dysphagia (Altman et al., 2010). Unfortunately, they adjusted for age and sex 
but not stroke severity in their analysis making it difficult to conclude dysphagia as an 
independent factor. Overall stroke severity is a possible reason for this increased LOS 
associated with dysphagia. However, time taken treating secondary complications such as 
pneumonia leads to delays in transferring to rehabilitation and this must be considered. 
Increased LOS associated with medical complications and especially pneumonia is well 
documented (Ingeman et al., 2011). There was a significant association between pneumonia 
and increased acute ward LOS in our study. 
 
13.4.3 Instrumental assessment. 
 Swallowing screening and bedside CSE underestimate aspiration and do not provide 
the diagnostic information required for informed dysphagia management decisions 




(Smithard et al., 1998; Splaingard et al., 1988). Daniels and colleagues found 25% in their 
cohort of unselected acute stroke patients silently aspirated (Daniels et al., 1998). 
Instrumental assessment referral rates in this selected dysphagic cohort therefore appear 
extremely low (13%) suggesting that the majority of dysphagia management was occurring 
without accurate diagnostic information. Sixty percent of all instrumental assessments 
occurred after the development of pneumonia. This use of pneumonia as an indicator of 
dysphagia or aspiration and as a trigger for instrumental assessment referral suggests a ‘wait 
and see’ approach. With an increased risk of mortality and increased length of stay associated 
with the development of pneumonia after stroke (Altman et al., 2010; Schmidt et al., 1994), 
this clinical reasoning is unacceptable. Sixty-three percent of those who developed pneumonia 
were on oral diets perhaps indicating inappropriate dysphagia management. Interestingly, this 
may not be a local issue. In a recent UK survey of 68 SLTs across a mixture of adult settings, 
69% had easy access to VFSS at work and 27% had easy access to VFSS at another local 
location yet only 49% of the SLTs reported using VFSS to make decisions about whether a 
patient should eat or drink (Cocks & Ferreira, 2013). When asked to rate factors that impacted 
decision-making about oral versus non-oral feeding, aspiration (amount, frequency and 
whether it was silent) was deemed important by only 86% of the SLTs. The introduction of 
strict clinical pathways that address the problems of identifying and monitoring silent 
aspiration and increased use of instrumental assessment may significant reduce the secondary 
complications for patients with dysphagia and the cost to the Health System. 
 
13.4.4 Cost implications. 
 The financial implications of pneumonia have gained interest especially in the United 
States. In the 1990s Garon and colleagues, in a North American-based study, attempted to 
quantify the cost of pneumonia after stroke and found an additional burden of approximately 




$10 000US per event and an average extended hospital LOS of seven days (Garon et al., 
1996). In another large community study (N=14,293), pneumonia resulted in a three-fold 
increased risk of 30-day death and a calculated cost of stroke related pneumonia to the United 
States was approximately $459 million (Katzan et al., 2003). More recently, Wilson and 
Howe completed a large-scale review of nationwide medical records, again, in the United 
States (183,976 admissions). The hospital stay cost for a stroke patient who developed 
pneumonia was calculated at over $23,000US greater than that of a patient who did not 
develop pneumonia (Wilson & Howe, 2012). Overall the outcomes for dysphagic patients in 
this study were poor with high pneumonia rates, high mortality rates and lengthy 
rehabilitation ward stays. These data come with significant cost implications. Stroke 
admissions with a secondary complication of pneumonia led to an average increase in cost of 
39% per patient across three DHBs in 2011. With an admission rate of 1310 patients referred 
for swallowing assessment in one of the research sites and a rate of pneumonia at 27%, the 
additional cost to this DHB alone was $1,363,177.40 in 2011. 
 Internationally, formal swallowing clinical pathways (Odderson et al., 1995) and 
swallowing screening (Hinchley et al., 2005) have been employed successfully to reduce 
pneumonia rates in patients after stroke. Preventative antibiotic prescription (WK 
Westendorp et al., 2012), ACE inhibitor use (Arai et al., 2005) and stringent oral cares (El-
Solh, 2011; Langdon et al., 2009; Watando et al., 2004) also show promising results in 
pneumonia reduction. In light of the data presented in this study, New Zealand stroke 
services need to review current practice and focus on improving the prognosis for this 
vulnerable population group. In view of the health and cost implications, there needs to be a 
significant emphasis on the prevention of pneumonia rather than monitoring for it and 
treating it after it develops. Increased use of sensitive dysphagia assessment tools for the 




identification of high-risk patients and increased attention to known predictors of 
pneumonia require priority attention.  
13.4.5 Limitations. 
It is well established that dysphagia is associated with poor functional outcomes and 
we would therefore expect dysphagic stroke outcome data to compare poorly with general 
stroke outcome data (Altman et al., 2010). The lack of a stroke severity measure in our 
study does, however, limit the interpretation of comparisons. It could be argued that patients 
with more severe strokes have dysphagia rather than dysphagia results to poorer outcomes. 
Clinically this distinction may be of little importance, as patients with dysphagia remain 
high-risk, incur high costs and require special attention.  
There are some significant considerations in benchmarking against the data in this 
study. The current study excluded those provided with palliative care after admission to 
hospital. The concurrent experimental trial must be acknowledged as half of the cohort 
received the addition of CRT alongside standard care. Both of these factors could lead to 
skewed data in favour of improved outcomes in our dysphagic cohort. Our dysphagic 
patients were followed up for three months after stroke in comparison to the National Acute 
Stroke Audit 2009 where patients were only reviewed until discharge from acute hospital. 
This may lead to increased reporting of secondary complications over time in our cohort. 
 
13.4.5 Summary. 
The outcomes for stroke patients with dysphagia in New Zealand are poor with high 
pneumonia rates and long hospital stays. The outcomes for stroke patients with dysphagia in 
New Zealand compare poorly to international data with an unacceptable rate of pneumonia 
of 27%.   


















FUTURE RESEARCH AND FINAL REMARKS 
__________________________________________________________________________ 
14.1 Future Research 
There is a strong relationship between disordered swallowing and impaired cough in 
patients with neurological disease (Bolser, 2010). Cough testing holds great promise in the 
endeavor to advance dysphagia assessment. Moreover, in view of the differing 
neurophysiological pathways and autonomous impairment in disease, assessment of cough 
reflex sensitivity, reflexive cough strength, voluntary cough and voluntary cough strength 
may provide different information and have independent value. Building interest in urge-to-
cough ratings holds promise in assessing the integrity of cortical components of cough after 
a neurological event. The development, validation and clinical utility of a combined cough 
test protocol would be clinically valuable. This may allow the clinician to understand a 
patient’s reflexive cough sensitivity and strength as well as their cortical control of cough in 
order to make informed management decisions.  
Objective assessments of laryngeal sensitivity (e.g., FEESST) and voluntary cough 
strength (e.g., airflow measures) have merit but require expertise and specialist equipment 
(Aviv et al., 1998; Smith-Hammond et al., 2009). Further research into the validation of 
subjective assessments of cough (CRT and subjective cough strength judgements) against 
these objective measures would add value to the clinical field. Validation of CRT against 
FEESST would allow CRT to be compared to laryngeal sensitivity. CRT presumably 
reaches both the upper and lower airways and this comparison will add to the developing 
understanding of the effects of citric acid inhalation on the airway. The difference between 
sensitivity of the SLN-innervated vocal cords and the RLN-innervated sub-glottis impacts 
on timeliness, and therefore efficiency, of airway protection. It is beneficial to understand 
whether CRT stimulates supra-glottically or both supra- and sub-glottically and whether 




time before first cough is indicative of level of airway stimulated or purely overall speed 
and efficiency of the sensory pathway. Subjective latency and strength of cough response to 
aspiration was recorded in Study II. Speed of initiation of cough in response to CRT was not 
recorded and may have added interest. It is possible that those patients who do not cough 
until later in the 15-second period have subtle sensory impairments. Visual observation of 
cough during CRT under endoscopic view may also allow further understanding of the 
presence or absence of an expiratory reflex prior to the series of coughs during CRT. If 
certain thresholds of citric acid trigger expiratory reflex prior to a cough reflex then the 
initial reflexes most certainly occur prior to cortical involvement and represent a purely 
brainstem response as the Addington group claim of their methods (W. Addington, 
Stephens, & Gilliland, 1999).  
Type of cough triggered during an aspiration event and with different methods of 
CRT deserves further study. As discussed previously, many types of cough are impaired 
after neurological disease. The type of cough triggered by an aspiration event has not been 
confirmed. Large amounts of aspiration or aspiration of highly toxic substances (e.g., spice, 
alcohol, citric) may trigger a strong, brisk brainstem controlled reflexive response e.g., an 
expiratory reflex followed by a laryngeal cough reflex. However, small amounts of 
aspiration or the accumulation of saliva may gradually trigger an urge-to-cough and a 
cortically modulated evoked cough response. In view of the high proportion of cortical 
strokes, it could be argued that cortically modulated cough is most commonly impaired and 
more relevant that a pure brainstem reflex. Urge-to-cough is reduced with old age and 
aspiration pneumonia suggesting a supramedullary dysfunction breaking down the desire to 
cough and motivation to cough sufficiently to compromise optimal health (Davenport, 2008; 
S. Ebihara et al., 2011; Yamanda et al., 2008). If patients with cortical stroke suffer from 
this impairment, they may be at risk of both silent aspiration and aspiration pneumonia yet 




still cough if the stimuli is strong enough to trigger a brainstem reflex. In fact, Hegland and 
colleagues concluded that reflex cough in the conscious person can always involve 
supramedullary activation even at high concentration levels (Hegland et al., 2012). 
This thesis has uncovered further questions regarding the reliability and validity of 
subjective cough judgement; an area relatively untouched in dysphagia assessment. We did 
not address validity of subjective cough judgement in this thesis and future studies where 
participants are rating coughs of a known strength would be valuable. Study III and IV 
revealed cues used by clinicians such as general health status and a bias towards visual cues. 
Future investigation may reveal which of these cues proves the most clinically useful and 
therefore guide future undergraduate and in-house training.  
Further work is justified in refining the CRT methodology and protocol. The 
advantage of CRT is that it can be standardised and therefore with careful protocol can 
avoid the interpretative variance of many subjective components of bedside clinical 
swallowing evaluation. Citric acid concentrations used in this study provide a useful 
working range but further testing of other concentrations may improve detection of subtle 
sensory deficits. Normative data has proven difficult secondary to the variance of cough 
response in the healthy population and a threshold at which you are at risk of silent 
aspiration appears more useful (Monroe et al., 2010). However, there will continue to be a 
group of people who do not cough on CRT who, perhaps unless also severely dysphagic, 
may not need further management. The effect of gender on cough threshold is well 
established and this may need to be accounted for in CRT protocols. The impact of 
medications on cough thresholds is also well documented but it is uncertain how this 
impacts positively or negatively on the silent aspiration risk of a patient with dysphagia. 
Further research is needed to provide clarity on both the impact of medication on silent 
aspiration and on the clinical interpretation of cough threshold results in these people. 




It could be argued that methodology that focuses on the dispersion of irritant to the 
larynx rather than the lower airways may be appropriate in the detection of silent aspiration. 
While citric acid and capsaicin continue to produce coughs during bilateral anesthesia of 
iSLN, tartaric acid cough is abolished (W. Addington, Stephens, & Goulding, 1999; 
Stockwell et al., 1993). Different agents therefore perhaps have different merits depending 
on whether the tester wants to know specifically about laryngeal sensitivity versus overall 
airway responsiveness. Nebuliser choice is clearly important for standardisation and 
thresholds will change if equipment changes. This is not ideal in a constantly changing 
healthcare system where resources are sparse and providers change regularly. Research into 
the impact of nebuliser, flow rate and particle size on thresholds in dysphagic patients would 
aid our understanding of the true impact in this specific use of CRT. Should the passive 
respiration approach continue to be used in CRT in the dysphagic population, further 
investigation on the effect on individual’s respiration rate, sitting position and time of day 
should also be considered on both CRT threshold and cough strength judgement. Studies on 
the repeatability of CRT in patients with dysphagia are needed. In healthy participants, 
repeatability has been proven and varies only by one threshold across time but it is unknown 
what threshold change indicates a clinically relevant change in function (Bickerman et al., 
1957). The study of intra-subject variation in a dysphagic population is required. 
Given the positive validation data presented in this thesis, further investigation of the 
clinical use of CRT is warranted. Integration of CRT results into multidisciplinary clinical 
decision-making and clinical pathways is a worthy research avenue in order to further explore 
the potential of CRT for influencing clinical outcomes. Exploring the use of CRT in different 
dysphagic populations would also be of value. This thesis focused primarily on acute stroke 
but cough sensitivity may differ across dysphagic populations and CRT may prove more 
valuable in some conditions compared with others. If some dysphagic population groups 




such as patients with COPD have heightened cough sensitivity, what threshold of citric acid 
indicates deterioration in swallowing safety? Does a different level of citric acid indicate 
silent aspiration risk in these populations? Hammer and Barlow found diminishing laryngeal 
sensitivity in patients with Parkinson’s disease in line with disease progression (Hammer et 
al., 2010). CRT may have potential as a monitoring technique in community settings to 
assess deterioration of function, or in the case of acute neurological disease, to monitor 
recovery.  
 
14.2 Final Remarks 
A valid, reliable bedside test for ‘silent aspiration’ holds great value for acute 
dysphagia management. This research programme has contributed to our understanding of 
the use of CRT in the identification of silent aspiration. Cough reflex testing with cough 
strength judgement is a valid and reliable tool for identifying silent aspiration in patients 
with dysphagia. CRT results are significantly associated with aspiration response on 
instrumental assessment and lower concentrations of citric acid provide a better predictive 
measure of silent aspiration. CRT methodology described in this thesis is appropriate for the 
neurological patient and sensitivity and specificity values of CRT for identifying silent 
aspiration are sufficient to endorse incorporation into clinical protocols. The addition of a 
measure of reflexive cough strength may add to clinical assessment but specific training is 
required to reach adequate reliability. Inclusion of CRT alone was not shown sufficient to 
change clinical outcomes and integration of CRT into clinical pathways may prove more 
successful. Further research evaluating the addition of CRT to a comprehensive CSE test 
battery would add greatly to the field of dysphagia assesssment.  
Adequate swallowing assessment remains a problem in dysphagia management with 
sub-optimal identification of silent aspiration by CSE, low instrumental assessment rates, 




and at a national level, high pneumonia rates when compared with published international 
data. Further work is required to ensure improved assessment practices such as CRT lead to 
changes in management practices that are sufficient to reduce the secondary complications 
of dysphagia.  
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INFORMATION SHEET 
Research Title:  
Cough reflex testing in swallowing assessment. 
  
Primary / Principal Researcher: 
Anna Miles 




MSc Student, University of Canterbury  
Speech and Language Therapy 
North Shore Hospital, Waitemata District Health Board 
Maggie-Lee Huckabee PhD 
Senior Lecturer, Department of Communication Disorders, University of 
Canterbury 
Senior Researcher, Van der Veer Institute for Parkinson’s and Brain 
Research  
Jacqueline Allen MBChB, FRACS  
Dept of Otolaryngology, North Shore Hospital,  
    Shakespeare Rd, Takapuna, Auckland, 0740 New Zealand 
 




Introduction and aims of the project: 
 You/ your whanau member/ friend has been asked to participate in a research 
project that will evaluate the use of a cough test as part of a swallowing assessment.  You 
have the right not to participate in the study, or subsequently withdraw from this study at 
any time. Any decision not to participate will not affect current, continuing or future health 
care at this or any other health care facility.  
 
In many patients with swallowing problems the ability to cough when food enters 
the lungs will be impaired.  Currently there is no way to reliably identify patients who have 
no cough and therefore no way of protecting their airway if food/drink slips down the 
wrong way (aspiration).  The data from this study will be used to develop a method of 
identifying these ‘at risk’ patients, and hence improving their management.  
 
 The aim of this project is to validate a cough test against accepted measures of 
swallowing and sensation in the throat. The cough test involves placing a facemask over the 
nose and mouth, and then quietly breathing in a mist that contains a substance called citric 
acid. This substance may make you cough. Citric acid has been used for the purpose of 
eliciting cough since the 1950s, with no adverse effects. The assessment of aspiration and 
sensation in the throat will involve the use of the well-established test called ‘flexible 
endoscopy’. This involves looking at your throat with a camera through a small tube placed 
in your nose. This assessment is part of routine clinical care for many patients and may be 
recommended if you participate in the study or not. If your swallowing or cough reflex is 
identified as being impaired as a result of a new stroke you will be reassessed using the 
cough test and flexible endoscopy. Reassessment will take place every four days for up to 3 
weeks from your first assessment.  Further reassessment will be discontinued before 3 
weeks if safe swallowing and a normal cough reflex is identified on re-assessment during 
this period. Your ward speech language therapist will be provided with the results of all 
your assessments and will then use this information to plan your treatment.  
 
Participant selection: 
 You/ your Whanau member/ friend has been identified as a potential participant for 
this study since being referred to a speech-language therapist with suspected or confirmed 




swallowing difficulties. Upon your consent, you will be selected for this study. The study 
will include a total of 100 participants. We acknowledge that you may wish to discuss this 
project with your Whanau before consenting. 
 
The research procedure: 
 If you agree to participate in the study, the following will occur:  
1. Once you/ your Whanau member/ friend has signed the consent form to participate 
in the study, you will be seen by the researchers for a number of assessments. 
2. Cough Reflex Testing- 
i) This test takes a maximum of 10 minutes to complete. 
ii) You will be given a facemask, which is attached to a device that turns water into 
a mist, called a nebuliser.  
iii) A small quantity of citric acid (of various doses) will be mixed into water. You 
will be asked to quietly breathe in through the mask for a period of 15 seconds 
iv) The mist you inhale may make you feel like coughing. You will be asked to 
cough if you feel the need to cough, but not to if you don’t. 
v) At each dose, the test will be repeated two more times to evaluate how 
consistently you cough when you breathe in the mist.  
iv) This will be repeated for 3 different doses of citric acid (0.8M, 0.6M, 0.4M) to 
determine what concentration of citric acid makes you cough.  
3. Flexible Endoscopic Study of Swallowing- 
This test takes a maximum of 20 minutes to complete. 
a. One of the researchers, trained in this procedure, will place a flexible endoscope 
through your nose. This allows the clinicians to view the inside of your throat 
and voice box. The scope sits above the voice box during the test. 
b. You will be asked to drink and eat small quantities of food and liquid. Your 
researcher will support you through the assessments in accordance with the 
hospital’s Tikanga Best Practice Policy and the option of a Karakia prior to 
assessment will be offered 




   
4. If you have had a stroke and food/ fluid goes into your airway or your cough reflex 
is weak on your first assessment, you will be asked to repeat the assessments every 
4 days to watch for improvement. This will continue for 3 weeks or until your 
swallow and cough have improved.  
 
5. If you consent to the study, your ward speech-language therapist will be provided 
with the results of the assessments to help in the management of your swallowing 
difficulties.    
 
Risks and Benefits: 
 It is possible that your overall outcomes may be improved because your ward 
therapist will be provided with more information about your cough, swallowing and 
sensation in your throat. There are no documented adverse side effects of the cough test. 
Nevertheless, it will be performed by trained research clinicians who will monitor you for 
any difficulty during the test. The other test, (Flexible Endoscopic Study of Swallowing) is 
considered a safe, well-recognised assessment tool. When carried out by experienced 
clinicians side effects are rare but may include nosebleed, and fainting. Some patients 
experience discomfort as the scope is inserted. 
 
Participation: 
 If you do agree to take part in this study, you are free to withdraw at any time, 
without having to give a reason. This will in no way affect any future care or treatment.  




Your participation in the study will be stopped should any harmful effects appear or if you 
feel it is not in your best interest to continue. 
 
Confidentiality: 
 Research findings will be presented at international research meetings and 
submitted for publication in peer-reviewed journals. Additionally, research findings will be 
made available to the local medical community through research presentations and regional 
forums. However, no material that could personally identify you will be used in any reports 
on this study. Consent forms will be kept in a locked filing cabinet in the speech and 
language therapy departments at the hospital or will be stored on password-protected 
computers. Research data will be stored for a period of ten years after data collection is 
complete, at which time they will be destroyed. With your permission, data from this study 
may be used in future related studies, which have been given ethical approval from the 
Northern Y Ethic Committee. 
 
Results: 
 If requested, you will be offered copies of the publications that arise from this 
research. However, you should be aware that a significant delay may occur between 
completion of data collection and completion of the final report. Alternatively, or in 
addition, you can choose to have the results of the study discussed with you personally by 
the lead investigator.  
 
Questions: 
 You may have a friend or whanau support to help you understand the risks and/or 
benefits of this study and any other explanation you may require. 
 
 Please contact your speech and language therapist if you require any further 
information about the study. Alternately, the primary researchers listed on the front page of 
this information sheet can be contacted during work hours at the numbers provided.  
 
 If you need an interpreter, this can be provided. 




To ensure ongoing cultural safety Nga Kai Tataki - Maori Research Review 
Committee Waitemata DHB encourage those who identify themselves as Maori and who 
are participating in health research or clinical trials to seek cultural support and advice from 
either Mo Wai Te Ora – Maori Health Services or their own Kaumatua or Whaea. For 
assistance please contact the Services Clinical Leader for Mo Wai Te Ora – Maori Health 
on 09 486 1491 ext: 2324 or the Maori Research Advisor on 09 486 1491 ext: 2553 
 
 If you have any queries or concerns about your rights as a participant in this study, 
you may wish to contact a Health and Disability Advocate, telephone: Auckland Central: 
09 525 2700 or  0800 555 050. Free Fax (NZ wide): 0800 2787 7678 (08002SUPPORT). 
Email (NZ wide):  advocacy@hdc.org.nz. 
  




   
Cough Reflex Testing in Swallowing Assessment 
English 
 
I wish to have an interpreter. Yes No 
Maori 
 
E hiahia ana ahau ki tetahi 




Oute mana’o ia iai se fa’amatala upu. Ioe Leai 
Tongan 
 




Ka inangaro au i  tetai tangata uri reo. Ae Kare 
Niuean 
 




I, ____________________________________, have read and I understand the Information 
Sheet about taking part in this study designed to collect information about the usefulness of 
cough reflex testing. I have had the opportunity to discuss this study. I am satisfied with the 
answers I have been given. 
 
I have had this project explained to me by __________________________. 
 
x I understand that taking part in this study is voluntary (my choice) and that should I 
withdraw from the study, this will in no way affect my current, continuing or future 
health care. I understand that I can withdraw from the study at anytime during the 
assessment phase. Once my assessments are completed, my details will be 











  Cough Reflex Testing in Swallowing Assessment 
 
x I understand my assessments will be recorded for the purpose of analysis only. 
Recorded material will be stored in a locked office and on a password-accessed 
computer. 
x I understand that the information obtained from this research may be published. 
However, I understand that my participation in this study is confidential and that no 
material that could identify me will be used in any reports on this study.  
x I understand that the investigation will be stopped if it should appear harmful to me 
and I know who to contact if I have any side effects to the study or have any 
questions about the study. 
x I understand the potential risks of participation in the study as explained to me by 
the researcher. 
x I have had time to consider whether to take part. 
 
I wish to receive a copy of the results.   YES  /  NO 
Address to send results:____________________________________________  
 
I, _________________________________ hereby consent to take part in this study.   
 
Date_________________________________________ 
 Signature _______________________________ 
Signature of researcher___________________ 
Name of researcher___________________ 
Name of primary researchers and contact phone numbers:  
Name: Anna Miles, Mary McFarlane, Dr. Jacqui Allen, Dr. Maggie-Lee Huckabee  
           
  





 Appendix 1 Information Sheet/ Score Sheet 
 
Inter-rater reliability of subjective judgment of cough strength during a cough reflex 
test 
 
Please read the following before completing the questionnaire. 
 
You are invited to participate in the above research project by completing the following 
questionnaire. The aim of the project is to investigate the agreement between speech-
language therapists in subjectively judging the strength of a patient’s cough. We are 
currently completing a research project which evaluates the usefulness of cough reflex 
testing for reducing chest infections in patients with stroke. Participants in this study 
receive concentrations of citric acid in a mist through a face mask to assess cough response. 
The participating therapists are asked to rate the participants’ cough response as a strong, 
weak or no cough. In order for this test to be useful clinically, it is important to ascertain 
the reliabilty of therapist’s judgements of a weak versus a strong cough.  
 
This reliability study is being carried out by Anna Miles under the supervision of Dr 
Maggie-Lee Huckabee, who can be contacted at XXX. They will be pleased to discuss any 
concerns you may have about participation in the project. This project has been reviewed 
and approved by the Department of Communication Disorders and the UC HEC Low Risk 
Approval process.  
 
The questionnaire is anonymous, and you will not be identified as a participant. You may 




withdraw your participation, including withdrawal of any information you have provided, 
until your questionnaire has been added to the others collected. Because it is anonymous, it 
cannot be retrieved after that. 
 
By completing the questionnaire it will be understood that you have consented to 
participate in the project, and that you consent to publication of the results of the project 
with the understanding that anonymity will be preserved 




Inter-rater reliability of subjective judgment of cough strength during a cough reflex 
test 
 
You will be shown a series of 10 video clips of patients completing a cough reflex test. 
Please rate the cough response as a strong, weak or no cough by circling your chosen 
rating. After a break, you will be shown the same 10 video clips in a different order and 
will be asked to rate the cough responses again. 
 
Key 
strong cough = 2 or more strong coughs 
weak cough = 2 or more weak coughs 
no cough = less than 2 coughs produced.  
 




Example strong weak no cough 
    
video clip 1 strong weak no cough 
video clip 2 strong weak no cough 
video clip 3 strong weak no cough 
video clip 4 strong weak no cough 
video clip 5 strong weak no cough 
video clip 6 strong weak no cough 
video clip 7 strong weak no cough 
video clip 8 strong weak no cough 
video clip 9 strong weak no cough 
video clip 10 strong weak no cough 
 






Example strong weak no cough 
    
video clip 1 strong weak no cough 
video clip 2 strong weak no cough 
video clip 3 strong weak no cough 
video clip 4 strong weak no cough 
video clip 5 strong weak no cough 
video clip 6 strong weak no cough 
video clip 7 strong weak no cough 
video clip 8 strong weak no cough 
video clip 9 strong weak no cough 
video clip 10 strong weak no cough 
 
 
Thank you for your participation. 
 
  








Inter-rater reliability of subjective judgment of cough strength during a cough reflex 
test  
 
Please read the following before completing the questionnaire. 
 
You are invited to participate in the above research project by completing the following 
questionnaire. The aim of the project is to investigate the agreement between speech-
language therapists’ subjective judgment of the strength of a patient’s cough. We are 
currently completing an HRC funded research project which evaluates the usefulness of 
cough reflex testing for reducing chest infections in patients with stroke- ‘Identifying Silent 
Aspiration after Stroke using Cough Test Testing’ Ethics Approval Number 
NTY/09/11/113). This research project forms part of my PhD at University of Canterbury 
under the supervision of Dr Maggie-Lee Huckabee. Research investigators include myself, 
Dr. Maggie-Lee Huckabee, Helen McLauchlan (Professional Leader- Counties Manukau 
DHB), Dr Alan Barber (Consultant Neurologist- Auckland City Hospital) and Dr Edward 
Wong (Consultant Neurologist- Middlemore Hospital). All inpatients referred to stroke 
services at Middlemore Hospital, Auckland City Hospital, North Shore Hospital and 
Christchurch Public Hospital and referred for swallowing evaluation in a 12 month period 
are being approached for participation in the study. Those participants who agree to 
participate are randomly assigned to either a 1) standard evaluation group or 2) standard 
evaluation with inclusion of cough testing. For those in the experimental group, citric acid 




in a mist will be inhaled through a face mask to assess cough response. Clinicians are 
encouraged to use these results to contribute to clinical decision making. Outcomes for both 
groups are being measured by chest infection rates at 3 months and other clinical indicators 
of swallowing impairment. If successful in reducing complications associated with stroke, 
this test can be easily implemented without significant cost or resources and consequently 
reduce the impact of stroke on health status and quality of life. The participating therapists 
are specifically asked to rate the participants’ cough response as a pass, weak or fail. In 
order for this test to be useful clinically, it is important to ascertain the reliabilty of 
therapist’s judgements of a weak versus a strong cough.  
 
By completing the questionnaire it will be understood that you have consented to 
participate in the project, and that you consent to publication of the results of the project 
with the understanding that anonymity will be preserved. Participation in the study requires 
that you view 10 video clips of patients undergoing cough reflex testing (approx 10 sec in 
duration each) and provide a subjective judgment on the ‘strength’ of the cough response 
observed.  The total time for completion of the study should not exceed 20 minutes.  
 
The questionnaire is anonymous, and you will not be identified as a participant. You may 
withdraw your participation, including withdrawal of any information you have provided, 
until your questionnaire has been added to the others collected. Because it is anonymous, it 
cannot be retrieved after that. The data will be available only to the listed researchers below 
and will be stored in a locked filing system for 10 years before being destroyed by Dr. 
Huckabee.  
 




This reliability study is being carried out by Anna Miles, who can be contacted  
a.miles@auckland.ac.nz under the supervision of Dr Maggie-Lee Huckabee maggie-
lee.huckabee@canterbury.ac.nz). 
 
They will be pleased to discuss any concerns you may have about participation in the 
project. This project has been reviewed and approved by the Department of 
Communication Disorders and the UC HEC Low Risk Approval process.  
  









1) How many years of clinical experience do you have? 
_____________________________ 
 
2) How many years of dysphagia experience do you have (if 
different)__________________ 
 














5) Do you use a cough reflex test clinically? 
_______________________________________ 
 
6) Are you aware of having a hearing or visual impairment that may hinder your ability to 
hear the video clips? ___________________ 
 
 
Qualitative Data Collection: 
 









Please rate the cough response as present or absent and then strong or weak. 
 
strong cough = 2 or more strong coughs  weak cough = 2 or more weak coughs 





      Present         or      Absent 
2nd Score 
 
           Strong         or           Weak 
example present absent strong weak 
video clip 1 present absent strong weak 
video clip 2 present absent strong weak 
video clip 3 present absent strong weak 
video clip 4 present absent strong weak 
video clip 5 present absent strong weak 
video clip 6 present absent strong weak 
video clip 7 present absent strong weak 
video clip 8 present absent strong weak 
video clip 9 present absent strong weak 
video clip 10 present absent strong weak 
 
Thank you for your participation. 
 
  








Research Title:  
Cough Testing after Stroke 
 
Primary / Principal Researcher: 
Helen McLauchlan 
Professional Leader Speech and Language Therapy  




Department of Speech and Language Therapy 
Auckland Hospital, Auckland District Health Board 
 
Maggie-Lee Huckabee PhD 
Senior Lecturer, Department of Communication Disorders, University of 
Canterbury 
Senior Researcher, Van der Veer Institute for Parkinson’s and Brain Research  
 
Edward Wong MD 
Department of Medicine 
Middlemore Hospital, Counties Manukau District Health Board 
 




Alan Barber MD 
Department of Medicine 
Auckland Hospital, Auckland District Health Board 
 
Introduction and aims of the project: 
 You are invited to participate in a research project that will evaluate the use of a 
cough reflex test for decreasing your risk of chest infection.  You have the right not to 
participate in the study, or subsequently withdraw from this study at any time. Any decision 
not to participate will not affect your current, continuing or future health care at this or any 
other health care facility.  
 
In many patients with neurological problems (e.g., stroke) the ability to cough when 
food enters the lungs will be affected.  Currently there is no way to reliably identify patients 
who have no cough and hence no way to protect the airway if food/drink slips down the 
wrong way.  The data from this study will be used to develop a method of identifying these 
‘at risk’ patient groups, and hence improving their management.  
 
The aim of this project is to evaluate health outcomes in two groups of patients. One 
group will receive routine assessment of swallowing. One group will receive the same 
assessment but with the inclusion of a simple cough reflex test. This cough test involves 
placing a facemask over your nose and mouth, and then passively breathing in a mist that 
contains a substance called citric acid that may make you cough. Citric acid has been used 
for the purpose of eliciting cough since the 1950s, with no adverse effects.  The speech 
language therapist that is evaluating your swallowing will then use this information to plan 
your treatment.  
 
Participant selection: 
 You have been identified as a potential participant for this study since you have 
been admitted to hospital because of a suspected or confirmed stroke and have been 
referred to a speech and language therapist for swallowing evaluation. Upon your consent, 
you will be selected for this study if you are able to breath for yourself (ie…are not on a 
breathing machine). The study will include a total of 300 participants who have been 




admitted with stroke. Half of these participants will be randomly assigned to receive the 
cough test; the other half will receive a standard clinical assessment as is currently 
completed. We acknowledge that you may wish to discuss this project with your Whanau 
before consenting. 
 
The research procedure: 
 If you agree to participate in the study, the following will occur:  
 
1. Once you have signed the consent form to participate in the study, you will be 
assigned a research participant number and an experimental group (cough or no 
cough group).  
 
2. Regardless of which group you are assigned to, your speech and language therapist 
will evaluate your ability to swallow as she would normally do in accordance with 
the hospital’s Tikanga Best Practice Policy.  She may ask you to move the muscles 
of your face, mouth and throat; and then may ask you to eat and drink some 
carefully selected foods and liquids. This evaluation will be completed as part of 
standard hospital care after stroke and is not influenced by your participation in this 
study. As with all swallow assessments, the option of a Karakia prior to assessment 
will be offered. 
 
3. If you are assigned to the group that does not receive cough testing, you do not need 
to do anything else for this study.  
 
4. If you are assigned to the group that receives the cough testing, this assessment will 
then follow the routine examination.  You will be given a facemask, which is 
attached to a device that turns water into a mist, called a nebuliser. A small quantity 
of citric acid, or saline will be mixed into the water. You will be asked to quietly 
breathe in through the mask for a period of 15 seconds.    
 
5. The mist you inhale may make you feel like coughing. You will be asked to cough 
if you feel the need to cough, but not to if you don’t.   





6. If you cough, the facemask will be taken off to allow you to relax.  The test will be 
repeated two more times to evaluate how consistently you cough when you breathe 
in the mist.   
 
7. If you do not cough on 2 of 3 presentations of the mist, the test will be finished.  
 
8. If you do cough on 2 of 3 trials, the test will continue with new instructions. You 
will be asked to try to suppress or stifle the cough as much as possible. 
 
9. This will also be repeated two more times. 
 
10.  Your speech and language therapist will use this information to plan your 
treatment. You will not need to do anything else.   
 
Outcome Measurements: 
Three months time after your evaluation, a researcher will review your medical 
record to evaluate if you had any complications related to your swallowing during your 
hospital stay and in the time after your discharge. This researcher will look specifically at 
any formal tests you have had of your swallowing (x-rays), what foods and liquids you 
were recommended, if you have had any antibiotics for chest infections, or if you were re-
admitted to hospital after your discharge.  
 
Risks and Benefits: 
 There will be no proven benefit to you from participation in this study. For those 
who do not receive the cough testing, your evaluation and management will proceed as if 
you were not involved in the study. For those who receive the cough testing, it is possible 
that your overall outcomes may be improved because the therapist who evaluated you has 
more information about your cough. There are no documented adverse side effects of 
cough challenge. Nevertheless, the cough challenge will be performed by trained research 
clinicians who will monitor you for adverse signs during the test.  
 





 If you do agree to take part in this study, you are free to withdraw at any time, 
without having to give a reason. This will in no way affect any future care or treatment.  
Your participation in the study will be stopped should any harmful effects appear or if you 
feel it is not in your best interest to continue. 
 
Confidentiality: 
 Research findings will be presented at international research meetings and 
submitted for publication in peer-reviewed journals. Additionally, research findings will be 
made available to the local medical community through research presentations and regional 
forums. However, no material that could personally identify you will be used in any reports 
on this study. Consent forms will be kept in a locked filing cabinet in the speech and 
language therapy departments at the hospital or will be stored on password-protected 
computers. Research data will be stored for a period of ten years after data collection is 
complete, at which time they will be destroyed. With your permission, data from this study 
may be used in future related studies, which have been given ethical approval from the 
Northern Y Ethic Committee. 
 
Results: 
 If requested, you will be offered copies of the publications that arise from this 
research. However, you should be aware that a significant delay may occur between 
completion of data collection and completion of the final report. Alternatively, or in 
addition, you can choose to have the results of the study discussed with you personally by 
the lead investigator.  
 
Questions: 
 You may have a friend or whanau support to help you understand the risks and/or 
benefits of this study and any other explanation you may require. Please contact your 
speech and language therapist if you require any further information about the study. 
Alternately, the primary researchers listed on the front page of this information sheet can be 
contacted during work hours at the numbers provided.  





 If you need an interpreter, this can be provided. 
 If you would like ADHB Maori Support please contact- Mata Forbes, Maori Health 
Service, Admin Suite, Auckland City Hospital on (09) 307 4949 ext. 23939 or mobile 021 
348 432. For CMDHB Maori Support please contact- Devi-Ann Hall. For WDHB Maori 
Support please contact Mo Wai Te Ora, Maori Health Services, North Shore Hospital, Te 
Raki Pai Whenua, (09) 486 8324 ext. 2324. For CDHB Maori Support please contact 
Samantha McFedries. 
 
 If you have any queries or concerns about your rights as a participant in this study, 
you may wish to contact a Health and Disability Advocate, telephone: 
 Auckland Central 09 525 2700 or  0800 555 050.  
 Free Fax (NZ wide): 0800 2787 7678 (08002SUPPORT)  
 Email (NZ wide):  advocacy@hdc.org.nz 
  











I wish to have an interpreter. Yes No 
Maori 
 
E hiahia ana ahau ki tetahi 




Oute mana’o ia iai se fa’amatala upu. Ioe Leai 
Tongan 
 




Ka inangaro au i  tetai tangata uri reo. Ae Kare 
Niuean 
 




I, ____________________________________, have read and I understand the Information 
Sheet dated _________________ for volunteers taking part in the study designed to collect 
information about the usefulness of cough reflex testing. I have had the opportunity to 
discuss this study. I am satisfied with the answers I have been given. 
 
I have had this project explained to me by __________________________. 
 
I understand that taking part in this study is voluntary (my choice) and that I may withdraw 
from the study at any time and this will in no way affect my current, continuing or future 




health care or my academic progress if I am a university student. I understand that if I 
choose to withdraw from the study, I may also withdraw all information that I have 
provided.  
  




Cough Reflex Testing 
 
I understand that the information obtained from this research may be published. However, I 
understand that my participation in this study is confidential and that no material that could 
identify me will be used in any reports on this study.  
 
I understand that the investigation will be stopped if it should appear harmful to me and I 
know who to contact if I have any side effects to the study or have any questions about the 
study. 
 
I understand the potential risks of participation in the study as explained to me by the 
researcher. 
 
I understand the compensation provisions for this study.  
 
I have had time to consider whether to take part. 
 
I wish to receive a copy of the results.       
YES  /  NO 
 
I, _________________________________ hereby consent to take part in this study.   
 
Date_________________________________________ 
 Signature _______________________________ 
Signature of researcher___________________ 
Name of researcher___________________ 
Name of primary researcher and contact phone numbers:  
Name: Helen McLauchlan at Middlemore Hospital   Anna Miles at Auckland Hospital 
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